

<!doctype html>
    <html lang="en-US" id="template-archives" class="base">
        <head>
        
        <script defer data-domain="context.center" src="https://plausible.io/js/plausible.js"></script>
        <link rel="alternate" type="application/rss+xml" title="Context Center RSS" href="https://context.center/rss/" />
    	<link rel="alternate" type="application/atom+xml" title="Context Center Feed" href="https://context.center/feed/" />
        <meta charset="utf-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <title>vaccine to prevent poliomyelitis</title>
        <link rel="original" http-equiv href="https://en.wikipedia.org/wiki/Polio_vaccine" />
        
            
                <!-- <link rel="stylesheet" href="https://context.center/assets/css/template-archives.css?v=2111835222" /> -->
                <link rel="stylesheet" href="https://context.center/assets/css/template-archives.css?v=2111835222" id=""></link>

            
        
        
            <link rel="canonical" href="https://en.wikipedia.org/wiki/Polio_vaccine" />
            

            <meta property="og:title"
                content="vaccine to prevent poliomyelitis">

            <meta property="og:description"
                content="Polio vaccines are vaccines used to prevent poliomyelitis (polio).[2] Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened...">


            <meta property="og:url"
                content="https://en.wikipedia.org/wiki/Polio_vaccine" />

            <meta property="og:site_name" content="Context Center" />

            <meta property="og:locale" content="en_US" />

            <meta name="twitter:site" content="@chronotope" />

            <meta name="twitter:description" content="Polio vaccines are vaccines used to prevent poliomyelitis (polio).[2] Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened..." />

            <!-- I prefer the summary_large_image Twitter card for posts. -->
            <meta name="twitter:card" content="summary_large_image" />
            <!-- You, you're the creator. -->
            <meta name="twitter:creator" content="@chronotope" />
            <!-- This property is for the article title, not site title. -->
            <meta name="twitter:title" content="vaccine to prevent poliomyelitis" />

            

            <meta property="og:image" content="https://context.center/assets/images/contexter/httpsenwikipediaorgwikiPolio_vaccine//Users/zuckerscharffa/Dev/context-center/_contexterCache/images/httpsenwikipediaorgwikiPolio_vaccine/Poliodrops.jpg" />
            <meta name="twitter:image" content="https://context.center/assets/images/contexter/httpsenwikipediaorgwikiPolio_vaccine//Users/zuckerscharffa/Dev/context-center/_contexterCache/images/httpsenwikipediaorgwikiPolio_vaccine/Poliodrops.jpg" />

            

            <meta property="og:type" content="website" />

            <script type="application/ld+json">
                {
                    "@context": "http://schema.org",
                    "@type": "WebPage",
                    "url": "https://en.wikipedia.org/wiki/Polio_vaccine",
                    "headline": "vaccine to prevent poliomyelitis",
                    "about": "Polio vaccines are vaccines used to prevent poliomyelitis (polio).[2] Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV).[2] The World Health Organization (WHO) recommends all children be fully vaccinated against polio.[2] The two vaccines have eliminated polio from most of the world,[3][4] and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018.[5][6]",

                    "image": [
                        
                        "https://upload.wikimedia.org/wikipedia/commons/2/20/Poliodrops.jpg"
                        
                        
                        "https://context.center/assets/images/contexter/httpsenwikipediaorgwikiPolio_vaccine//Users/zuckerscharffa/Dev/context-center/_contexterCache/images/httpsenwikipediaorgwikiPolio_vaccine/Poliodrops.jpg"
                        
                    ],
                    "isAccessibleForFree": "True",
                    "isPartOf": {
                        "@type": ["CreativeWork", "Product"],
                        "name": "Fight With Tools",
                        "productID": "fightwithtools.dev"
                    },
                    "license": "http://creativecommons.org/licenses/by-sa/4.0/",
                    "archivedAt": "https://context.center/timegate/https:/en.wikipedia.org/wiki/Polio_vaccine/",
                    "sameAs": "https://en.wikipedia.org/wiki/Polio_vaccine",
                }
            </script>


        
        
        </head>
        <body >
            <div class="wrapper">
                <header>
                    <div class="left">
                        <h1>Archived: vaccine to prevent poliomyelitis</h1>
                        <p>This is a simplified archive of the page at <a href="https://en.wikipedia.org/wiki/Polio_vaccine" target="_blank">https://en.wikipedia.org/wiki/Polio_vaccine</a></p>
                    </div>

                            <div id="share-embed">
                                <span>Use this page embed on your own site:</span>
                                <textarea id="html-embed" name="story" rows="8" cols="40">
                                    <script>window.contexterSetup=window.contexterSetup||function(){window.contexterSetupComplete=!0;class ContexterLink extends HTMLAnchorElement{constructor(){super()}connectedCallback(){this.setAttribute("target","_blank")}}customElements.define("contexter-link",ContexterLink,{extends:"a"}),customElements.define("contexter-inner",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__inner"}}),customElements.define("contexter-thumbnail",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__thumbnail"}}),customElements.define("contexter-byline",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__byline"}}),customElements.define("contexter-keywordset",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__keywordset"}}),customElements.define("contexter-linkset",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__linkset"}}),customElements.define("contexter-meta",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__meta"}}),customElements.define("contexter-summary",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="p-summary entry-summary"}}),customElements.define("contexter-box-head",class extends HTMLElement{constructor(){super()}connectedCallback(){this.className="contexter-box__head"}}),customElements.define("contexter-box-inner",class extends HTMLElement{constructor(){super()}connectedCallback(){}});class ContexterBox extends HTMLElement{constructor(){super(),this.first=!0,this.shadow=this.attachShadow({mode:"open"})}connectedCallback(){if(this.first){this.first=!1;var style=document.createElement("style"),lightDomStyle=(style.innerHTML=`:host {--background: #f5f6f7;--border: darkblue;--blue: #0000ee;--font-color: black;--inner-border: black;font-family: Franklin,Arial,Helvetica,sans-serif;font-size: 14px;background: var(--background);width: 600px;color: var(--font-color);min-height: 90px;display: block;padding: 8px;border: 1px solid var(--border);cursor: pointer;box-sizing: border-box;margin: 6px;contain: content;margin: 6px auto;}// can only select top-level nodes with slotted::slotted(*) {max-width: 100%;display:block;}::slotted([slot=thumbnail]) {max-width: 100%;display:block;}::slotted([slot=header]) {width: 100%;font-size: 1.25rem;font-weight: bold;display:block;margin-bottom: 6px;}::slotted([slot=author]) {max-width: 50%;font-size: 12px;display:inline-block;float: left;}::slotted([slot=time]) {max-width: 50%;font-size: 12px;display:inline-block;float: right;}::slotted([slot=summary]) {width: 100%;margin-top: 6px;padding: 10px 2px;border-top: 1px solid var(--inner-border);font-size: 15px;display:inline-block;margin-bottom: 6px;}contexter-meta {height: auto;margin-bottom: 4px;width: 100%;display: grid;position: relative;min-height: 16px;grid-template-columns: repeat(2, 1fr);}::slotted([slot=keywords]) {width: 80%;padding: 2px 4px;border-top: 1px solid var(--inner-border);font-size: 11px;display: block;float: right;font-style: italic;text-align: right;grid-column: 2/2;grid-row: 1;align-self: end;justify-self: end;}::slotted([slot=keywords]):empty {border-top: 0px solid var(--inner-border);}::slotted([slot=archive-link]) {font-size: 1em;display: inline;}::slotted([slot=archive-link])::after {content: "|";display: inline;color: var(--font-color);text-decoration: none;margin: 0 .5em;}::slotted([slot=read-link]) {font-size: 1em;display: inline;}contexter-linkset {width: 80%;padding: 2px 4px;font-size: 13px;float: left;font-weight: bold;grid-row: 1;grid-column: 1/2;align-self: end;justify-self: start;}/* Extra small devices (phones, 600px and down) */@media only screen and (max-width: 600px) {:host {width: 310px;}}/* Small devices (portrait tablets and large phones, 600px and up) */@media only screen and (min-width: 600px) {...}/* Medium devices (landscape tablets, 768px and up) */@media only screen and (min-width: 768px) {...}/* Large devices (laptops/desktops, 992px and up) */@media only screen and (min-width: 992px) {...}/* Extra large devices (large laptops and desktops, 1200px and up) */@media only screen and (min-width: 1200px) {...}@media (prefers-color-scheme: dark){:host {--background: #354150;--border: #1f2b37;--blue: #55b0ff;--font-color: #ffffff;--inner-border: #787a7c;background: var(--background);border: 1px solid var(--border)}}`,document.createElement("style"));lightDomStyle.innerHTML=`contexter-box {contain: content;}contexter-box .read-link {font-weight: bold;}contexter-box a {color: #0000ee;}contexter-box img {width: 100%;border: 0;padding: 0;margin: 0;}/* Extra small devices (phones, 600px and down) */@media only screen and (max-width: 600px) {...}/* Small devices (portrait tablets and large phones, 600px and up) */@media only screen and (min-width: 600px) {...}/* Medium devices (landscape tablets, 768px and up) */@media only screen and (min-width: 768px) {...}/* Large devices (laptops/desktops, 992px and up) */@media only screen and (min-width: 992px) {...}/* Extra large devices (large laptops and desktops, 1200px and up) */@media only screen and (min-width: 1200px) {...}@media (prefers-color-scheme: dark){contexter-box a {color: #55b0ff;}}`,this.appendChild(lightDomStyle),this.shadow.appendChild(style);const innerContainer=document.createElement("contexter-box-inner"),innerSlotThumbnail=(this.shadow.appendChild(innerContainer),document.createElement("slot")),innerSlotHeader=(innerSlotThumbnail.name="thumbnail",innerContainer.appendChild(innerSlotThumbnail),document.createElement("slot")),innerSlotAuthor=(innerSlotHeader.name="header",innerContainer.appendChild(innerSlotHeader),document.createElement("slot")),innerSlotTime=(innerSlotAuthor.name="author",innerContainer.appendChild(innerSlotAuthor),document.createElement("slot")),innerSlotSummary=(innerSlotTime.name="time",innerContainer.appendChild(innerSlotTime),document.createElement("slot")),metaContainer=(innerSlotSummary.name="summary",innerContainer.appendChild(innerSlotSummary),document.createElement("contexter-meta")),innerSlotInfo=(innerContainer.appendChild(metaContainer),document.createElement("slot")),linkContainer=(innerSlotInfo.name="keywords",metaContainer.appendChild(innerSlotInfo),document.createElement("contexter-linkset")),innerSlotArchiveLink=(metaContainer.appendChild(linkContainer),document.createElement("slot")),innerSlotReadLink=(innerSlotArchiveLink.name="archive-link",linkContainer.appendChild(innerSlotArchiveLink),document.createElement("slot"));innerSlotReadLink.name="read-link",linkContainer.appendChild(innerSlotReadLink),this.className="contexter-box",this.onclick=e=>{if(!e.target.className.includes("read-link")&&!e.target.className.includes("title-link")){const mainLinks=this.querySelectorAll("a.main-link");mainLinks[0].click()}}}}}customElements.define("contexter-box",ContexterBox)},window.contexterSetupComplete||window.contexterSetup();</script><contexter-box class="link-card h-entry hentry" itemscope="" itemtype="https://schema.org/CreativeWork"><contexter-thumbnail class="thumbnail" slot="thumbnail"><img src="https://upload.wikimedia.org/wikipedia/commons/2/20/Poliodrops.jpg" alt="" itemprop="image" /></contexter-thumbnail><contexter-box-head slot="header" class="p-name entry-title" itemprop="headline"><contexter-box-head slot="header" class="p-name entry-title" itemprop="headline"><a is="contexter-link" href="https://en.wikipedia.org/wiki/Polio_vaccine" itemprop="url">vaccine to prevent poliomyelitis</a></contexter-box-head></contexter-box-head><contexter-byline class="p-author author" slot="author"><span class="p-name byline" rel="author" itemprop="author">Contributors to Wikimedia projects</span></contexter-byline><time class="dt-published published" slot="time" itemprop="datePublished" datetime="2003-03-05T19:38:01.000Z">2/5/2003</time><contexter-summary class="p-summary entry-summary" itemprop="abstract" slot="summary"><p>Polio vaccines are vaccines used to prevent poliomyelitis (polio).[2] Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV).[2] The World Health Organization (WHO) recommends all children be fully vaccinated against polio.[2] The two vaccines have eliminated polio from most of the world,[3][4] and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018.[5][6]</p></contexter-summary><contexter-keywordset itemprop="keywords" slot="keywords"></contexter-keywordset><a href="https://web.archive.org/web/20220406201344/https://en.wikipedia.org/wiki/Polio_vaccine" is="contexter-link" target="_blank" rel="timemap" class="read-link archive-link" itemprop="archivedAt" slot="archive-link">Archived</a><a is="contexter-link" href="https://en.wikipedia.org/wiki/Polio_vaccine" class="read-link main-link" itemprop="sameAs" slot="read-link">Read</a></contexter-box>
                                </textarea><br />
                                <button onclick="(function(e){ navigator.clipboard.writeText(document.getElementById('html-embed').value); })()">Copy</button>
                            </div>
                            
                            <script>window.contexterSetup=window.contexterSetup||function(){window.contexterSetupComplete=!0;class ContexterLink extends HTMLAnchorElement{constructor(){super()}connectedCallback(){this.setAttribute("target","_blank")}}customElements.define("contexter-link",ContexterLink,{extends:"a"}),customElements.define("contexter-inner",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__inner"}}),customElements.define("contexter-thumbnail",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__thumbnail"}}),customElements.define("contexter-byline",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__byline"}}),customElements.define("contexter-keywordset",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__keywordset"}}),customElements.define("contexter-linkset",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__linkset"}}),customElements.define("contexter-meta",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__meta"}}),customElements.define("contexter-summary",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="p-summary entry-summary"}}),customElements.define("contexter-box-head",class extends HTMLElement{constructor(){super()}connectedCallback(){this.className="contexter-box__head"}}),customElements.define("contexter-box-inner",class extends HTMLElement{constructor(){super()}connectedCallback(){}});class ContexterBox extends HTMLElement{constructor(){super(),this.first=!0,this.shadow=this.attachShadow({mode:"open"})}connectedCallback(){if(this.first){this.first=!1;var style=document.createElement("style"),lightDomStyle=(style.innerHTML=`:host {--background: #f5f6f7;--border: darkblue;--blue: #0000ee;--font-color: black;--inner-border: black;font-family: Franklin,Arial,Helvetica,sans-serif;font-size: 14px;background: var(--background);width: 600px;color: var(--font-color);min-height: 90px;display: block;padding: 8px;border: 1px solid var(--border);cursor: pointer;box-sizing: border-box;margin: 6px;contain: content;margin: 6px auto;}// can only select top-level nodes with slotted::slotted(*) {max-width: 100%;display:block;}::slotted([slot=thumbnail]) {max-width: 100%;display:block;}::slotted([slot=header]) {width: 100%;font-size: 1.25rem;font-weight: bold;display:block;margin-bottom: 6px;}::slotted([slot=author]) {max-width: 50%;font-size: 12px;display:inline-block;float: left;}::slotted([slot=time]) {max-width: 50%;font-size: 12px;display:inline-block;float: right;}::slotted([slot=summary]) {width: 100%;margin-top: 6px;padding: 10px 2px;border-top: 1px solid var(--inner-border);font-size: 15px;display:inline-block;margin-bottom: 6px;}contexter-meta {height: auto;margin-bottom: 4px;width: 100%;display: grid;position: relative;min-height: 16px;grid-template-columns: repeat(2, 1fr);}::slotted([slot=keywords]) {width: 80%;padding: 2px 4px;border-top: 1px solid var(--inner-border);font-size: 11px;display: block;float: right;font-style: italic;text-align: right;grid-column: 2/2;grid-row: 1;align-self: end;justify-self: end;}::slotted([slot=keywords]):empty {border-top: 0px solid var(--inner-border);}::slotted([slot=archive-link]) {font-size: 1em;display: inline;}::slotted([slot=archive-link])::after {content: "|";display: inline;color: var(--font-color);text-decoration: none;margin: 0 .5em;}::slotted([slot=read-link]) {font-size: 1em;display: inline;}contexter-linkset {width: 80%;padding: 2px 4px;font-size: 13px;float: left;font-weight: bold;grid-row: 1;grid-column: 1/2;align-self: end;justify-self: start;}/* Extra small devices (phones, 600px and down) */@media only screen and (max-width: 600px) {:host {width: 310px;}}/* Small devices (portrait tablets and large phones, 600px and up) */@media only screen and (min-width: 600px) {...}/* Medium devices (landscape tablets, 768px and up) */@media only screen and (min-width: 768px) {...}/* Large devices (laptops/desktops, 992px and up) */@media only screen and (min-width: 992px) {...}/* Extra large devices (large laptops and desktops, 1200px and up) */@media only screen and (min-width: 1200px) {...}@media (prefers-color-scheme: dark){:host {--background: #354150;--border: #1f2b37;--blue: #55b0ff;--font-color: #ffffff;--inner-border: #787a7c;background: var(--background);border: 1px solid var(--border)}}`,document.createElement("style"));lightDomStyle.innerHTML=`contexter-box {contain: content;}contexter-box .read-link {font-weight: bold;}contexter-box a {color: #0000ee;}contexter-box img {width: 100%;border: 0;padding: 0;margin: 0;}/* Extra small devices (phones, 600px and down) */@media only screen and (max-width: 600px) {...}/* Small devices (portrait tablets and large phones, 600px and up) */@media only screen and (min-width: 600px) {...}/* Medium devices (landscape tablets, 768px and up) */@media only screen and (min-width: 768px) {...}/* Large devices (laptops/desktops, 992px and up) */@media only screen and (min-width: 992px) {...}/* Extra large devices (large laptops and desktops, 1200px and up) */@media only screen and (min-width: 1200px) {...}@media (prefers-color-scheme: dark){contexter-box a {color: #55b0ff;}}`,this.appendChild(lightDomStyle),this.shadow.appendChild(style);const innerContainer=document.createElement("contexter-box-inner"),innerSlotThumbnail=(this.shadow.appendChild(innerContainer),document.createElement("slot")),innerSlotHeader=(innerSlotThumbnail.name="thumbnail",innerContainer.appendChild(innerSlotThumbnail),document.createElement("slot")),innerSlotAuthor=(innerSlotHeader.name="header",innerContainer.appendChild(innerSlotHeader),document.createElement("slot")),innerSlotTime=(innerSlotAuthor.name="author",innerContainer.appendChild(innerSlotAuthor),document.createElement("slot")),innerSlotSummary=(innerSlotTime.name="time",innerContainer.appendChild(innerSlotTime),document.createElement("slot")),metaContainer=(innerSlotSummary.name="summary",innerContainer.appendChild(innerSlotSummary),document.createElement("contexter-meta")),innerSlotInfo=(innerContainer.appendChild(metaContainer),document.createElement("slot")),linkContainer=(innerSlotInfo.name="keywords",metaContainer.appendChild(innerSlotInfo),document.createElement("contexter-linkset")),innerSlotArchiveLink=(metaContainer.appendChild(linkContainer),document.createElement("slot")),innerSlotReadLink=(innerSlotArchiveLink.name="archive-link",linkContainer.appendChild(innerSlotArchiveLink),document.createElement("slot"));innerSlotReadLink.name="read-link",linkContainer.appendChild(innerSlotReadLink),this.className="contexter-box",this.onclick=e=>{if(!e.target.className.includes("read-link")&&!e.target.className.includes("title-link")){const mainLinks=this.querySelectorAll("a.main-link");mainLinks[0].click()}}}}}customElements.define("contexter-box",ContexterBox)},window.contexterSetupComplete||window.contexterSetup();</script><contexter-box class="link-card h-entry hentry" itemscope="" itemtype="https://schema.org/CreativeWork"><contexter-thumbnail class="thumbnail" slot="thumbnail"><img src="https://upload.wikimedia.org/wikipedia/commons/2/20/Poliodrops.jpg" alt="" itemprop="image" /></contexter-thumbnail><contexter-box-head slot="header" class="p-name entry-title" itemprop="headline"><contexter-box-head slot="header" class="p-name entry-title" itemprop="headline"><a is="contexter-link" href="https://en.wikipedia.org/wiki/Polio_vaccine" itemprop="url">vaccine to prevent poliomyelitis</a></contexter-box-head></contexter-box-head><contexter-byline class="p-author author" slot="author"><span class="p-name byline" rel="author" itemprop="author">Contributors to Wikimedia projects</span></contexter-byline><time class="dt-published published" slot="time" itemprop="datePublished" datetime="2003-03-05T19:38:01.000Z">2/5/2003</time><contexter-summary class="p-summary entry-summary" itemprop="abstract" slot="summary"><p>Polio vaccines are vaccines used to prevent poliomyelitis (polio).[2] Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV).[2] The World Health Organization (WHO) recommends all children be fully vaccinated against polio.[2] The two vaccines have eliminated polio from most of the world,[3][4] and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018.[5][6]</p></contexter-summary><contexter-keywordset itemprop="keywords" slot="keywords"></contexter-keywordset><a href="https://web.archive.org/web/20220406201344/https://en.wikipedia.org/wiki/Polio_vaccine" is="contexter-link" target="_blank" rel="timemap" class="read-link archive-link" itemprop="archivedAt" slot="archive-link">Archived</a><a is="contexter-link" href="https://en.wikipedia.org/wiki/Polio_vaccine" class="read-link main-link" itemprop="sameAs" slot="read-link">Read</a></contexter-box>
                            


                </header>
                <main>
                
                    <div id="readability-page-1" class="page"><div id="mw-content-text" lang="en" dir="ltr">

<table><caption><span title="International nonproprietary name (INN): Polio vaccine">Polio vaccine</span></caption><tbody><tr><td colspan="2"><a href="/wiki/File:Poliodrops.jpg"><img alt="Poliodrops.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/20/Poliodrops.jpg/220px-Poliodrops.jpg" decoding="async" width="220" height="240" srcset="//upload.wikimedia.org/wikipedia/commons/2/20/Poliodrops.jpg 1.5x" data-file-width="264" data-file-height="288"></a></td></tr><tr><th colspan="2"><a href="/wiki/Vaccine" title="Vaccine">Vaccine description</a></th></tr><tr><th scope="row">Target</th><td><a href="/wiki/Poliomyelitis" title="Poliomyelitis">Poliomyelitis</a></td></tr><tr><th scope="row"><a href="/wiki/Vaccine#Types" title="Vaccine">Vaccine type</a></th><td>IPV: inactivated<br>OPV: attenuated</td></tr><tr><th colspan="2">Clinical data</th></tr><tr><th scope="row"><a href="/wiki/Drug_nomenclature#Trade_names" title="Drug nomenclature">Trade names</a></th><td>Ipol, Poliovax, others</td></tr><tr><th scope="row"><a href="/wiki/American_Society_of_Health-System_Pharmacists" title="American Society of Health-System Pharmacists">AHFS</a>/<a href="/wiki/Drugs.com" title="Drugs.com">Drugs.com</a></th><td><span title="www.drugs.com"><a rel="nofollow" href="https://www.drugs.com/monograph/poliovirus-vaccine-inactivated.html">Monograph</a></span></td></tr><tr><th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th><td><span title="medlineplus.gov"><a rel="nofollow" href="https://medlineplus.gov/druginfo/meds/a601177.html">a601177</a></span></td></tr><tr><th scope="row"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">License data</a></th><td><div>
<ul><li><small><abbr title="United States">US</abbr></small>&nbsp;<a href="/wiki/DailyMed" title="DailyMed">DailyMed</a>:&nbsp;<span title="dailymed.nlm.nih.gov"><a rel="nofollow" href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=Ipol">Ipol</a></span></li></ul></div>
</td></tr><tr><th scope="row"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy<br>category</a></th><td><div>
<ul><li><small><abbr title="Australia">AU</abbr>:</small> B2<sup id="cite_ref-Drugs.com_pregnancy_1-0"><a href="#cite_note-Drugs.com_pregnancy-1">[1]</a></sup></li>
<li></li></ul>
</div></td></tr><tr><th scope="row"><a href="/wiki/Route_of_administration" title="Route of administration">Routes of<br>administration</a></th><td>IPV: <a href="/wiki/Parenteral" title="Parenteral">parenteral</a><br>OPV: <a href="/wiki/Oral_administration" title="Oral administration">oral</a></td></tr><tr><th scope="row"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></th><td><div><ul><li><a href="/wiki/ATC_code_J07" title="ATC code J07">J07BF01</a> (<span title="www.whocc.no"><a rel="nofollow" href="https://www.whocc.no/atc_ddd_index/?code=J07BF01">WHO</a></span>) <a href="/wiki/ATC_code_J07" title="ATC code J07">J07BF02</a> (<span title="www.whocc.no"><a rel="nofollow" href="https://www.whocc.no/atc_ddd_index/?code=J07BF02">WHO</a></span>) <a href="/wiki/ATC_code_J07" title="ATC code J07">J07BF03</a> (<span title="www.whocc.no"><a rel="nofollow" href="https://www.whocc.no/atc_ddd_index/?code=J07BF03">WHO</a></span>) <a href="/wiki/ATC_code_J07" title="ATC code J07">J07BF04</a> (<span title="www.whocc.no"><a rel="nofollow" href="https://www.whocc.no/atc_ddd_index/?code=J07BF04">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2">Legal status</th></tr><tr><th scope="row"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></th><td><div>
<ul><li><small><abbr title="United States">US</abbr>:</small> <a href="/wiki/Prescription_drug" title="Prescription drug">℞-only</a> </li></ul></div>
</td></tr><tr><th colspan="2">Identifiers</th></tr><tr><th scope="row"><a href="/wiki/CAS_Registry_Number" title="CAS Registry Number">CAS Number</a></th><td><div><ul><li><span title="commonchemistry.cas.org"><a rel="nofollow" href="https://commonchemistry.cas.org/detail?cas_rn=1008119-78-5">1008119-78-5</a></span></li></ul></div></td></tr><tr><th scope="row"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></th><td><div><ul><li><span title="www.drugbank.ca"><a rel="nofollow" href="https://www.drugbank.ca/drugs/DB10796">DB10796</a></span><sup>&nbsp;<img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600"></sup></li><li><span title="www.drugbank.ca"><a rel="nofollow" href="https://www.drugbank.ca/drugs/DB10797">DB10797</a></span></li></ul></div></td></tr><tr><th scope="row"><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></th><td><div><ul><li>None</li></ul></div></td></tr><tr><td colspan="2"><span>&nbsp;<sup><img alt="☒" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png" decoding="async" width="7" height="8" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x" data-file-width="525" data-file-height="600"><img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600"></sup>&nbsp;<a href="/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation" title="Wikipedia:WikiProject Chemicals/Chembox validation">(what is this?)</a></span><span>&nbsp;&nbsp;<span><a href="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&amp;rev1=450061491&amp;page2=Polio+vaccine">(verify)</a></span></span></td></tr></tbody></table>
<p><b>Polio vaccines</b> are <a href="/wiki/Vaccine" title="Vaccine">vaccines</a> used to prevent <a href="/wiki/Poliomyelitis" title="Poliomyelitis">poliomyelitis</a> (polio).<sup id="cite_ref-WHO2016_2-0"><a href="#cite_note-WHO2016-2">[2]</a></sup> Two types are used: an <a href="/wiki/Inactivated_vaccine" title="Inactivated vaccine">inactivated</a> poliovirus given by injection (IPV) and a <a href="/wiki/Attenuated_vaccine" title="Attenuated vaccine">weakened</a> poliovirus given by mouth (OPV).<sup id="cite_ref-WHO2016_2-1"><a href="#cite_note-WHO2016-2">[2]</a></sup> The <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO) recommends all children be fully vaccinated against polio.<sup id="cite_ref-WHO2016_2-2"><a href="#cite_note-WHO2016-2">[2]</a></sup> The two vaccines have eliminated polio from most of the world,<sup id="cite_ref-Aylward_2006_3-0"><a href="#cite_note-Aylward_2006-3">[3]</a></sup><sup id="cite_ref-4"><a href="#cite_note-4">[4]</a></sup> and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018.<sup id="cite_ref-gwp2013_5-0"><a href="#cite_note-gwp2013-5">[5]</a></sup><sup id="cite_ref-6"><a href="#cite_note-6">[6]</a></sup>
</p><p>The inactivated polio vaccines are very safe.<sup id="cite_ref-WHO2016_2-3"><a href="#cite_note-WHO2016-2">[2]</a></sup> Mild redness or pain may occur at the site of injection.<sup id="cite_ref-WHO2016_2-4"><a href="#cite_note-WHO2016-2">[2]</a></sup> Oral polio vaccines cause about three cases of vaccine-associated paralytic poliomyelitis per million doses given.<sup id="cite_ref-WHO2016_2-5"><a href="#cite_note-WHO2016-2">[2]</a></sup> This compares with 5,000 cases per million who are paralysed following a polio infection.<sup id="cite_ref-WHO2017Fs114_7-0"><a href="#cite_note-WHO2017Fs114-7">[7]</a></sup> Both types of vaccine are generally safe to give during <a href="/wiki/Pregnancy" title="Pregnancy">pregnancy</a> and in those who have <a href="/wiki/HIV/AIDS" title="HIV/AIDS">HIV/AIDS</a> but are otherwise well.<sup id="cite_ref-WHO2016_2-6"><a href="#cite_note-WHO2016-2">[2]</a></sup> However, the emergence of circulating vaccine-derived poliovirus (cVDPV), a form of the vaccine virus that has reverted to causing <a href="/wiki/Poliomyelitis" title="Poliomyelitis">poliomyelitis</a>, has led to the development of novel oral polio vaccine type 2 (nOPV2) which aims to make the vaccine safer and thus stop further outbreaks of cVDPV2.<sup id="cite_ref-GPEI-nOPV2_8-0"><a href="#cite_note-GPEI-nOPV2-8">[8]</a></sup>
</p><p>The first successful demonstration of a polio vaccine was by <a href="/wiki/Hilary_Koprowski" title="Hilary Koprowski">Hilary Koprowski</a> in 1950, with a live attenuated virus which people drank.<sup id="cite_ref-Kowproski_obit_9-0"><a href="#cite_note-Kowproski_obit-9">[9]</a></sup> The vaccine was not approved for use in the United States, but was used successfully elsewhere.<sup id="cite_ref-Kowproski_obit_9-1"><a href="#cite_note-Kowproski_obit-9">[9]</a></sup> The success of an inactivated (killed) polio vaccine, developed by <a href="/wiki/Jonas_Salk" title="Jonas Salk">Jonas Salk</a>, was <a href="/wiki/Announcement_of_Polio_vaccine_success" title="Announcement of Polio vaccine success">announced in 1955</a>.<sup id="cite_ref-WHO2016_2-7"><a href="#cite_note-WHO2016-2">[2]</a></sup><sup id="cite_ref-10"><a href="#cite_note-10">[10]</a></sup> Another attenuated live oral polio vaccine was developed by <a href="/wiki/Albert_Sabin" title="Albert Sabin">Albert Sabin</a> and came into commercial use in 1961.<sup id="cite_ref-WHO2016_2-8"><a href="#cite_note-WHO2016-2">[2]</a></sup><sup id="cite_ref-11"><a href="#cite_note-11">[11]</a></sup>
</p><p>Polio vaccine is on the <a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">World Health Organization's List of Essential Medicines</a>.<sup id="cite_ref-WHO21st_12-0"><a href="#cite_note-WHO21st-12">[12]</a></sup>
</p>

<h2><span id="Medical_uses">Medical uses</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=1" title="Edit section: Medical uses">edit</a><span>]</span></span></h2>
<div><p><a href="/wiki/File:Polio_vaccine_poster.jpg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b8/Polio_vaccine_poster.jpg/220px-Polio_vaccine_poster.jpg" decoding="async" width="220" height="267" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b8/Polio_vaccine_poster.jpg/330px-Polio_vaccine_poster.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b8/Polio_vaccine_poster.jpg/440px-Polio_vaccine_poster.jpg 2x" data-file-width="700" data-file-height="849"></a></p><div><p>This 1963 poster featured CDC's national symbol of <a href="/wiki/Public_health" title="Public health">public health</a>, the "<a href="/wiki/Wellbee" title="Wellbee">Wellbee</a>", encouraging the public to receive an oral polio vaccine.</p></div></div>
<p>Interruption of person-to-person transmission of the virus by vaccination is important in global <a href="/wiki/Poliomyelitis_eradication" title="Poliomyelitis eradication">polio eradication</a>,<sup id="cite_ref-Fine_13-0"><a href="#cite_note-Fine-13">[13]</a></sup> since no long-term <a href="/wiki/Asymptomatic_carrier" title="Asymptomatic carrier">carrier</a> state exists for poliovirus in individuals with normal immune function, polio viruses have no nonprimate reservoir in nature,<sup id="cite_ref-14"><a href="#cite_note-14">[14]</a></sup> and survival of the virus in the environment for an extended period of time appears to be remote. There are two types of vaccine: inactivated polio vaccine (IPV) and oral polio vaccine (OPV).
</p>
<h3><span id="Inactivated">Inactivated</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=2" title="Edit section: Inactivated">edit</a><span>]</span></span></h3>
<p>When the IPV (injection) is used, 90% or more of individuals develop protective antibodies to all three <a href="/wiki/Serotype" title="Serotype">serotypes</a> of <a href="/wiki/Poliovirus" title="Poliovirus">polio virus</a> after two doses of inactivated polio vaccine (IPV), and at least 99% are immune to polio virus following three doses. The duration of immunity induced by IPV is not known with certainty, although a complete series is thought to provide protection for many years.<sup id="cite_ref-Robertson_1993_15-0"><a href="#cite_note-Robertson_1993-15">[15]</a></sup> IPV replaced the oral vaccine in many developed countries in the 1990s mainly due to the (small) risk of vaccine-derived polio in the oral vaccine.<sup id="cite_ref-16"><a href="#cite_note-16">[16]</a></sup><sup id="cite_ref-17"><a href="#cite_note-17">[17]</a></sup>
</p>
<h3><span id="Attenuated">Attenuated</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=3" title="Edit section: Attenuated">edit</a><span>]</span></span></h3>
<p>Oral polio vaccines were easier to administer than IPV, as it eliminated the need for sterile syringes and therefore was more suitable for mass vaccination campaigns. OPV also provided longer-lasting <a href="/wiki/Immunity_(medical)" title="Immunity (medical)">immunity</a> than the Salk vaccine, as it provides both <a href="/wiki/Humoral_immunity" title="Humoral immunity">humoral immunity</a> and <a href="/wiki/Cell-mediated_immunity" title="Cell-mediated immunity">cell-mediated immunity</a>.<sup id="cite_ref-ReferenceZ_18-0"><a href="#cite_note-ReferenceZ-18">[18]</a></sup>
</p><p>One dose of OPV produces immunity to all three poliovirus serotypes in roughly 50% of recipients.<sup id="cite_ref-PinkPages_19-0"><a href="#cite_note-PinkPages-19">[19]</a></sup> Three doses of live-attenuated OPV produce protective antibodies to all three poliovirus types in more than 95% of recipients. OPV produces excellent immunity in the <a href="/wiki/Intestine" title="Intestine">intestine</a>, the primary site of wild poliovirus entry, which helps prevent infection with wild virus in areas where the virus is <a href="/wiki/Endemic_(epidemiology)" title="Endemic (epidemiology)">endemic</a>.<sup id="cite_ref-Peds_20-0"><a href="#cite_note-Peds-20">[20]</a></sup> The live virus used in the vaccine can rarely shed in the stool and can rarely spread to others within a community. The live virus also has stringent requirements for transport and storage, which are a problem in some hot or remote areas. As with other live-virus vaccines, immunity initiated by OPV is probably lifelong.<sup id="cite_ref-Robertson_1993_15-1"><a href="#cite_note-Robertson_1993-15">[15]</a></sup>
</p><p>The trivalent (against <a href="/wiki/Wild_type" title="Wild type">wild types</a> 1, 2, and 3) OPV has been used to nearly eradicate polio infection worldwide.<sup id="cite_ref-ReferenceA_21-0"><a href="#cite_note-ReferenceA-21">[21]</a></sup> Led by the Global Polio Eradication Initiative, 155 countries switched to use the bivalent (against wild types 1 and 3) between 17 April and 1 May 2016.<sup id="cite_ref-22"><a href="#cite_note-22">[22]</a></sup> The bivalent OPV is more effective against types 1 and 3, but does not cover type 2.<sup id="cite_ref-pmid28838179_23-0"><a href="#cite_note-pmid28838179-23">[23]</a></sup> The United States as of 2017 continues to recommend the use of a trivalent version, but a fully inactivated version.<sup id="cite_ref-ReferenceA_21-1"><a href="#cite_note-ReferenceA-21">[21]</a></sup> The switch to the bivalent vaccine and associated missing immunity against type 2 strains, among other factors, led to outbreaks of circulating vaccine-derived poliovirus type 2(cVDPV2), which increased from 2 cases in 2016 to 1037 cases in 2020.<sup id="cite_ref-24"><a href="#cite_note-24">[24]</a></sup> As a response, a novel oral polio vaccine type 2 (nOPV2) was developed with the aim to provide a safer form of vaccination against type 2 strains with less risk of reverting to infectious polio.<sup id="cite_ref-GPEI-nOPV2_8-1"><a href="#cite_note-GPEI-nOPV2-8">[8]</a></sup>
</p>
<h3><span id="Schedule">Schedule</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=4" title="Edit section: Schedule">edit</a><span>]</span></span></h3>
<div><p><a href="/wiki/File:Share_of_one-year-olds_vaccinated_against_polio_(Pol3),_OWID.svg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Share_of_one-year-olds_vaccinated_against_polio_%28Pol3%29%2C_OWID.svg/420px-Share_of_one-year-olds_vaccinated_against_polio_%28Pol3%29%2C_OWID.svg.png" decoding="async" width="420" height="296" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Share_of_one-year-olds_vaccinated_against_polio_%28Pol3%29%2C_OWID.svg/630px-Share_of_one-year-olds_vaccinated_against_polio_%28Pol3%29%2C_OWID.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Share_of_one-year-olds_vaccinated_against_polio_%28Pol3%29%2C_OWID.svg/840px-Share_of_one-year-olds_vaccinated_against_polio_%28Pol3%29%2C_OWID.svg.png 2x" data-file-width="850" data-file-height="600"></a></p><div><p>Share of one-year-olds vaccinated against polio in 2015<sup id="cite_ref-25"><a href="#cite_note-25">[25]</a></sup></p></div></div>
<p>In countries with endemic polio or where the risk of imported cases is high, the WHO recommends OPV vaccine at birth followed by a primary series of three OPV doses and at least one IPV dose starting at 6 weeks of age, with a minimum of 4 weeks between OPV doses. In countries with &gt;90% immunization coverage and low risk of importation, the WHO recommends one or two IPV doses starting at 2 months of age followed by at least two OPV doses, with the doses separated by 4–8 weeks depending on the risk of exposure. In countries with the highest levels of coverage and the lowest risks of importation and transmission, the WHO recommends a primary series of three IPV injections, with a booster dose after an interval of six months or more if the first dose was administered before 2 months of age.<sup id="cite_ref-WHO2016_2-9"><a href="#cite_note-WHO2016-2">[2]</a></sup>
</p>
<h2><span id="Side_effects">Side effects</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=5" title="Edit section: Side effects">edit</a><span>]</span></span></h2>
<p>The inactivated polio vaccines are very safe. Mild redness or pain may occur at the site of injection. Oral polio vaccine results in vaccine-associated paralytic poliomyelitis in about three per million doses. They are generally safe to give to those who are <a href="/wiki/Pregnancy" title="Pregnancy">pregnant</a>, and those who have <a href="/wiki/HIV/AIDS" title="HIV/AIDS">HIV/AIDS</a>, but who are otherwise well.<sup id="cite_ref-WHO2016_2-10"><a href="#cite_note-WHO2016-2">[2]</a></sup>
</p>
<h3><span id="Allergic_reaction_to_the_vaccine">Allergic reaction to the vaccine</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=6" title="Edit section: Allergic reaction to the vaccine">edit</a><span>]</span></span></h3>
<p>Inactivated polio vaccine can cause an allergic reaction in a few people since the vaccine contains trace amounts of antibiotics, streptomycin, polymyxin B, and neomycin. It should not be given to anyone who has an allergic reaction to these medicines. Signs and symptoms of an allergic reaction, which usually appear within minutes or a few hours after receiving the injected vaccine, include breathing difficulties, weakness, hoarseness or wheezing, heart rate fluctuations, skin rash and dizziness.<sup id="cite_ref-26"><a href="#cite_note-26">[26]</a></sup>
</p>
<h3><span id="Vaccine-induced_polio">Vaccine-induced polio</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=7" title="Edit section: Vaccine-induced polio">edit</a><span>]</span></span></h3>
<div><p><a href="/wiki/File:Number_of_cVDPV_cases_since_2000.png"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4b/Number_of_cVDPV_cases_since_2000.png/290px-Number_of_cVDPV_cases_since_2000.png" decoding="async" width="290" height="185" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4b/Number_of_cVDPV_cases_since_2000.png/435px-Number_of_cVDPV_cases_since_2000.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4b/Number_of_cVDPV_cases_since_2000.png/580px-Number_of_cVDPV_cases_since_2000.png 2x" data-file-width="717" data-file-height="457"></a></p><div><p>cVDPV cases (red line) outnumbered wild polio cases (blue line) for the first time in 2017</p></div></div>
<p>A potential, adverse effect of the OPV is its known ability to recombine to a form that causes neurological infection and paralysis.<sup id="cite_ref-Shimizu_2004_27-0"><a href="#cite_note-Shimizu_2004-27">[27]</a></sup> This genetic reversal of the pathogen to a virulent form takes a considerable time (at least 12 months) and does not affect the person who was originally vaccinated. The vaccine-derived attenuated virus is normally excreted from vaccinated people for a limited period. Thus, in areas with poor sanitation and low vaccination coverage, the spontaneous reversal of the vaccine-derived virus to a virulent form and its spreading in the environment can lead to unvaccinated people becoming infected.<sup id="cite_ref-28"><a href="#cite_note-28">[28]</a></sup> Clinical disease, including paralysis, caused by vaccine-derived poliovirus (VDPV) is indistinguishable from that caused by wild polioviruses.<sup id="cite_ref-Cono_29-0"><a href="#cite_note-Cono-29">[29]</a></sup> Outbreaks of vaccine-associated paralytic poliomyelitis (VAPP), caused by a circulating vaccine-derived poliovirus (cVDPV),<sup id="cite_ref-who-Q&amp;A_30-0"><a href="#cite_note-who-Q&amp;A-30">[30]</a></sup> have been reported, and tend to occur in areas of low coverage by OPV, presumably because the OPV is itself protective against the related outbreak strain.<sup id="cite_ref-Kew_2002_31-0"><a href="#cite_note-Kew_2002-31">[31]</a></sup><sup id="cite_ref-Yang_2003_32-0"><a href="#cite_note-Yang_2003-32">[32]</a></sup> With wild polio cases at record lows, 2017 was the first year where more cases of cVDPV were recorded than the wild poliovirus, a trend that is expected to continue.<sup id="cite_ref-33"><a href="#cite_note-33">[33]</a></sup>
</p><p>To combat this, the WHO in 2016, decided to switch from the trivalent polio vaccine to the bivalent polio vaccine.<sup id="cite_ref-34"><a href="#cite_note-34">[34]</a></sup> This vaccine no longer contains the type 2 polio virus because it was eradicated in 1999.<sup id="cite_ref-35"><a href="#cite_note-35">[35]</a></sup>
</p>
<h3><span id="Contamination_concerns">Contamination concerns</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=8" title="Edit section: Contamination concerns">edit</a><span>]</span></span></h3>
<p>In 1960, the <a href="/wiki/Rhesus_monkey" title="Rhesus monkey">rhesus monkey</a> kidney cells used to prepare the poliovirus vaccines were determined to be infected with the <a href="/wiki/SV40" title="SV40">simian virus-40</a> (SV40),<sup id="cite_ref-SV_36-0"><a href="#cite_note-SV-36">[36]</a></sup> which was also discovered in 1960 and is a naturally occurring <a href="/wiki/Virus" title="Virus">virus</a> that infects monkeys. In 1961, SV40 was found to cause tumors in <a href="/wiki/Rodent" title="Rodent">rodents</a>.<sup id="cite_ref-Eddy_1961_37-0"><a href="#cite_note-Eddy_1961-37">[37]</a></sup> More recently, the virus was found in certain forms of <a href="/wiki/Cancer" title="Cancer">cancer</a> in humans, for instance <a href="/wiki/Brain_tumor" title="Brain tumor">brain</a> and <a href="/wiki/Bone_tumor" title="Bone tumor">bone tumors</a>, <a href="/wiki/Pleural" title="Pleural">pleural</a> and <a href="/wiki/Peritoneal" title="Peritoneal">peritoneal</a> mesothelioma, and some types of <a href="/wiki/Non-Hodgkin_lymphoma" title="Non-Hodgkin lymphoma">non-Hodgkin lymphoma</a>.<sup id="cite_ref-38"><a href="#cite_note-38">[38]</a></sup><sup id="cite_ref-39"><a href="#cite_note-39">[39]</a></sup> However, SV40 has not been determined to cause these cancers.<sup id="cite_ref-Engels_40-0"><a href="#cite_note-Engels-40">[40]</a></sup>
</p><p>SV40 was found to be present in stocks of the injected form of the IPV in use between 1955 and 1963.<sup id="cite_ref-SV_36-1"><a href="#cite_note-SV-36">[36]</a></sup> It is not found in the OPV form.<sup id="cite_ref-SV_36-2"><a href="#cite_note-SV-36">[36]</a></sup> Over 98 million Americans received one or more doses of polio vaccine between 1955 and 1963 when a proportion of vaccine was contaminated with SV40; an estimated 10–30 million Americans may have received a dose of vaccine contaminated with SV40.<sup id="cite_ref-SV_36-3"><a href="#cite_note-SV-36">[36]</a></sup> Later analysis suggested that vaccines produced by the former <a href="/wiki/Soviet_bloc" title="Soviet bloc">Soviet bloc</a> countries until 1980, and used in the <a href="/wiki/USSR" title="USSR">USSR</a>, <a href="/wiki/China" title="China">China</a>, <a href="/wiki/Japan" title="Japan">Japan</a>, and several <a href="/wiki/Africa" title="Africa">African</a> countries, may have been contaminated, meaning hundreds of millions more may have been exposed to SV40.<sup id="cite_ref-41"><a href="#cite_note-41">[41]</a></sup>
</p><p>In 1998, the <a href="/wiki/National_Cancer_Institute" title="National Cancer Institute">National Cancer Institute</a> undertook a large study, using cancer case information from the institute's SEER database. The published findings from the study revealed no increased incidence of cancer in persons who may have received vaccine containing SV40.<sup id="cite_ref-Strickler_1998_42-0"><a href="#cite_note-Strickler_1998-42">[42]</a></sup> Another large study in Sweden examined cancer rates of 700,000 individuals who had received potentially contaminated polio vaccine as late as 1957; the study again revealed no increased cancer incidence between persons who received polio vaccines containing SV40 and those who did not.<sup id="cite_ref-Olin_1998_43-0"><a href="#cite_note-Olin_1998-43">[43]</a></sup> The question of whether SV40 causes cancer in humans remains controversial, however, and the development of improved assays for detection of SV40 in human tissues will be needed to resolve the controversy.<sup id="cite_ref-Engels_40-1"><a href="#cite_note-Engels-40">[40]</a></sup>
</p>
<div><p><a href="/wiki/File:Bundesarchiv_B_145_Bild-F025952-0015,_Bonn,_Gesundheitsamt,_Schutzimpfung.jpg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/Bundesarchiv_B_145_Bild-F025952-0015%2C_Bonn%2C_Gesundheitsamt%2C_Schutzimpfung.jpg/220px-Bundesarchiv_B_145_Bild-F025952-0015%2C_Bonn%2C_Gesundheitsamt%2C_Schutzimpfung.jpg" decoding="async" width="220" height="139" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/Bundesarchiv_B_145_Bild-F025952-0015%2C_Bonn%2C_Gesundheitsamt%2C_Schutzimpfung.jpg/330px-Bundesarchiv_B_145_Bild-F025952-0015%2C_Bonn%2C_Gesundheitsamt%2C_Schutzimpfung.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/59/Bundesarchiv_B_145_Bild-F025952-0015%2C_Bonn%2C_Gesundheitsamt%2C_Schutzimpfung.jpg/440px-Bundesarchiv_B_145_Bild-F025952-0015%2C_Bonn%2C_Gesundheitsamt%2C_Schutzimpfung.jpg 2x" data-file-width="800" data-file-height="506"></a></p></div>
<p>During the race to develop an oral polio vaccine, several large-scale human trials were undertaken. By 1958, the National Institutes of Health had determined that OPV produced using the Sabin strains were the safest.<sup id="cite_ref-Sanofi_44-0"><a href="#cite_note-Sanofi-44">[44]</a></sup> Between 1957 and 1960, however, <a href="/wiki/Hilary_Koprowski" title="Hilary Koprowski">Hilary Koprowski</a> continued to administer his vaccine around the world. In Africa, the vaccines were administered to roughly one million people in the Belgian territories (now the <a href="/wiki/Democratic_Republic_of_the_Congo" title="Democratic Republic of the Congo">Democratic Republic of the Congo</a>, <a href="/wiki/Rwanda" title="Rwanda">Rwanda</a>, and <a href="/wiki/Burundi" title="Burundi">Burundi</a>).<sup id="cite_ref-Plotkin_45-0"><a href="#cite_note-Plotkin-45">[45]</a></sup><sup id="cite_ref-Kowproski5_46-0"><a href="#cite_note-Kowproski5-46">[46]</a></sup> The results of these human trials have been controversial,<sup id="cite_ref-Collins_2000_47-0"><a href="#cite_note-Collins_2000-47">[47]</a></sup> and unfounded <a href="/wiki/OPV_AIDS_hypothesis" title="OPV AIDS hypothesis">accusations in the 1990s</a> arose that the vaccine had created the conditions necessary for transmission of <a href="/wiki/Simian_immunodeficiency_virus" title="Simian immunodeficiency virus">simian immunodeficiency virus</a> from <a href="/wiki/Common_chimpanzee" title="Common chimpanzee">chimpanzees</a> to humans, causing <a href="/wiki/HIV/AIDS" title="HIV/AIDS">HIV/AIDS</a>. These hypotheses, however, <a href="/wiki/OPV_AIDS_hypothesis" title="OPV AIDS hypothesis">have been conclusively refuted</a>.<sup id="cite_ref-Plotkin_45-1"><a href="#cite_note-Plotkin-45">[45]</a></sup> By 2004, cases of poliomyelitis in Africa had been reduced to just a small number of isolated regions in the western portion of the continent, with sporadic cases elsewhere. Recent local opposition to vaccination campaigns have evolved due to lack of adequate information,<sup id="cite_ref-48"><a href="#cite_note-48">[48]</a></sup><sup id="cite_ref-49"><a href="#cite_note-49">[49]</a></sup> often relating to fears that the vaccine might induce <a href="/wiki/Infertility" title="Infertility">sterility</a>.<sup id="cite_ref-50"><a href="#cite_note-50">[50]</a></sup> The disease has since resurged in <a href="/wiki/Nigeria" title="Nigeria">Nigeria</a> and in several other African nations without necessary information, which <a href="/wiki/Epidemiologist" title="Epidemiologist">epidemiologists</a> believe is due to refusals by certain local populations to allow their children to receive the polio vaccine.<sup id="cite_ref-Jegede_51-0"><a href="#cite_note-Jegede-51">[51]</a></sup>
</p>
<h2><span id="Manufacture">Manufacture</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=9" title="Edit section: Manufacture">edit</a><span>]</span></span></h2>
<h3><span id="Inactivated_2">Inactivated</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=10" title="Edit section: Inactivated">edit</a><span>]</span></span></h3>
<p>The Salk vaccine, IPV, is based on three wild, <a href="/wiki/Virulent" title="Virulent">virulent</a> reference strains, Mahoney (type 1 poliovirus), MEF-1 (type 2 poliovirus), and Saukett (type 3 poliovirus), grown in a type of monkey <a href="/wiki/Kidney" title="Kidney">kidney</a> tissue culture (<a href="/wiki/Vero_cell" title="Vero cell">Vero cell</a> line), which are then inactivated with <a href="/wiki/Formalin" title="Formalin">formalin</a>.<sup id="cite_ref-Kew_2005_52-0"><a href="#cite_note-Kew_2005-52">[52]</a></sup> The injected Salk vaccine confers <a href="/wiki/Immunoglobulin_G" title="Immunoglobulin G">IgG</a>-mediated immunity in the bloodstream, which prevents polio infection from progressing to <a href="/wiki/Viremia" title="Viremia">viremia</a> and protects the <a href="/wiki/Motor_neurons" title="Motor neurons">motor neurons</a>, thus eliminating the risk of <a href="/wiki/Bulbar_polio" title="Bulbar polio">bulbar polio</a> and <a href="/wiki/Post-polio_syndrome" title="Post-polio syndrome">post-polio syndrome</a>.
</p><p>In the United States, vaccine is administered along with the <a href="/wiki/Tetanus_vaccine" title="Tetanus vaccine">tetanus</a>, <a href="/wiki/Diphtheria" title="Diphtheria">diphtheria</a>, and <a href="/wiki/Acellular" title="Acellular">acellular</a> <a href="/wiki/Pertussis" title="Pertussis">pertussis</a> vaccines (<a href="/wiki/DTaP" title="DTaP">DTaP</a>) and a pediatric dose of <a href="/wiki/Hepatitis_B" title="Hepatitis B">hepatitis B</a> vaccine.<sup id="cite_ref-PinkPages_19-1"><a href="#cite_note-PinkPages-19">[19]</a></sup> In the UK, IPV is combined with tetanus, diphtheria, pertussis, and <i><a href="/wiki/Haemophilus_influenzae" title="Haemophilus influenzae">Haemophilus influenzae</a></i> type b vaccines.<sup id="cite_ref-UK_53-0"><a href="#cite_note-UK-53">[53]</a></sup>
</p>
<h3><span id="Attenuated_2">Attenuated</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=11" title="Edit section: Attenuated">edit</a><span>]</span></span></h3>
<div><p><a href="/wiki/File:Immunization_Certificate.jpg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/5c/Immunization_Certificate.jpg/220px-Immunization_Certificate.jpg" decoding="async" width="220" height="139" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/5c/Immunization_Certificate.jpg/330px-Immunization_Certificate.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/5c/Immunization_Certificate.jpg/440px-Immunization_Certificate.jpg 2x" data-file-width="1045" data-file-height="659"></a></p><div><p>Sabin immunization certificate</p></div></div>
<div><p><a href="/wiki/File:Poliomyelitis_Vaccine_Type_I_Type_III_in_Dragee_Candy_(Human_Diploid_Cell),_Live_at_PRC70_Exhibition_(20191203153024).jpg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/7e/Poliomyelitis_Vaccine_Type_I_Type_III_in_Dragee_Candy_%28Human_Diploid_Cell%29%2C_Live_at_PRC70_Exhibition_%2820191203153024%29.jpg/220px-Poliomyelitis_Vaccine_Type_I_Type_III_in_Dragee_Candy_%28Human_Diploid_Cell%29%2C_Live_at_PRC70_Exhibition_%2820191203153024%29.jpg" decoding="async" width="220" height="147" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/7e/Poliomyelitis_Vaccine_Type_I_Type_III_in_Dragee_Candy_%28Human_Diploid_Cell%29%2C_Live_at_PRC70_Exhibition_%2820191203153024%29.jpg/330px-Poliomyelitis_Vaccine_Type_I_Type_III_in_Dragee_Candy_%28Human_Diploid_Cell%29%2C_Live_at_PRC70_Exhibition_%2820191203153024%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/7e/Poliomyelitis_Vaccine_Type_I_Type_III_in_Dragee_Candy_%28Human_Diploid_Cell%29%2C_Live_at_PRC70_Exhibition_%2820191203153024%29.jpg/440px-Poliomyelitis_Vaccine_Type_I_Type_III_in_Dragee_Candy_%28Human_Diploid_Cell%29%2C_Live_at_PRC70_Exhibition_%2820191203153024%29.jpg 2x" data-file-width="5184" data-file-height="3456"></a></p><div><p>Example of OPV in <a href="/wiki/Dragee" title="Dragee">dragee</a> candy</p></div></div>
<p>OPV is an <a href="/wiki/Attenuated_vaccine" title="Attenuated vaccine">attenuated vaccine</a>, produced by the passage of the virus through nonhuman cells at a sub<a href="/wiki/Physiological" title="Physiological">physiological</a> temperature, which produces spontaneous mutations in the viral genome.<sup id="cite_ref-Sabin_1960_54-0"><a href="#cite_note-Sabin_1960-54">[54]</a></sup> Oral polio vaccines were developed by several groups, one of which was led by <a href="/wiki/Albert_Sabin" title="Albert Sabin">Albert Sabin</a>. Other groups, led by <a href="/wiki/Hilary_Koprowski" title="Hilary Koprowski">Hilary Koprowski</a> and <a href="/wiki/H._R._Cox" title="H. R. Cox">H.R. Cox</a>, developed their own attenuated vaccine strains. In 1958, the <a href="/wiki/National_Institutes_of_Health" title="National Institutes of Health">National Institutes of Health</a> created a special committee on live polio vaccines. The various vaccines were carefully evaluated for their ability to induce immunity to polio, while retaining a low incidence of neuropathogenicity in monkeys. Large-scale clinical trials performed in the Soviet Union in late 1950s to early 1960s by <a href="/wiki/Mikhail_Chumakov" title="Mikhail Chumakov">Mikhail Chumakov</a> and his colleagues demonstrated safety and high efficacy of the vaccine.<sup id="cite_ref-55"><a href="#cite_note-55">[55]</a></sup><sup id="cite_ref-56"><a href="#cite_note-56">[56]</a></sup> Based on these results, the Sabin strains were chosen for worldwide distribution.<sup id="cite_ref-Sanofi_44-1"><a href="#cite_note-Sanofi-44">[44]</a></sup> Fifty-seven <a href="/wiki/Nucleotide" title="Nucleotide">nucleotide</a> substitutions distinguish the attenuated Sabin 1 strain from its virulent parent (the Mahoney serotype), two nucleotide substitutions attenuate the Sabin 2 strain, and 10 substitutions are involved in attenuating the Sabin 3 strain.<sup id="cite_ref-Kew_2005_52-1"><a href="#cite_note-Kew_2005-52">[52]</a></sup> The primary attenuating factor common to all three Sabin vaccines is a mutation located in the virus's <a href="/wiki/Internal_ribosome_entry_site" title="Internal ribosome entry site">internal ribosome entry site</a>,<sup id="cite_ref-57"><a href="#cite_note-57">[57]</a></sup> which alters <a href="/wiki/Stem-loop" title="Stem-loop">stem-loop</a> structures and reduces the ability of poliovirus to translate its RNA template within the host cell.<sup id="cite_ref-58"><a href="#cite_note-58">[58]</a></sup> The attenuated poliovirus in the Sabin vaccine replicates very efficiently in the gut, the primary site of infection and replication, but is unable to replicate efficiently within <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a> tissue. In 1961, type 1 and 2 <a href="/wiki/Monovalent_vaccine" title="Monovalent vaccine">monovalent</a> oral poliovirus vaccine (MOPV) was licensed, and in 1962, type 3 MOPV was licensed. In 1963, trivalent OPV (TOPV) was licensed, and became the vaccine of choice in the United States and most other countries of the world, largely replacing the inactivated polio vaccine.<sup id="cite_ref-Pearce_59-0"><a href="#cite_note-Pearce-59">[59]</a></sup> A second wave of mass immunizations led to a further dramatic decline in the number of polio cases. Between 1962 and 1965, about 100 million Americans (roughly 56% of the population at that time) received the Sabin vaccine. The result was a substantial reduction in the number of poliomyelitis cases, even from the much-reduced levels following the introduction of the Salk vaccine.<sup id="cite_ref-Smallman_60-0"><a href="#cite_note-Smallman-60">[60]</a></sup>
</p><p>OPV is usually provided in vials containing 10–20 doses of vaccine. A single dose of oral polio vaccine (usually two drops) contains 1,000,000 infectious units of Sabin 1 (effective against PV1), 100,000 infectious units of the Sabin 2 strain, and 600,000 infectious units of Sabin 3. The vaccine contains small traces of <a href="/wiki/Antibiotics" title="Antibiotics">antibiotics</a>—<a href="/wiki/Neomycin" title="Neomycin">neomycin</a> and <a href="/wiki/Streptomycin" title="Streptomycin">streptomycin</a>—but does not contain <a href="/wiki/Preservative" title="Preservative">preservatives</a>.<sup id="cite_ref-PAHO_61-0"><a href="#cite_note-PAHO-61">[61]</a></sup>
</p>
<h2><span id="History">History</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=12" title="Edit section: History">edit</a><span>]</span></span></h2>

<p>In a generic sense, vaccination works by priming the <a href="/wiki/Immune_system" title="Immune system">immune system</a> with an '<a href="/wiki/Immunogen" title="Immunogen">immunogen</a>'. Stimulating immune response, by use of an infectious agent, is known as <a href="/wiki/Immunization" title="Immunization">immunization</a>. The development of immunity to polio efficiently blocks person-to-person transmission of wild poliovirus, thereby protecting both individual vaccine recipients and <a href="/wiki/Herd_immunity" title="Herd immunity">the wider community</a>.<sup id="cite_ref-Fine_13-1"><a href="#cite_note-Fine-13">[13]</a></sup>
</p><p>The development of two polio vaccines led to the first modern mass <a href="/wiki/Inoculation" title="Inoculation">inoculations</a>. The last cases of paralytic poliomyelitis caused by endemic transmission of wild virus in the United States occurred in 1979, with an outbreak among the <a href="/wiki/Amish" title="Amish">Amish</a> in several <a href="/wiki/Midwest" title="Midwest">Midwest</a> states.<sup id="cite_ref-PinkPages_19-2"><a href="#cite_note-PinkPages-19">[19]</a></sup>
</p>
<h3><span id="1930s">1930s</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=13" title="Edit section: 1930s">edit</a><span>]</span></span></h3>
<p>In the 1930s, poliovirus was perceived as especially terrifying, as little was known of how the disease was transmitted or how it could be prevented. This virus was also notable for primarily impacting affluent children, making it a prime target for vaccine development, despite its relatively low mortality and morbidity.<sup id="cite_ref-:0_62-0"><a href="#cite_note-:0-62">[62]</a></sup> Despite this, the community of researchers in the field thus far had largely observed an informal moratorium on any vaccine development as it was perceived to present too high a risk for too little likelihood of success<sup id="cite_ref-:1_63-0"><a href="#cite_note-:1-63">[63]</a></sup><sup id="cite_ref-:2_64-0"><a href="#cite_note-:2-64">[64]</a></sup>
</p><p>This shifted in the early 1930s when American groups took up the challenge: <a href="/wiki/Maurice_Brodie" title="Maurice Brodie">Maurice Brodie</a> led a team from the public health laboratory of the city of New York and Dr. <a href="/w/index.php?title=John_A._Kolmer&amp;action=edit&amp;redlink=1" title="John A. Kolmer (page does not exist)">John A. Kolmer</a> collaborated with the <a href="/wiki/Temple_University_College_of_Public_Health" title="Temple University College of Public Health">Research Institute of Cutaneous Medicine</a> in Philadelphia. The rivalry between these two researchers lent itself to a race-like mentality which, combined with a lack of oversight of medical studies, was reflected in the methodology and outcomes of each of these early vaccine development ventures.<sup id="cite_ref-:3_65-0"><a href="#cite_note-:3-65">[65]</a></sup><sup id="cite_ref-66"><a href="#cite_note-66">[66]</a></sup><sup id="cite_ref-:0_62-1"><a href="#cite_note-:0-62">[62]</a></sup>
</p>
<h4><span id="Kolmer.27s_live_vaccine"></span><span id="Kolmer's_live_vaccine">Kolmer's live vaccine</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=14" title="Edit section: Kolmer's live vaccine">edit</a><span>]</span></span></h4>
<p>Kolmer began his vaccine development project in 1932 and ultimately focused on producing an attenuated or <i>live virus vaccine</i>. Inspired by the success of vaccines for rabies and 
yellow fever, he hoped to use a similar process to denature the polio virus.<sup id="cite_ref-:3_65-1"><a href="#cite_note-:3-65">[65]</a></sup> In order to go about <a href="/wiki/Attenuated_vaccine" title="Attenuated vaccine">attenuating</a> his polio vaccine, he repeatedly passed the virus through monkeys.<sup id="cite_ref-:4_67-0"><a href="#cite_note-:4-67">[67]</a></sup> Using methods of production that were later described as “hair-raisingly amateurish, the therapeutic equivalent of bath-tub gin,"<sup id="cite_ref-68"><a href="#cite_note-68">[68]</a></sup> Kolmer ground the spinal cords of his infected monkeys and soaked them in a salt solution. He then filtered the solution through mesh, treated it with <a href="/wiki/Ricinoleic_acid" title="Ricinoleic acid">ricinolate</a>, and refrigerated the product for 14 days<sup id="cite_ref-:3_65-2"><a href="#cite_note-:3-65">[65]</a></sup> to ultimately create what would later be prominently critiqued as a "veritable witches brew".<sup id="cite_ref-69"><a href="#cite_note-69">[69]</a></sup>
</p><p>In keeping with the norms of the time, Kolmer completed a relatively small animal trial with 42 monkeys before proceeding to <a href="/wiki/Self-experimentation_in_medicine" title="Self-experimentation in medicine">self experimentation</a> in 1934.<sup id="cite_ref-:2_64-1"><a href="#cite_note-:2-64">[64]</a></sup> He tested his vaccine upon himself, his two children, and his assistant.<sup id="cite_ref-:2_64-2"><a href="#cite_note-:2-64">[64]</a></sup> He gave his vaccine to just 23 more children before declaring it safe and sending it out to doctors and health departments for a larger test of efficacy.<sup id="cite_ref-:2_64-3"><a href="#cite_note-:2-64">[64]</a></sup> By April 1935, he was able to report having tested the vaccine on 100 children without ill effect.<sup id="cite_ref-:5_70-0"><a href="#cite_note-:5-70">[70]</a></sup> Kolmer's first formal presentation of results would not come about until November 1935 where he presented the results of 446 children and adults he had vaccinated with his attenuated vaccine.<sup id="cite_ref-:5_70-1"><a href="#cite_note-:5-70">[70]</a></sup> He also reported that together the <a href="/wiki/Temple_University_College_of_Public_Health" title="Temple University College of Public Health">Research Institute of Cutaneous Medicine</a> and the <a href="/wiki/Marion_Merrell_Dow" title="Marion Merrell Dow">Merrell Company of Cincinnati</a> (the manufacturer who held the patent for his ricinoleating process) had distributed 12,000 doses of vaccine to some 700 physicians across the United States and Canada.<sup id="cite_ref-:5_70-2"><a href="#cite_note-:5-70">[70]</a></sup> Kolmer did not describe any monitoring of this experimental vaccination program nor did he provide these physicians with instructions in how to administer the vaccine or how to report side effects.<sup id="cite_ref-:5_70-3"><a href="#cite_note-:5-70">[70]</a></sup> Kolmer dedicated the bulk of his publications thereafter to explaining what he believed to be the cause of the 10+ reported cases of paralytic polio following vaccination, in many cases in towns where no polio outbreak had occurred.<sup id="cite_ref-:5_70-4"><a href="#cite_note-:5-70">[70]</a></sup><sup id="cite_ref-Offit_2007_71-0"><a href="#cite_note-Offit_2007-71">[71]</a></sup> Six of these cases had been fatal.<sup id="cite_ref-:5_70-5"><a href="#cite_note-:5-70">[70]</a></sup> Kolmer had no control group but asserted that many more children would have gotten sick.<sup id="cite_ref-Offit_2007_71-1"><a href="#cite_note-Offit_2007-71">[71]</a></sup>
</p>
<h4><span id="Brodie.27s_inactivated_vaccine"></span><span id="Brodie's_inactivated_vaccine">Brodie's inactivated vaccine</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=15" title="Edit section: Brodie's inactivated vaccine">edit</a><span>]</span></span></h4>
<p>At nearly the same time as Kolmer's project, <a href="/wiki/Maurice_Brodie" title="Maurice Brodie">Maurice Brodie</a> had joined immunologist Dr. <a href="/wiki/William_Hallock_Park" title="William Hallock Park">William H. Park</a> at the <a href="/wiki/New_York_City_Health_Department" title="New York City Health Department">New York City Health Department</a> where they worked together on poliovirus. With the aid of grant funding from the President's Birthday Ball Commission (a predecessor to what would become the <a href="/wiki/March_of_Dimes" title="March of Dimes">March of Dimes</a>), Brodie was able to pursue development of an inactivated or "killed virus" vaccine. Brodie's process also began by grinding the spinal cords of infectious monkeys and then treating the cords with various germicides,<sup id="cite_ref-:6_72-0"><a href="#cite_note-:6-72">[72]</a></sup> ultimately finding a solution of formaldehyde to be the most effective. By the June 1, 1934, Brodie was able to publish his first scholarly article describing his successful induction of immunity in three monkeys with inactivated polio virus.<sup id="cite_ref-73"><a href="#cite_note-73">[73]</a></sup><sup id="cite_ref-:7_74-0"><a href="#cite_note-:7-74">[74]</a></sup> Through continued study on an additional 26 monkeys, Brodie ultimately concluded that administration of live virus vaccine tended to result in <a href="/wiki/Humoral_immunity" title="Humoral immunity">humoral immunity</a> while administration of killed virus vaccine tended to result in <a href="/wiki/Cell-mediated_immunity" title="Cell-mediated immunity">tissue immunity</a>.<sup id="cite_ref-:5_70-6"><a href="#cite_note-:5-70">[70]</a></sup>
</p><p>Soon after, following a similar protocol to Kolmer, Brodie proceeded with <a href="/wiki/Self-experimentation_in_medicine" title="Self-experimentation in medicine">self experimentation</a> upon himself and his co-workers at the <a href="/wiki/New_York_State_Department_of_Health" title="New York State Department of Health">NYC Health Department</a> laboratory.<sup id="cite_ref-:2_64-4"><a href="#cite_note-:2-64">[64]</a></sup> Brodie's progress was eagerly covered by popular press as the public hoped for a successful vaccine to become available.<sup id="cite_ref-:7_74-1"><a href="#cite_note-:7-74">[74]</a></sup> Such reporting did not make mention of the 12 children in a New York City Asylum who were subjected to early safety trials.<sup id="cite_ref-:2_64-5"><a href="#cite_note-:2-64">[64]</a></sup> As none of the subjects experienced ill effects, Dr. Park, described by contemporaries as "never one to let grass grow under his feet,"<sup id="cite_ref-75"><a href="#cite_note-75">[75]</a></sup> declared the vaccine safe.<sup id="cite_ref-:4_67-1"><a href="#cite_note-:4-67">[67]</a></sup> When a severe polio outbreak overwhelmed <a href="/wiki/Kern_County,_California" title="Kern County, California">Kern County</a>, <a href="/wiki/California" title="California">California</a> it became the first trial site for the new vaccine on very short notice. Between November 1934 - May 1935, over 1,500 doses of the vaccine were administered in Kern County. While initial results were very promising, insufficient staffing and poor protocol design left Brodie open to criticism when he published the California results in August 1935.<sup id="cite_ref-:7_74-2"><a href="#cite_note-:7-74">[74]</a></sup><sup id="cite_ref-:5_70-7"><a href="#cite_note-:5-70">[70]</a></sup> Through private physicians, Brodie also conducted a broader field study, including 9,000 children who received the vaccine and 4,500 age- and location-matched controls who did not receive a vaccine. Again, results were promising. Of those who received the vaccine, only a few went on to develop polio. Most had been exposed prior to vaccination and none had received the full series of vaccine doses being studied.<sup id="cite_ref-:5_70-8"><a href="#cite_note-:5-70">[70]</a></sup> Additionally, a polio epidemic in <a href="/wiki/Raleigh,_North_Carolina" title="Raleigh, North Carolina">Raleigh</a>, <a href="/wiki/North_Carolina" title="North Carolina">North Carolina</a> provided an opportunity for the <a href="/wiki/United_States_Public_Health_Service" title="United States Public Health Service">U.S. Public Health Service</a> to conduct a highly structured trial of the Brodie vaccine using funding from the Birthday Ball Commission.<sup id="cite_ref-:4_67-2"><a href="#cite_note-:4-67">[67]</a></sup><sup id="cite_ref-:5_70-9"><a href="#cite_note-:5-70">[70]</a></sup>
</p>
<h4><span id="Academic_reception">Academic reception</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=16" title="Edit section: Academic reception">edit</a><span>]</span></span></h4>
<p>While their work was ongoing, the larger community of <a href="/wiki/Bacteriologist" title="Bacteriologist">bacteriologists</a> began to raise concerns regarding the safety and efficacy of the new poliovirus vaccines.<sup id="cite_ref-:1_63-1"><a href="#cite_note-:1-63">[63]</a></sup> At this time there was very little oversight of medical studies, and ethical treatment of study participants largely relied upon moral pressure from <a href="/wiki/Peer_review" title="Peer review">peer academic</a> scientists.<sup id="cite_ref-:3_65-3"><a href="#cite_note-:3-65">[65]</a></sup> Brodie's inactivated vaccines faced scrutiny from many who felt killed virus vaccines could not be efficacious. While researchers were able to replicate the <a href="/wiki/Cell-mediated_immunity" title="Cell-mediated immunity">tissue immunity</a> he had produced in his animal trials, prevailing wisdom was that <a href="/wiki/Humoral_immunity" title="Humoral immunity">humoral immunity</a> was essential for an efficacious vaccine.<sup id="cite_ref-:5_70-10"><a href="#cite_note-:5-70">[70]</a></sup> Kolmer directly questioned the killed virus approach in scholarly journals.<sup id="cite_ref-:6_72-1"><a href="#cite_note-:6-72">[72]</a></sup> Kolmer's studies however had raised even more concern with increasing reports of children becoming paralysed following vaccination with his live virus vaccine and notably, with paralysis beginning at the arm rather than the foot in many cases.<sup id="cite_ref-:8_76-0"><a href="#cite_note-:8-76">[76]</a></sup> Both Kolmer and Brodie were called to present their research at the Annual Meeting of the <a href="/wiki/American_Public_Health_Association" title="American Public Health Association">American Public Health Association</a> in <a href="/wiki/Milwaukee" title="Milwaukee">Milwaukee</a> WI in October 1935.<sup id="cite_ref-:1_63-2"><a href="#cite_note-:1-63">[63]</a></sup> Additionally, Dr. <a href="/wiki/Thomas_Milton_Rivers" title="Thomas Milton Rivers">Thomas M. Rivers</a> was asked to discuss each of the presented papers as a prominent critic of the vaccine development effort.<sup id="cite_ref-:1_63-3"><a href="#cite_note-:1-63">[63]</a></sup> This resulted in the <a href="/wiki/American_Public_Health_Association" title="American Public Health Association">APHA</a> arranging a Symposium on <a href="/wiki/Poliomyelitis" title="Poliomyelitis">Poliomyelitis</a> to be delivered at the Annual Meeting of their Southern Branch the following month.<sup id="cite_ref-:1_63-4"><a href="#cite_note-:1-63">[63]</a></sup> It was during the discussion at this meeting that Dr. James Leake of the <a href="/wiki/United_States_Public_Health_Service" title="United States Public Health Service">U.S. Public Health Service</a> stood to immediately present clinical evidence that the Kolmer vaccine had caused several deaths and then allegedly accused Kolmer of being a murderer.<sup id="cite_ref-:1_63-5"><a href="#cite_note-:1-63">[63]</a></sup> As Rivers recalled in his oral history, "All hell broke loose, and it seemed as if everybody was trying to talk at the same time....Jimmy Leake used the strongest language that I have ever heard used at a scientific meeting."<sup id="cite_ref-:1_63-6"><a href="#cite_note-:1-63">[63]</a></sup> In response to the attacks from all sides, Brodie was reported to have stood up and stated, "It looks as though, according to Dr. Rivers, my vaccine is no good, and, according to Dr. Leake, Dr Kolmer's is dangerous."<sup id="cite_ref-:1_63-7"><a href="#cite_note-:1-63">[63]</a></sup> Kolmer simply responded by stating, "Gentlemen, this is one time I wish the floor would open up and swallow me."<sup id="cite_ref-:1_63-8"><a href="#cite_note-:1-63">[63]</a></sup> Ultimately, Kolmer's live vaccine was undoubtedly shown to be dangerous and had already been withdrawn in September 1935 prior to the Milwaukee meeting.<sup id="cite_ref-:8_76-1"><a href="#cite_note-:8-76">[76]</a></sup><sup id="cite_ref-Offit_2007_71-2"><a href="#cite_note-Offit_2007-71">[71]</a></sup><sup id="cite_ref-:5_70-11"><a href="#cite_note-:5-70">[70]</a></sup> While the consensus of the symposium was largely sceptical of the efficacy of Brodie's vaccine, its safety was not in question and the recommendation was for a much larger well-controlled trial.<sup id="cite_ref-:8_76-2"><a href="#cite_note-:8-76">[76]</a></sup> However, when three children became ill with paralytic polio following a dose of the vaccine, the directors of the <a href="/wiki/Warm_Springs_Historic_District" title="Warm Springs Historic District">Warm Springs Foundation</a> in Georgia (acting as the primary funders for the project) requested it be withdrawn in December 1935.<sup id="cite_ref-:8_76-3"><a href="#cite_note-:8-76">[76]</a></sup> Following its withdrawal, the previously observed moratorium on human poliomyelitis vaccine development resumed and there would not be another attempt for nearly 20 years.<sup id="cite_ref-:5_70-12"><a href="#cite_note-:5-70">[70]</a></sup><sup id="cite_ref-Offit_2007_71-3"><a href="#cite_note-Offit_2007-71">[71]</a></sup>
</p><p>While Brodie had arguably made the most progress in the pursuit of a poliovirus vaccine, he suffered the most significant career repercussions due to his status as a less widely known researcher.<sup id="cite_ref-:7_74-3"><a href="#cite_note-:7-74">[74]</a></sup> Modern researchers recognize that Brodie may well have developed an effective polio vaccine, however the basic science and technology of the time was insufficient to understand and utilize this breakthrough.<sup id="cite_ref-:5_70-13"><a href="#cite_note-:5-70">[70]</a></sup> Brodie's work using formalin-inactivated virus would later become the basis for the Salk vaccine, but he would not live to see this success.<sup id="cite_ref-:5_70-14"><a href="#cite_note-:5-70">[70]</a></sup> Brodie was fired from his position within three months of the symposium's publication.<sup id="cite_ref-:5_70-15"><a href="#cite_note-:5-70">[70]</a></sup> While he was able to find another laboratory position, he died of a heart attack only three years later at age 36.<sup id="cite_ref-:5_70-16"><a href="#cite_note-:5-70">[70]</a></sup><sup id="cite_ref-:7_74-4"><a href="#cite_note-:7-74">[74]</a></sup> By contrast, Park, who was believed in the community to be reaching senility at this point in his older age, was able to retire from his position with honors<sup id="cite_ref-:1_63-9"><a href="#cite_note-:1-63">[63]</a></sup> prior to his death in 1939.<sup id="cite_ref-:4_67-3"><a href="#cite_note-:4-67">[67]</a></sup> Kolmer, already an established and well respected researcher, returned to <a href="/wiki/Temple_University" title="Temple University">Temple University</a> as a professor of medicine.<sup id="cite_ref-:5_70-17"><a href="#cite_note-:5-70">[70]</a></sup> Kolmer had a very productive career, receiving multiple awards, and publishing countless papers, articles, and textbooks up until his retirement in 1957.<sup id="cite_ref-:4_67-4"><a href="#cite_note-:4-67">[67]</a></sup><sup id="cite_ref-:1_63-10"><a href="#cite_note-:1-63">[63]</a></sup><sup id="cite_ref-Offit_2007_71-4"><a href="#cite_note-Offit_2007-71">[71]</a></sup><sup id="cite_ref-77"><a href="#cite_note-77">[77]</a></sup>
</p>
<h3><span id="1948">1948</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=17" title="Edit section: 1948">edit</a><span>]</span></span></h3>
<p>A breakthrough came in 1948 when a research group headed by <a href="/wiki/John_Enders" title="John Enders">John Enders</a> at the <a href="/wiki/Children%27s_Hospital_Boston" title="Children's Hospital Boston">Children's Hospital Boston</a> successfully cultivated the poliovirus in human tissue in the laboratory.<sup id="cite_ref-Enders_78-0"><a href="#cite_note-Enders-78">[78]</a></sup> This group had recently successfully grown <a href="/wiki/Mumps" title="Mumps">mumps</a> in cell culture. In March 1948, <a href="/wiki/Thomas_H._Weller" title="Thomas H. Weller">Thomas H. Weller</a> was attempting to grow <i>varicella</i> virus in embryonic lung tissue. He had inoculated the planned number of tubes when he noticed that there were a few unused tubes. He retrieved a sample of <a href="/wiki/Mouse_brain" title="Mouse brain">mouse brain</a> infected with poliovirus and added it to the remaining test tubes, on the off chance that the virus might grow. The <i>varicella</i> cultures failed to grow, but the polio cultures were successful. This development greatly facilitated vaccine research and ultimately allowed for the development of vaccines against polio. Enders and his colleagues, <a href="/wiki/Thomas_H._Weller" title="Thomas H. Weller">Thomas H. Weller</a> and <a href="/wiki/Frederick_C._Robbins" title="Frederick C. Robbins">Frederick C. Robbins</a>, were recognized in 1954 for their efforts with a <a href="/wiki/Nobel_Prize_in_Physiology_or_Medicine" title="Nobel Prize in Physiology or Medicine">Nobel Prize in Physiology or Medicine</a>.<sup id="cite_ref-Nobel_1954_79-0"><a href="#cite_note-Nobel_1954-79">[79]</a></sup> Other important advances that led to the development of polio vaccines were: the identification of three poliovirus <a href="/wiki/Serotype" title="Serotype">serotypes</a> (Poliovirus type 1 – PV1, or Mahoney; PV2, Lansing; and PV3, Leon); the finding that prior to paralysis, the virus must be present in the blood; and the demonstration that administration of antibodies in the form of <a href="/wiki/Gamma_globulin" title="Gamma globulin">gamma globulin</a> protects against paralytic polio.<sup id="cite_ref-:1_63-11"><a href="#cite_note-:1-63">[63]</a></sup><sup id="cite_ref-Kew_2005_52-2"><a href="#cite_note-Kew_2005-52">[52]</a></sup><sup id="cite_ref-pmid13034471_80-0"><a href="#cite_note-pmid13034471-80">[80]</a></sup>
</p>
<h3><span id="1950.E2.80.931955"></span><span id="1950–1955">1950–1955</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=18" title="Edit section: 1950–1955">edit</a><span>]</span></span></h3>

<div><p><a href="/wiki/File:Salk_headlines.jpg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/eb/Salk_headlines.jpg/220px-Salk_headlines.jpg" decoding="async" width="220" height="284" srcset="//upload.wikimedia.org/wikipedia/commons/e/eb/Salk_headlines.jpg 1.5x" data-file-width="308" data-file-height="397"></a></p><div><p>1955 newspaper headlines on the development of an effective polio vaccine</p></div></div>
<p>During the early 1950s, polio rates in the U.S. were above 25,000 annually; in 1952 and 1953, the U.S. experienced an outbreak of 58,000 and 35,000 polio cases, respectively, up from a typical number of some 20,000 a year, with deaths in those years numbering 3,200 and 1,400.<sup id="cite_ref-81"><a href="#cite_note-81">[81]</a></sup> Amid this U.S. polio epidemic, millions of dollars were invested in finding and marketing a polio vaccine by commercial interests, including Lederle Laboratories in New York under the direction of <a href="/wiki/H._R._Cox" title="H. R. Cox">H. R. Cox</a>. Also working at Lederle was Polish-born <a href="/wiki/Virologist" title="Virologist">virologist</a> and <a href="/wiki/Immunologist" title="Immunologist">immunologist</a> <a href="/wiki/Hilary_Koprowski" title="Hilary Koprowski">Hilary Koprowski</a> of the Wistar Institute in Philadelphia, who tested the first successful polio vaccine, in 1950.<sup id="cite_ref-Kowproski_obit_9-2"><a href="#cite_note-Kowproski_obit-9">[9]</a></sup><sup id="cite_ref-Kowproski5_46-1"><a href="#cite_note-Kowproski5-46">[46]</a></sup> His vaccine, however, being a live attenuated virus taken orally, was still in the research stage and would not be ready for use until five years after Jonas Salk's polio vaccine (a dead-virus injectable vaccine) had reached the market. Koprowski's attenuated vaccine was prepared by successive passages through the brains of Swiss albino mice. By the seventh passage, the vaccine strains could no longer infect nervous tissue or cause paralysis. After one to three further passages on rats, the vaccine was deemed safe for human use.<sup id="cite_ref-Sanofi_44-2"><a href="#cite_note-Sanofi-44">[44]</a></sup><sup id="cite_ref-82"><a href="#cite_note-82">[82]</a></sup> On 27 February 1950, Koprowski's live, attenuated vaccine was tested for the first time on an 8-year-old boy living at <a href="/wiki/Letchworth_Village" title="Letchworth Village">Letchworth Village</a>, an institution for the physically and mentally disabled located in New York. After the child suffered no side effects, Koprowski enlarged his experiment to include 19 other children.<sup id="cite_ref-Sanofi_44-3"><a href="#cite_note-Sanofi-44">[44]</a></sup><sup id="cite_ref-83"><a href="#cite_note-83">[83]</a></sup>
</p>
<h4><span id="Jonas_Salk">Jonas Salk</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=19" title="Edit section: Jonas Salk">edit</a><span>]</span></span></h4>
<div><p><a href="/wiki/File:PittPolioVaccineCoL.jpg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/13/PittPolioVaccineCoL.jpg/220px-PittPolioVaccineCoL.jpg" decoding="async" width="220" height="249" srcset="//upload.wikimedia.org/wikipedia/commons/1/13/PittPolioVaccineCoL.jpg 1.5x" data-file-width="330" data-file-height="374"></a></p><div><p>Administration of the polio inoculation, including by <a href="/wiki/Jonas_Salk" title="Jonas Salk">Salk</a> himself, in 1957 at the <a href="/wiki/University_of_Pittsburgh" title="University of Pittsburgh">University of Pittsburgh</a>, where his team had developed the vaccine</p></div></div>
<div><p><a href="/wiki/File:Polio_immunization_days_PHIL_2445.png"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Polio_immunization_days_PHIL_2445.png/300px-Polio_immunization_days_PHIL_2445.png" decoding="async" width="300" height="195" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Polio_immunization_days_PHIL_2445.png/450px-Polio_immunization_days_PHIL_2445.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/53/Polio_immunization_days_PHIL_2445.png/600px-Polio_immunization_days_PHIL_2445.png 2x" data-file-width="1338" data-file-height="870"></a></p><div><p>Mass polio vaccination in <a href="/wiki/Columbus,_Georgia" title="Columbus, Georgia">Columbus, Georgia</a><i> circa</i> 1961 for the National Polio Immunization Program</p></div></div>
<p>The first effective polio vaccine was developed in 1952 by <a href="/wiki/Jonas_Salk" title="Jonas Salk">Jonas Salk</a> and a team at the <a href="/wiki/University_of_Pittsburgh" title="University of Pittsburgh">University of Pittsburgh</a> that included <a href="/wiki/Julius_Youngner" title="Julius Youngner">Julius Youngner</a>, Byron Bennett, L. James Lewis, and Lorraine Friedman, which required years of subsequent testing. Salk went on CBS radio to report a successful test on a small group of adults and children on 26 March 1953; two days later, the results were published in <i><a href="/wiki/JAMA_(journal)" title="JAMA (journal)">JAMA</a></i>.<sup id="cite_ref-Offit_2007_71-5"><a href="#cite_note-Offit_2007-71">[71]</a></sup> <a href="/wiki/Leone_N._Farrell" title="Leone N. Farrell">Leone N. Farrell</a> invented a key laboratory technique that enabled the mass production of the vaccine by a team she led in Toronto.<sup id="cite_ref-84"><a href="#cite_note-84">[84]</a></sup><sup id="cite_ref-85"><a href="#cite_note-85">[85]</a></sup> Beginning 23 February 1954, the vaccine was tested at Arsenal Elementary School and the <a href="/wiki/D._T._Watson_Home_for_Crippled_Children" title="D. T. Watson Home for Crippled Children">Watson Home for Children</a> in <a href="/wiki/Pittsburgh,_Pennsylvania" title="Pittsburgh, Pennsylvania">Pittsburgh, Pennsylvania</a>.<sup id="cite_ref-Shors2008_86-0"><a href="#cite_note-Shors2008-86">[86]</a></sup>
</p><p>Salk's vaccine was then used in a test called the Francis Field Trial, led by <a href="/wiki/Thomas_Francis,_Jr." title="Thomas Francis, Jr.">Thomas Francis</a>, the largest medical experiment in history at that time. The test began with about 4,000 children at Franklin Sherman Elementary School in <a href="/wiki/McLean,_Virginia" title="McLean, Virginia">McLean, Virginia</a>,<sup id="cite_ref-Conis_87-0"><a href="#cite_note-Conis-87">[87]</a></sup><sup id="cite_ref-test_88-0"><a href="#cite_note-test-88">[88]</a></sup> and eventually involved 1.8 million children, in 44 states from <a href="/wiki/Maine" title="Maine">Maine</a> to <a href="/wiki/California" title="California">California</a>.<sup id="cite_ref-MoD_2004_89-0"><a href="#cite_note-MoD_2004-89">[89]</a></sup> By the conclusion of the study, roughly 440,000 received one or more injections of the vaccine, about 210,000 children received a <a href="/wiki/Placebo" title="Placebo">placebo</a>, consisting of harmless <a href="/wiki/Culture_media" title="Culture media">culture media</a>, and 1.2 million children received no vaccination and served as a control group, who would then be observed to see if any contracted polio.<sup id="cite_ref-Sanofi_44-4"><a href="#cite_note-Sanofi-44">[44]</a></sup>
</p><p>The results of the field trial were announced 12 April 1955 (the tenth anniversary of the death of President <a href="/wiki/Franklin_D._Roosevelt" title="Franklin D. Roosevelt">Franklin D. Roosevelt</a>, whose <a href="/wiki/Franklin_D._Roosevelt%27s_paralytic_illness" title="Franklin D. Roosevelt's paralytic illness">paralytic illness</a> was generally believed to have been caused by polio). The Salk vaccine had been 60–70% effective against PV1 (poliovirus type 1), over 90% effective against PV2 and PV3, and 94% effective against the development of bulbar polio.<sup id="cite_ref-Smith_1990_90-0"><a href="#cite_note-Smith_1990-90">[90]</a></sup> Soon after Salk's vaccine was licensed in 1955, children's vaccination campaigns were launched. In the U.S, following a mass immunization campaign promoted by the <a href="/wiki/March_of_Dimes" title="March of Dimes">March of Dimes</a>, the annual number of polio cases fell from 35,000 in 1953 to 5,600 by 1957.<sup id="cite_ref-Sass_91-0"><a href="#cite_note-Sass-91">[91]</a></sup> By 1961 only 161 cases were recorded in the United States.<sup id="cite_ref-Hinman_92-0"><a href="#cite_note-Hinman-92">[92]</a></sup>
</p><p>A week before the announcement of the Francis Field Trial results in April 1955, <a href="/w/index.php?title=Pierre_L%C3%A9pine&amp;action=edit&amp;redlink=1" title="Pierre Lépine (page does not exist)">Pierre Lépine</a> at the <a href="/wiki/Pasteur_Institute" title="Pasteur Institute">Pasteur Institute</a> in Paris had also announced an effective polio vaccine.<sup id="cite_ref-93"><a href="#cite_note-93">[93]</a></sup><sup id="cite_ref-94"><a href="#cite_note-94">[94]</a></sup>
</p>
<h4><span id="Safety_incidents">Safety incidents</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=20" title="Edit section: Safety incidents">edit</a><span>]</span></span></h4>
<p>In April 1955, soon after mass polio vaccination began in the US, the Surgeon General began to receive reports of patients who contracted paralytic polio about a week after being vaccinated with Salk polio vaccine from the <a href="/wiki/Cutter_Laboratories" title="Cutter Laboratories">Cutter</a> pharmaceutical company, with the paralysis limited to the limb the vaccine was injected into. The Cutter vaccine had been used in vaccinating 200,000 children in the western and midwestern United States.<sup id="cite_ref-MC1383764_95-0"><a href="#cite_note-MC1383764-95">[95]</a></sup> Later investigations showed that the Cutter vaccine had caused 40,000 cases of polio, killing 10.<sup id="cite_ref-MC1383764_95-1"><a href="#cite_note-MC1383764-95">[95]</a></sup> In response the Surgeon General pulled all polio vaccines made by Cutter Laboratories from the market, but not before 250 cases of paralytic illness had occurred. Wyeth polio vaccine was also reported to have paralyzed and killed several children.
It was soon discovered that some lots of Salk polio vaccine made by Cutter and Wyeth had not been properly inactivated, allowing live poliovirus into more than 100,000 doses of vaccine. In May 1955, the National Institutes of Health and Public Health Services established a Technical Committee on Poliomyelitis Vaccine to test and review all polio vaccine lots and advise the Public Health Service as to which lots should be released for public use. These incidents reduced public confidence in polio vaccine, leading to a drop in vaccination rates.<sup id="cite_ref-Juskewitch2010_96-0"><a href="#cite_note-Juskewitch2010-96">[96]</a></sup>
</p>
<h3><span id="1961">1961</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=21" title="Edit section: 1961">edit</a><span>]</span></span></h3>
<div><p><a href="/wiki/File:Gallo,_Robert_C._and_Sabin,_Albert_B.jpg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Gallo%2C_Robert_C._and_Sabin%2C_Albert_B.jpg/170px-Gallo%2C_Robert_C._and_Sabin%2C_Albert_B.jpg" decoding="async" width="170" height="187" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Gallo%2C_Robert_C._and_Sabin%2C_Albert_B.jpg/255px-Gallo%2C_Robert_C._and_Sabin%2C_Albert_B.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Gallo%2C_Robert_C._and_Sabin%2C_Albert_B.jpg/340px-Gallo%2C_Robert_C._and_Sabin%2C_Albert_B.jpg 2x" data-file-width="2232" data-file-height="2461"></a></p></div>
<p>At the same time that Salk was testing his vaccine, both <a href="/wiki/Albert_Sabin" title="Albert Sabin">Albert Sabin</a> and Hilary Koprowski continued working on developing a vaccine using live virus. During a meeting in Stockholm to discuss polio vaccines in November 1955, Sabin presented results obtained on a group of 80 volunteers, while Koprowski read a paper detailing the findings of a trial enrolling 150 people.<sup id="cite_ref-Sanofi_44-5"><a href="#cite_note-Sanofi-44">[44]</a></sup> Sabin and Koprowski both eventually succeeded in developing vaccines. Because of the commitment to the Salk vaccine in America, Sabin and Koprowski both did their testing outside the United States, Sabin in Mexico<sup id="cite_ref-Sabin_1960_54-1"><a href="#cite_note-Sabin_1960-54">[54]</a></sup> and the Soviet Union,<sup id="cite_ref-NMAH_97-0"><a href="#cite_note-NMAH-97">[97]</a></sup> Koprowski in the Congo and Poland.<sup id="cite_ref-Kowproski5_46-2"><a href="#cite_note-Kowproski5-46">[46]</a></sup> In 1957, Sabin developed a trivalent vaccine containing attenuated strains of all three types of poliovirus.<sup id="cite_ref-NMAH_97-1"><a href="#cite_note-NMAH-97">[97]</a></sup> In 1959, ten million children in the <a href="/wiki/Soviet_Union" title="Soviet Union">Soviet Union</a> received the Sabin oral vaccine. For this work, Sabin was given the medal of the <a href="/wiki/Order_of_Friendship_of_Peoples" title="Order of Friendship of Peoples">Order of Friendship of Peoples</a>, described as the Soviet Union's highest civilian honor.<sup id="cite_ref-98"><a href="#cite_note-98">[98]</a></sup> Sabin's oral vaccine using live virus came into commercial use in 1961.<sup id="cite_ref-WHO2016_2-11"><a href="#cite_note-WHO2016-2">[2]</a></sup>
</p><p>Once Sabin's oral vaccine became widely available, it supplanted Salk's injected vaccine, which had been tarnished in the public's opinion by the <a href="/wiki/Cutter_incident" title="Cutter incident">Cutter incident</a> of 1955, in which Salk vaccines improperly prepared by one company resulted in several children dying or becoming paralyzed.<sup id="cite_ref-Offit_2007_71-6"><a href="#cite_note-Offit_2007-71">[71]</a></sup>
</p>
<h3><span id="1987">1987</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=22" title="Edit section: 1987">edit</a><span>]</span></span></h3>
<p>An enhanced-<a href="/wiki/Potency_(pharmacology)" title="Potency (pharmacology)">potency</a> IPV was licensed in the United States in November 1987, and is currently the vaccine of choice there.<sup id="cite_ref-PinkPages_19-3"><a href="#cite_note-PinkPages-19">[19]</a></sup> The first dose of polio vaccine is given shortly after birth, usually between 1 and 2 months of age, and a second dose is given at 4 months of age.<sup id="cite_ref-PinkPages_19-4"><a href="#cite_note-PinkPages-19">[19]</a></sup> The timing of the third dose depends on the vaccine formulation, but should be given between 6 and 18 months of age.<sup id="cite_ref-UK_53-1"><a href="#cite_note-UK-53">[53]</a></sup> A booster vaccination is given at 4 to 6 years of age, for a total of four doses at or before school entry.<sup id="cite_ref-Peds_20-1"><a href="#cite_note-Peds-20">[20]</a></sup> In some countries, a fifth vaccination is given during <a href="/wiki/Adolescence" title="Adolescence">adolescence</a>.<sup id="cite_ref-UK_53-2"><a href="#cite_note-UK-53">[53]</a></sup> Routine vaccination of adults (18 years of age and older) in developed countries is neither necessary nor recommended because most adults are already immune and have a very small risk of exposure to wild poliovirus in their home countries.<sup id="cite_ref-PinkPages_19-5"><a href="#cite_note-PinkPages-19">[19]</a></sup> In 2002, a <a href="/wiki/Pentavalent" title="Pentavalent">pentavalent</a> (five-component) combination vaccine (called Pediarix)<sup id="cite_ref-99"><a href="#cite_note-99">[99]</a></sup><sup id="cite_ref-pediarix_100-0"><a href="#cite_note-pediarix-100">[100]</a></sup> containing IPV was approved for use in the United States.<sup id="cite_ref-101"><a href="#cite_note-101">[101]</a></sup><sup id="cite_ref-pediarix_100-1"><a href="#cite_note-pediarix-100">[100]</a></sup>
</p>
<h3><span id="1988">1988</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=23" title="Edit section: 1988">edit</a><span>]</span></span></h3>
<div><p><a href="/wiki/File:Somali_boy_receives_a_polio_vaccination.jpg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/67/Somali_boy_receives_a_polio_vaccination.jpg/220px-Somali_boy_receives_a_polio_vaccination.jpg" decoding="async" width="220" height="145" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/67/Somali_boy_receives_a_polio_vaccination.jpg/330px-Somali_boy_receives_a_polio_vaccination.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/67/Somali_boy_receives_a_polio_vaccination.jpg/440px-Somali_boy_receives_a_polio_vaccination.jpg 2x" data-file-width="3000" data-file-height="1982"></a></p><div><p>A <a href="/wiki/Somali_people" title="Somali people">Somali</a> boy is injected with inactivated poliovirus vaccine (<a href="/wiki/Mogadishu" title="Mogadishu">Mogadishu</a>, 1993)</p></div></div>
<p>A global effort to eradicate polio, led by the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO), <a href="/wiki/UNICEF" title="UNICEF">UNICEF</a>,<sup id="cite_ref-102"><a href="#cite_note-102">[102]</a></sup> and the <a href="/wiki/The_Rotary_Foundation" title="The Rotary Foundation">Rotary Foundation</a>, began in 1988, and has relied largely on the oral polio vaccine developed by <a href="/wiki/Albert_Sabin" title="Albert Sabin">Albert Sabin</a> and <a href="/wiki/Mikhail_Chumakov" title="Mikhail Chumakov">Mikhail Chumakov</a> (Sabin-Chumakov vaccine).<sup id="cite_ref-Watch_103-0"><a href="#cite_note-Watch-103">[103]</a></sup>
</p>
<h3><span id="After_1990">After 1990</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=24" title="Edit section: After 1990">edit</a><span>]</span></span></h3>
<p>Polio was eliminated in the Americas by 1994.<sup id="cite_ref-MMWR_1994_104-0"><a href="#cite_note-MMWR_1994-104">[104]</a></sup> The disease was officially eliminated in 36 Western Pacific countries, including China and Australia, in 2000.<sup id="cite_ref-Pacific_105-0"><a href="#cite_note-Pacific-105">[105]</a></sup><sup id="cite_ref-D'Souza_2002_106-0"><a href="#cite_note-D'Souza_2002-106">[106]</a></sup> Europe was declared polio-free in 2002.<sup id="cite_ref-WHO_Europe_2002_107-0"><a href="#cite_note-WHO_Europe_2002-107">[107]</a></sup> Since January 2011, no cases of the disease have been reported in India, hence in February 2012, the country was taken off the WHO list of polio-endemic countries. In March 2014, India was declared a polio-free country.<sup id="cite_ref-108"><a href="#cite_note-108">[108]</a></sup><sup id="cite_ref-109"><a href="#cite_note-109">[109]</a></sup><sup id="cite_ref-110"><a href="#cite_note-110">[110]</a></sup>
</p><p>Although poliovirus transmission has been interrupted in much of the world, transmission of wild poliovirus does continue and creates an ongoing risk for the importation of wild poliovirus into previously polio-free regions. If importations of poliovirus occur, outbreaks of poliomyelitis may develop, especially in areas with low vaccination coverage and poor sanitation. As a result, high levels of vaccination coverage must be maintained.<sup id="cite_ref-MMWR_1994_104-1"><a href="#cite_note-MMWR_1994-104">[104]</a></sup> In November 2013, the WHO announced a polio outbreak in Syria. In response, the Armenian government put out a notice asking <a href="/wiki/Syrian_Armenians" title="Syrian Armenians">Syrian Armenians</a> under age 15 to get the polio vaccine.<sup id="cite_ref-111"><a href="#cite_note-111">[111]</a></sup> As of 2014, polio virus had spread to 10 countries, mainly in Africa, Asia, and the <a href="/wiki/Middle_East" title="Middle East">Middle East</a>, with Pakistan, Syria, and <a href="/wiki/Cameroon" title="Cameroon">Cameroon</a> advising vaccinations to outbound travellers.<sup id="cite_ref-DarrasJr.2014_112-0"><a href="#cite_note-DarrasJr.2014-112">[112]</a></sup>
</p><p>Polio vaccination programs have been resisted by some people in Pakistan, Afghanistan, and Nigeria - the three countries as of 2017 with remaining polio cases. Almost all Muslim religious and political leaders have endorsed the vaccine,<sup id="cite_ref-113"><a href="#cite_note-113">[113]</a></sup> but a fringe minority believes that the vaccines are secretly being used for sterilization of Muslims.<sup id="cite_ref-Jegede_51-1"><a href="#cite_note-Jegede-51">[51]</a></sup> The fact that the CIA organized a fake vaccination program in 2011 to help find <a href="/wiki/Osama_Bin_Laden" title="Osama Bin Laden">Osama Bin Laden</a> is an additional cause of distrust.<sup id="cite_ref-Pakistan_114-0"><a href="#cite_note-Pakistan-114">[114]</a></sup> In 2015, the WHO announced a deal with the <a href="/wiki/Taliban" title="Taliban">Taliban</a> to encourage them to distribute the vaccine in areas they control.<sup id="cite_ref-115"><a href="#cite_note-115">[115]</a></sup> However, the Pakistani Taliban was not supportive. On 11 September 2016, two unidentified gunmen associated with the Pakistani Taliban, Jamaat-ul-Ahrar, shot Zakaullah Khan, a doctor who was administering polio vaccines in Pakistan. The leader of the Jamaat-ul-Ahrar claimed responsibility for the shooting and stated that the group would continue this type of attack. Such resistance to and scepticism of vaccinations has consequently slowed down the polio eradication process within the two remaining endemic countries.<sup id="cite_ref-Pakistan_114-1"><a href="#cite_note-Pakistan-114">[114]</a></sup>
</p><p>In 2020 WHO and partners created nopv2 vaccine for a endgame. Nopv2 was invented by collaboration of many institutes. Some scientists were Cara C. Burns,Andrew Macadam,Konstantin Chumakov and others.<sup id="cite_ref-116"><a href="#cite_note-116">[116]</a></sup>
</p>
<h2><span id="Travel_requirements">Travel requirements</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=25" title="Edit section: Travel requirements">edit</a><span>]</span></span></h2>
<div><p><a href="/wiki/File:Polio_vaccination_travel_requirements_map.svg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/af/Polio_vaccination_travel_requirements_map.svg/400px-Polio_vaccination_travel_requirements_map.svg.png" decoding="async" width="400" height="203" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/af/Polio_vaccination_travel_requirements_map.svg/600px-Polio_vaccination_travel_requirements_map.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/af/Polio_vaccination_travel_requirements_map.svg/800px-Polio_vaccination_travel_requirements_map.svg.png 2x" data-file-width="2754" data-file-height="1398"></a></p><div><p>Polio vaccination is required for travellers... </p><p><span>&nbsp;</span>&nbsp;From all countries, to all countries</p> <p><span>&nbsp;</span>&nbsp;From some countries, to all countries</p> <p><span>&nbsp;</span>&nbsp;From some countries, to all countries</p> <p><span>&nbsp;</span>&nbsp;From some countries, to some countries</p> <p><span>&nbsp;</span>&nbsp;To some countries</p> <p><span>&nbsp;</span>&nbsp;From some countries</p></div></div>

<p>Travellers who wish to enter or leave certain countries must be vaccinated against polio, usually at most 12 months and at least 4 weeks before crossing the border, and be able to present a vaccination record/certificate at the border checks.<sup id="cite_ref-WHO_Travel_and_Health_117-0"><a href="#cite_note-WHO_Travel_and_Health-117">[117]</a></sup><sup><span title="Page / location: 25–27">: 25–27 </span></sup> Most requirements apply only to travel to or from so-called 'polio-endemic', 'polio-affected', 'polio-exporting', 'polio-transmission', or 'high-risk' countries.<sup id="cite_ref-WHO_country_list_118-0"><a href="#cite_note-WHO_country_list-118">[118]</a></sup> As of August 2020, Afghanistan and Pakistan are the only polio-endemic countries in the world (where <a href="/wiki/Polio_eradication" title="Polio eradication">wild polio has not yet been eradicated</a>).<sup id="cite_ref-:9_119-0"><a href="#cite_note-:9-119">[119]</a></sup> Several countries have additional precautionary polio vaccination travel requirements, for example to and from 'key at-risk countries', which as of December 2020 include China, Indonesia, Mozambique, Myanmar, and Papua New Guinea.<sup id="cite_ref-WHO_country_list_118-1"><a href="#cite_note-WHO_country_list-118">[118]</a></sup><sup id="cite_ref-120"><a href="#cite_note-120">[120]</a></sup>
</p>
<table>
<tbody><tr>
<th colspan="2">Polio vaccination requirements for international travel<sup id="cite_ref-WHO_country_list_118-2"><a href="#cite_note-WHO_country_list-118">[118]</a></sup>
</th></tr>
<tr>
<th>Country
</th>
<th>Details
</th></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/5c/Flag_of_the_Taliban.svg/23px-Flag_of_the_Taliban.svg.png" decoding="async" width="23" height="12" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/5c/Flag_of_the_Taliban.svg/35px-Flag_of_the_Taliban.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/5c/Flag_of_the_Taliban.svg/46px-Flag_of_the_Taliban.svg.png 2x" data-file-width="1000" data-file-height="500">&nbsp;</span><a href="/wiki/Afghanistan" title="Afghanistan">Afghanistan</a>
</td>
<td>Travellers from polio-endemic countries (Pakistan) need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of polio vaccination (received between 4 weeks and 12 months before departure) upon arrival. Residents and ALL travellers staying in Afghanistan longer than 4 weeks need proof of polio vaccination (received between 4 weeks and 12 months before departure) when departing from Afghanistan.<sup id="cite_ref-WHO_country_list_118-3"><a href="#cite_note-WHO_country_list-118">[118]</a></sup><sup id="cite_ref-121"><a href="#cite_note-121">[121]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e7/Flag_of_Belize.svg/23px-Flag_of_Belize.svg.png" decoding="async" width="23" height="14" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e7/Flag_of_Belize.svg/35px-Flag_of_Belize.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e7/Flag_of_Belize.svg/46px-Flag_of_Belize.svg.png 2x" data-file-width="1000" data-file-height="600">&nbsp;</span><a href="/wiki/Belize" title="Belize">Belize</a>
</td>
<td>Travellers from Afghanistan and Pakistan need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival. Belize residents travelling countries with confirmed polio cases also need proof of vaccination.<sup id="cite_ref-122"><a href="#cite_note-122">[122]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Flag_of_Brunei.svg/23px-Flag_of_Brunei.svg.png" decoding="async" width="23" height="12" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Flag_of_Brunei.svg/35px-Flag_of_Brunei.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Flag_of_Brunei.svg/46px-Flag_of_Brunei.svg.png 2x" data-file-width="1440" data-file-height="720">&nbsp;</span><a href="/wiki/Brunei" title="Brunei">Brunei</a>
</td>
<td>Travellers from polio-exporting countries need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-123"><a href="#cite_note-123">[123]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Flag_of_Egypt.svg/23px-Flag_of_Egypt.svg.png" decoding="async" width="23" height="15" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Flag_of_Egypt.svg/35px-Flag_of_Egypt.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Flag_of_Egypt.svg/45px-Flag_of_Egypt.svg.png 2x" data-file-width="900" data-file-height="600">&nbsp;</span><a href="/wiki/Egypt" title="Egypt">Egypt</a>
</td>
<td>Travellers from Afghanistan, Angola, Benin, Cameroon, the Central African Republic, China, Congo-Kinshasa, Ethiopia, Ghana, Indonesia, Kenya, Mozambique, Myanmar, Niger, Nigeria, Pakistan, Papua New Guinea, Philippines, and Somalia need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-124"><a href="#cite_note-124">[124]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Flag_of_Georgia.svg/23px-Flag_of_Georgia.svg.png" decoding="async" width="23" height="15" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Flag_of_Georgia.svg/35px-Flag_of_Georgia.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Flag_of_Georgia.svg/45px-Flag_of_Georgia.svg.png 2x" data-file-width="900" data-file-height="600">&nbsp;</span><a href="/wiki/Georgia_(country)" title="Georgia (country)">Georgia</a>
</td>
<td>Travellers from at-risk countries need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival. Travellers without proof are offered OPV vaccination upon arrival.<sup id="cite_ref-125"><a href="#cite_note-125">[125]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/41/Flag_of_India.svg/23px-Flag_of_India.svg.png" decoding="async" width="23" height="15" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/41/Flag_of_India.svg/35px-Flag_of_India.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/41/Flag_of_India.svg/45px-Flag_of_India.svg.png 2x" data-file-width="1350" data-file-height="900">&nbsp;</span><a href="/wiki/India" title="India">India</a>
</td>
<td>Travellers from Afghanistan, Congo-Kinshasa, Ethiopia, Kenya, Nigeria, Pakistan, Somalia, and Syria need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-126"><a href="#cite_note-126">[126]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/c/ca/Flag_of_Iran.svg/23px-Flag_of_Iran.svg.png" decoding="async" width="23" height="13" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/ca/Flag_of_Iran.svg/35px-Flag_of_Iran.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/ca/Flag_of_Iran.svg/46px-Flag_of_Iran.svg.png 2x" data-file-width="630" data-file-height="360">&nbsp;</span><a href="/wiki/Iran" title="Iran">Iran</a>
</td>
<td>Travellers from Afghanistan, Pakistan, and Nigeria need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival. Travellers without proof will be vaccinated upon arrival.<sup id="cite_ref-127"><a href="#cite_note-127">[127]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f6/Flag_of_Iraq.svg/23px-Flag_of_Iraq.svg.png" decoding="async" width="23" height="15" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f6/Flag_of_Iraq.svg/35px-Flag_of_Iraq.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f6/Flag_of_Iraq.svg/45px-Flag_of_Iraq.svg.png 2x" data-file-width="900" data-file-height="600">&nbsp;</span><a href="/wiki/Iraq" title="Iraq">Iraq</a>
</td>
<td>Travellers aged 15+ from Afghanistan and Pakistan need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival; children under age 15 must have received three doses of polio vaccine before travel. Travellers without proof will be vaccinated upon arrival. Travellers departing Iraq to Afghanistan and Pakistan must also provide proof of vaccination upon departure.<sup id="cite_ref-128"><a href="#cite_note-128">[128]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/c/c0/Flag_of_Jordan.svg/23px-Flag_of_Jordan.svg.png" decoding="async" width="23" height="12" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/c0/Flag_of_Jordan.svg/35px-Flag_of_Jordan.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c0/Flag_of_Jordan.svg/46px-Flag_of_Jordan.svg.png 2x" data-file-width="1200" data-file-height="600">&nbsp;</span><a href="/wiki/Jordan" title="Jordan">Jordan</a>
</td>
<td>Travellers from Afghanistan and Pakistan need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-129"><a href="#cite_note-129">[129]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/Flag_of_Lebanon.svg/23px-Flag_of_Lebanon.svg.png" decoding="async" width="23" height="15" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/Flag_of_Lebanon.svg/35px-Flag_of_Lebanon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/59/Flag_of_Lebanon.svg/45px-Flag_of_Lebanon.svg.png 2x" data-file-width="900" data-file-height="600">&nbsp;</span><a href="/wiki/Lebanon" title="Lebanon">Lebanon</a>
</td>
<td>Travellers from and to polio-affected countries need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-130"><a href="#cite_note-130">[130]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/05/Flag_of_Libya.svg/23px-Flag_of_Libya.svg.png" decoding="async" width="23" height="12" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/05/Flag_of_Libya.svg/35px-Flag_of_Libya.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/05/Flag_of_Libya.svg/46px-Flag_of_Libya.svg.png 2x" data-file-width="960" data-file-height="480">&nbsp;</span><a href="/wiki/Libya" title="Libya">Libya</a>
</td>
<td>Travellers from Afghanistan and Pakistan need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-131"><a href="#cite_note-131">[131]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Flag_of_Maldives.svg/23px-Flag_of_Maldives.svg.png" decoding="async" width="23" height="15" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Flag_of_Maldives.svg/35px-Flag_of_Maldives.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Flag_of_Maldives.svg/45px-Flag_of_Maldives.svg.png 2x" data-file-width="720" data-file-height="480">&nbsp;</span><a href="/wiki/Maldives" title="Maldives">Maldives</a>
</td>
<td>Travellers from and to polio-exporting countries, as well as <a href="/wiki/Hajj" title="Hajj">Hajj</a> and <a href="/wiki/Umrah" title="Umrah">Umrah</a> pilgrims, need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-132"><a href="#cite_note-132">[132]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Flag_of_Morocco.svg/23px-Flag_of_Morocco.svg.png" decoding="async" width="23" height="15" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Flag_of_Morocco.svg/35px-Flag_of_Morocco.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Flag_of_Morocco.svg/45px-Flag_of_Morocco.svg.png 2x" data-file-width="900" data-file-height="600">&nbsp;</span><a href="/wiki/Morocco" title="Morocco">Morocco</a>
</td>
<td>Travellers from polio-affected countries need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-133"><a href="#cite_note-133">[133]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9b/Flag_of_Nepal.svg/16px-Flag_of_Nepal.svg.png" decoding="async" width="16" height="20" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9b/Flag_of_Nepal.svg/25px-Flag_of_Nepal.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9b/Flag_of_Nepal.svg/33px-Flag_of_Nepal.svg.png 2x" data-file-width="512" data-file-height="624">&nbsp;&nbsp;&nbsp;</span><a href="/wiki/Nepal" title="Nepal">Nepal</a>
</td>
<td>Travellers from Afghanistan, Kenya, Nigeria, Pakistan, and Papua New Guinea need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-134"><a href="#cite_note-134">[134]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/dd/Flag_of_Oman.svg/23px-Flag_of_Oman.svg.png" decoding="async" width="23" height="12" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/dd/Flag_of_Oman.svg/35px-Flag_of_Oman.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/dd/Flag_of_Oman.svg/46px-Flag_of_Oman.svg.png 2x" data-file-width="1200" data-file-height="600">&nbsp;</span><a href="/wiki/Oman" title="Oman">Oman</a>
</td>
<td>Travellers from polio-exporting countries need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-135"><a href="#cite_note-135">[135]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/32/Flag_of_Pakistan.svg/23px-Flag_of_Pakistan.svg.png" decoding="async" width="23" height="15" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/32/Flag_of_Pakistan.svg/35px-Flag_of_Pakistan.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/32/Flag_of_Pakistan.svg/45px-Flag_of_Pakistan.svg.png 2x" data-file-width="900" data-file-height="600">&nbsp;</span><a href="/wiki/Pakistan" title="Pakistan">Pakistan</a>
</td>
<td>Travellers from ALL countries planning to stay in Pakistan for more than 4 weeks need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV vaccination upon arrival. Residents and ALL travellers staying in Pakistan longer than 4 weeks need proof of OPV vaccination when departing from Pakistan.<sup id="cite_ref-WHO_country_list_118-4"><a href="#cite_note-WHO_country_list-118">[118]</a></sup><sup id="cite_ref-136"><a href="#cite_note-136">[136]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Flag_of_the_Philippines.svg/23px-Flag_of_the_Philippines.svg.png" decoding="async" width="23" height="12" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Flag_of_the_Philippines.svg/35px-Flag_of_the_Philippines.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/99/Flag_of_the_Philippines.svg/46px-Flag_of_the_Philippines.svg.png 2x" data-file-width="1200" data-file-height="600">&nbsp;</span><a href="/wiki/Philippines" title="Philippines">Philippines</a>
</td>
<td>Travellers from or to high-risk countries need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of polio vaccination upon arrival or before departure, respectively.<sup id="cite_ref-WHO_country_list_118-5"><a href="#cite_note-WHO_country_list-118">[118]</a></sup> Due to an <a href="/wiki/2019%E2%80%9320_Philippines_polio_outbreak" title="2019–20 Philippines polio outbreak">ongoing local VDPV2 outbreak</a>, the government recommends all others travellers to consider getting a polio vaccine or booster dose, depending on their situation.<sup id="cite_ref-137"><a href="#cite_note-137">[137]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Flag_of_Qatar.svg/23px-Flag_of_Qatar.svg.png" decoding="async" width="23" height="9" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Flag_of_Qatar.svg/35px-Flag_of_Qatar.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Flag_of_Qatar.svg/46px-Flag_of_Qatar.svg.png 2x" data-file-width="1400" data-file-height="550">&nbsp;</span><a href="/wiki/Qatar" title="Qatar">Qatar</a>
</td>
<td>Travellers from polio-exporting countries (identified by Qatar as: Afghanistan, Nigeria, Pakistan and Philippines) need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-138"><a href="#cite_note-138">[138]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Flag_of_Saint_Kitts_and_Nevis.svg/23px-Flag_of_Saint_Kitts_and_Nevis.svg.png" decoding="async" width="23" height="15" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Flag_of_Saint_Kitts_and_Nevis.svg/35px-Flag_of_Saint_Kitts_and_Nevis.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Flag_of_Saint_Kitts_and_Nevis.svg/45px-Flag_of_Saint_Kitts_and_Nevis.svg.png 2x" data-file-width="900" data-file-height="600">&nbsp;</span><a href="/wiki/Saint_Kitts_and_Nevis" title="Saint Kitts and Nevis">Saint Kitts and Nevis</a>
</td>
<td>Travellers from polio-endemic countries as identified by WHO (Afghanistan and Pakistan) need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-WHO_country_list_118-6"><a href="#cite_note-WHO_country_list-118">[118]</a></sup><sup id="cite_ref-139"><a href="#cite_note-139">[139]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Flag_of_Saudi_Arabia.svg/23px-Flag_of_Saudi_Arabia.svg.png" decoding="async" width="23" height="15" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Flag_of_Saudi_Arabia.svg/35px-Flag_of_Saudi_Arabia.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Flag_of_Saudi_Arabia.svg/45px-Flag_of_Saudi_Arabia.svg.png 2x" data-file-width="900" data-file-height="600">&nbsp;</span><a href="/wiki/Saudi_Arabia" title="Saudi Arabia">Saudi Arabia</a>
</td>
<td>Travellers from active-transmission (including wild or vaccine-derived poliovirus) and at-risk countries, as well as all travellers from Afghanistan, Congo-Kinshasa, Mozambique, Myanmar, Niger, Nigeria, Pakistan, Papua New Guinea, Somalia, Syria, and Yemen, need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival. Regardless of immunisation status, all travellers from Afghanistan, Myanmar, Nigeria, Pakistan, Papua New Guinea, Somalia, Syria, and Yemen will be given an Oral Polio Vaccine dose upon arrival.<sup id="cite_ref-140"><a href="#cite_note-140">[140]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fc/Flag_of_Seychelles.svg/23px-Flag_of_Seychelles.svg.png" decoding="async" width="23" height="12" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fc/Flag_of_Seychelles.svg/35px-Flag_of_Seychelles.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fc/Flag_of_Seychelles.svg/46px-Flag_of_Seychelles.svg.png 2x" data-file-width="1200" data-file-height="600">&nbsp;</span><a href="/wiki/Seychelles" title="Seychelles">Seychelles</a>
</td>
<td>Travellers from countries with polio outbreaks need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival.<sup id="cite_ref-141"><a href="#cite_note-141">[141]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Flag_of_Syria.svg/23px-Flag_of_Syria.svg.png" decoding="async" width="23" height="15" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Flag_of_Syria.svg/35px-Flag_of_Syria.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/53/Flag_of_Syria.svg/45px-Flag_of_Syria.svg.png 2x" data-file-width="900" data-file-height="600">&nbsp;</span><a href="/wiki/Syria" title="Syria">Syria</a>
</td>
<td>Travellers from Cameroon, Equatorial Guinea, and Pakistan need <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of OPV or IPV vaccination (received between 4 weeks and 12 months before departure) upon arrival. ALL Syria residents departing Syria to any country also need proof of vaccination.<sup id="cite_ref-142"><a href="#cite_note-142">[142]</a></sup>
</td></tr>
<tr>
<td><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/49/Flag_of_Ukraine.svg/23px-Flag_of_Ukraine.svg.png" decoding="async" width="23" height="15" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/49/Flag_of_Ukraine.svg/35px-Flag_of_Ukraine.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/49/Flag_of_Ukraine.svg/45px-Flag_of_Ukraine.svg.png 2x" data-file-width="1200" data-file-height="800">&nbsp;</span><a href="/wiki/Ukraine" title="Ukraine">Ukraine</a>
</td>
<td>Long-term visitors departing to states with wild or circulating vaccine-derived poliovirus transmission should present <a href="/wiki/Carte_Jaune" title="Carte Jaune">Carte Jaune</a> proof of vaccination with at least one dose of bivalent OPV or IPV (received between 4 weeks and 12 months before departure). Persons obliged to undertake urgent international travel must be immunised with a single dose of polio vaccine before their departure.<sup id="cite_ref-WHO_country_list_118-7"><a href="#cite_note-WHO_country_list-118">[118]</a></sup> There is also risk of poliovirus transmission inside Ukraine itself, and travellers to Ukraine are recommended to be up to date with their polio vaccination before entry.<sup id="cite_ref-143"><a href="#cite_note-143">[143]</a></sup>
</td></tr></tbody></table>

<h2><span id="Society_and_culture">Society and culture</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=26" title="Edit section: Society and culture">edit</a><span>]</span></span></h2>
<h3><span id="Cost">Cost</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=27" title="Edit section: Cost">edit</a><span>]</span></span></h3>
<p>The <a href="/wiki/Global_Alliance_for_Vaccines_and_Immunization" title="Global Alliance for Vaccines and Immunization">Global Alliance for Vaccines and Immunization</a> supplies the inactivated vaccine to developing countries for as little as <a href="/wiki/Euro" title="Euro">€</a>0.75 (about <span>US$0.86</span>) per dose in 10-dose vials, in 2015.<sup id="cite_ref-144"><a href="#cite_note-144">[144]</a></sup>
</p>
<h3><span id="Misconceptions">Misconceptions</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=28" title="Edit section: Misconceptions">edit</a><span>]</span></span></h3>
<p>A misconception has been present in Pakistan that polio vaccine contained <i><a href="/wiki/Haram" title="Haram">haram</a></i> ingredients and could cause impotence and infertility in male children, leading some parents not to have their children vaccinated. This belief is most common in the <a href="/wiki/Khyber_Pakhtunkhwa" title="Khyber Pakhtunkhwa">Khyber Pakhtunkhwa</a> province and the <a href="/wiki/FATA" title="FATA">FATA</a> region. Attacks on polio vaccination teams have also occurred, thereby hampering international efforts to eradicate polio in Pakistan and globally.<sup id="cite_ref-145"><a href="#cite_note-145">[145]</a></sup><sup id="cite_ref-146"><a href="#cite_note-146">[146]</a></sup>
</p>
<h3><span id="Popular_culture">Popular culture</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=29" title="Edit section: Popular culture">edit</a><span>]</span></span></h3>
<p>The 1964 pop song <a href="/wiki/A_Spoonful_of_Sugar" title="A Spoonful of Sugar">A Spoonful of Sugar</a> (Helps the Medicine Go Down) refers to the oral vaccine administered on a sugar cube.
</p>
<h2><span id="References">References</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=30" title="Edit section: References">edit</a><span>]</span></span></h2>
<div><ol>
<li id="cite_note-Drugs.com_pregnancy-1"><span><b><a href="#cite_ref-Drugs.com_pregnancy_1-0">^</a></b></span> <span><span title="www.drugs.com"><a rel="nofollow" href="https://www.drugs.com/pregnancy/poliovirus-vaccine-inactivated.html">Use During Pregnancy and Breastfeeding</a></span></span>
</li>
<li id="cite_note-WHO2016-2"><span>^ <a href="#cite_ref-WHO2016_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WHO2016_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-WHO2016_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-WHO2016_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-WHO2016_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-WHO2016_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-WHO2016_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-WHO2016_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-WHO2016_2-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-WHO2016_2-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-WHO2016_2-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-WHO2016_2-11"><sup><i><b>l</b></i></sup></a></span> <span><cite id="CITEREFWorld_Health_Organization2016">World Health Organization (March 2016). <a rel="nofollow" href="https://web.archive.org/web/20160410123722/http://www.who.int/wer/2016/wer9112/en/">"Polio vaccines: WHO position paper"</a>. <i>Weekly Epidemiological Record</i>. <b>91</b> (12): 145–68. <a href="/wiki/Hdl_(identifier)" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" href="//hdl.handle.net/10665%2F254399">10665/254399</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/27039410">27039410</a>. Archived from <a rel="nofollow" href="https://www.who.int/wer/2016/wer9112/en/">the original</a> on 10 April 2016. <a rel="nofollow" href="https://www.who.int/immunization/policy/position_papers/WHO_PP_polio_summary_mar2016.pdf?ua=1">Lay summary</a> <span>(PDF)</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Weekly+Epidemiological+Record&amp;rft.atitle=Polio+vaccines%3A+WHO+position+paper&amp;rft.volume=91&amp;rft.issue=12&amp;rft.pages=145-68&amp;rft.date=2016-03&amp;rft_id=info%3Ahdl%2F10665%2F254399&amp;rft_id=info%3Apmid%2F27039410&amp;rft.au=World+Health+Organization&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fwer%2F2016%2Fwer9112%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span> </span>
</li>
<li id="cite_note-Aylward_2006-3"><span><b><a href="#cite_ref-Aylward_2006_3-0">^</a></b></span> <span><cite id="CITEREFAylward2006">Aylward RB (2006). "Eradicating polio: today's challenges and tomorrow's legacy". <i>Annals of Tropical Medicine and Parasitology</i>. <b>100</b> (5–6): 401–413. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1179%2F136485906X97354">10.1179/136485906X97354</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/16899145">16899145</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:25327986">25327986</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Tropical+Medicine+and+Parasitology&amp;rft.atitle=Eradicating+polio%3A+today%27s+challenges+and+tomorrow%27s+legacy&amp;rft.volume=100&amp;rft.issue=5%E2%80%936&amp;rft.pages=401-413&amp;rft.date=2006&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25327986%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16899145&amp;rft_id=info%3Adoi%2F10.1179%2F136485906X97354&amp;rft.aulast=Aylward&amp;rft.aufirst=RB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-4"><span><b><a href="#cite_ref-4">^</a></b></span> <span><cite id="CITEREFSchonbergerKaplanKim-FarleyMoore1984">Schonberger LB, Kaplan J, Kim-Farley R, Moore M, Eddins DL, Hatch M (1984). "Control of paralytic poliomyelitis in the United States". <i>Reviews of Infectious Diseases</i>. 6 Suppl 2: S424–S426. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1093%2Fclinids%2F6.Supplement_2.S424">10.1093/clinids/6.Supplement_2.S424</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/6740085">6740085</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reviews+of+Infectious+Diseases&amp;rft.atitle=Control+of+paralytic+poliomyelitis+in+the+United+States&amp;rft.volume=6+Suppl+2&amp;rft.pages=S424-S426&amp;rft.date=1984&amp;rft_id=info%3Adoi%2F10.1093%2Fclinids%2F6.Supplement_2.S424&amp;rft_id=info%3Apmid%2F6740085&amp;rft.aulast=Schonberger&amp;rft.aufirst=LB&amp;rft.au=Kaplan%2C+J&amp;rft.au=Kim-Farley%2C+R&amp;rft.au=Moore%2C+M&amp;rft.au=Eddins%2C+DL&amp;rft.au=Hatch%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-gwp2013-5"><span><b><a href="#cite_ref-gwp2013_5-0">^</a></b></span> <span><cite><a rel="nofollow" href="http://polioeradication.org/wp-content/uploads/2019/02/global-wild-poliovirus-2013-2018-20190201.pdf">"Global Wild Poliovirus 2014–2019"</a> <span>(PDF)</span><span>. Retrieved <span>3 February</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Global+Wild+Poliovirus+2014%E2%80%932019&amp;rft_id=http%3A%2F%2Fpolioeradication.org%2Fwp-content%2Fuploads%2F2019%2F02%2Fglobal-wild-poliovirus-2013-2018-20190201.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-6"><span><b><a href="#cite_ref-6">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.who.int/features/qa/07/en/">"Does polio still exist? Is it curable?"</a>. <i><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO)</i><span>. Retrieved <span>21 May</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization+%28WHO%29&amp;rft.atitle=Does+polio+still+exist%3F+Is+it+curable%3F&amp;rft_id=https%3A%2F%2Fwww.who.int%2Ffeatures%2Fqa%2F07%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-WHO2017Fs114-7"><span><b><a href="#cite_ref-WHO2017Fs114_7-0">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.who.int/mediacentre/factsheets/fs114/en/">"Poliomyelitis"</a>. <i><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO)</i>. <a rel="nofollow" href="https://web.archive.org/web/20170418105535/http://www.who.int/mediacentre/factsheets/fs114/en/">Archived</a> from the original on 18 April 2017<span>. Retrieved <span>25 April</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization+%28WHO%29&amp;rft.atitle=Poliomyelitis&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs114%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-GPEI-nOPV2-8"><span>^ <a href="#cite_ref-GPEI-nOPV2_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-GPEI-nOPV2_8-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://polioeradication.org/nopv2/">"GPEI-nOPV2"</a><span>. Retrieved <span>1 August</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GPEI-nOPV2&amp;rft_id=https%3A%2F%2Fpolioeradication.org%2Fnopv2%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Kowproski_obit-9"><span>^ <a href="#cite_ref-Kowproski_obit_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kowproski_obit_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Kowproski_obit_9-2"><sup><i><b>c</b></i></sup></a></span> <span><cite id="CITEREFFox2013">Fox M (20 April 2013). <a rel="nofollow" href="https://www.nytimes.com/2013/04/21/us/hilary-koprowski-developed-live-virus-polio-vaccine-dies-at-96.html">"Hilary Koprowski, Who Developed First Live-Virus Polio Vaccine, Dies at 96"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Hilary+Koprowski%2C+Who+Developed+First+Live-Virus+Polio+Vaccine%2C+Dies+at+96&amp;rft.date=2013-04-20&amp;rft.aulast=Fox&amp;rft.aufirst=Margalit&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2013%2F04%2F21%2Fus%2Fhilary-koprowski-developed-live-virus-polio-vaccine-dies-at-96.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-10"><span><b><a href="#cite_ref-10">^</a></b></span> <span><cite id="CITEREFBazin2011">Bazin H (2011). <a rel="nofollow" href="https://books.google.com/books?id=orjaA_7sYZQC&amp;pg=PA395"><i>Vaccination: A History</i></a>. John Libbey Eurotext. p.&nbsp;395. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-2742007752" title="Special:BookSources/978-2742007752"><bdi>978-2742007752</bdi></a>. <a rel="nofollow" href="https://web.archive.org/web/20170908183608/https://books.google.com/books?id=orjaA_7sYZQC&amp;pg=PA395">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Vaccination%3A+A+History&amp;rft.pages=395&amp;rft.pub=John+Libbey+Eurotext&amp;rft.date=2011&amp;rft.isbn=978-2742007752&amp;rft.aulast=Bazin&amp;rft.aufirst=H&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DorjaA_7sYZQC%26pg%3DPA395&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-11"><span><b><a href="#cite_ref-11">^</a></b></span> <span><cite id="CITEREFSmithLeggat2005">Smith DR, Leggat PA (2005). <a rel="nofollow" href="https://doi.org/10.2739%2Fkurumemedj.52.111">"Pioneering figures in medicine: Albert Bruce Sabin – inventor of the oral polio vaccine"</a>. <i>The Kurume Medical Journal</i>. <b>52</b> (3): 111–116. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<span title="Freely accessible"><a rel="nofollow" href="https://doi.org/10.2739%2Fkurumemedj.52.111">10.2739/kurumemedj.52.111</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/16422178">16422178</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Kurume+Medical+Journal&amp;rft.atitle=Pioneering+figures+in+medicine%3A+Albert+Bruce+Sabin+%E2%80%93+inventor+of+the+oral+polio+vaccine&amp;rft.volume=52&amp;rft.issue=3&amp;rft.pages=111-116&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.2739%2Fkurumemedj.52.111&amp;rft_id=info%3Apmid%2F16422178&amp;rft.aulast=Smith&amp;rft.aufirst=DR&amp;rft.au=Leggat%2C+PA&amp;rft_id=%2F%2Fdoi.org%2F10.2739%252Fkurumemedj.52.111&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-WHO21st-12"><span><b><a href="#cite_ref-WHO21st_12-0">^</a></b></span> <span><cite id="CITEREFWorld_Health_Organization2019"><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. <a href="/wiki/Hdl_(identifier)" title="Hdl (identifier)">hdl</a>:<span title="Freely accessible"><a rel="nofollow" href="//hdl.handle.net/10665%2F325771">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=World+Health+Organization+model+list+of+essential+medicines%3A+21st+list+2019&amp;rft.place=Geneva&amp;rft.pub=World+Health+Organization&amp;rft.date=2019&amp;rft_id=info%3Ahdl%2F10665%2F325771&amp;rft.au=World+Health+Organization&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Fine-13"><span>^ <a href="#cite_ref-Fine_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Fine_13-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFFineCarneiro1999">Fine PE, Carneiro IA (November 1999). <a rel="nofollow" href="https://doi.org/10.1093%2Foxfordjournals.aje.a009924">"Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative"</a>. <i>American Journal of Epidemiology</i>. <b>150</b> (10): 1001–1021. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<span title="Freely accessible"><a rel="nofollow" href="https://doi.org/10.1093%2Foxfordjournals.aje.a009924">10.1093/oxfordjournals.aje.a009924</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/10568615">10568615</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Epidemiology&amp;rft.atitle=Transmissibility+and+persistence+of+oral+polio+vaccine+viruses%3A+implications+for+the+global+poliomyelitis+eradication+initiative&amp;rft.volume=150&amp;rft.issue=10&amp;rft.pages=1001-1021&amp;rft.date=1999-11&amp;rft_id=info%3Adoi%2F10.1093%2Foxfordjournals.aje.a009924&amp;rft_id=info%3Apmid%2F10568615&amp;rft.aulast=Fine&amp;rft.aufirst=PE&amp;rft.au=Carneiro%2C+IA&amp;rft_id=%2F%2Fdoi.org%2F10.1093%252Foxfordjournals.aje.a009924&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-14"><span><b><a href="#cite_ref-14">^</a></b></span> <span><cite id="CITEREFKoikeTayaKurataAbe1991">Koike S, Taya C, Kurata T, Abe S, Ise I, Yonekawa H, Nomoto A (February 1991). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC50932">"Transgenic mice susceptible to poliovirus"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>88</b> (3): 951–955. <a href="/wiki/Bibcode_(identifier)" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" href="https://ui.adsabs.harvard.edu/abs/1991PNAS...88..951K">1991PNAS...88..951K</a>. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<span title="Freely accessible"><a rel="nofollow" href="https://doi.org/10.1073%2Fpnas.88.3.951">10.1073/pnas.88.3.951</a></span>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC50932">50932</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/1846972">1846972</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Transgenic+mice+susceptible+to+poliovirus&amp;rft.volume=88&amp;rft.issue=3&amp;rft.pages=951-955&amp;rft.date=1991-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC50932%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F1846972&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.88.3.951&amp;rft_id=info%3Abibcode%2F1991PNAS...88..951K&amp;rft.aulast=Koike&amp;rft.aufirst=S&amp;rft.au=Taya%2C+C&amp;rft.au=Kurata%2C+T&amp;rft.au=Abe%2C+S&amp;rft.au=Ise%2C+I&amp;rft.au=Yonekawa%2C+H&amp;rft.au=Nomoto%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC50932&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Robertson_1993-15"><span>^ <a href="#cite_ref-Robertson_1993_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Robertson_1993_15-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFRobertson">Robertson S. <a rel="nofollow" href="https://web.archive.org/web/20191019064736/https://www.who.int/ihr/polio1993en.pdf"><i>Module 6: Poliomyelitis</i></a> <span>(PDF)</span>. The Immunological Basis for Immunization Series. <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO). WHO/EPI/GEN/93.16. Archived from <a rel="nofollow" href="https://www.who.int/ihr/polio1993en.pdf">the original</a> <span>(PDF)</span> on 19 October 2019<span>. Retrieved <span>18 October</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Module+6%3A+Poliomyelitis&amp;rft.series=The+Immunological+Basis+for+Immunization+Series&amp;rft.pub=World+Health+Organization+%28WHO%29&amp;rft.aulast=Robertson&amp;rft.aufirst=Susan&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fihr%2Fpolio1993en.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-16"><span><b><a href="#cite_ref-16">^</a></b></span> <span><cite id="CITEREFCanada2007">Canada, Public Health Agency of (18 July 2007). <a rel="nofollow" href="https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-17-poliomyelitis-vaccine.html">"Poliomyelitis vaccine: Canadian Immunization Guide"</a>. <i>www.canada.ca</i><span>. Retrieved <span>1 August</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.canada.ca&amp;rft.atitle=Poliomyelitis+vaccine%3A+Canadian+Immunization+Guide&amp;rft.date=2007-07-18&amp;rft.aulast=Canada&amp;rft.aufirst=Public+Health+Agency+of&amp;rft_id=https%3A%2F%2Fwww.canada.ca%2Fen%2Fpublic-health%2Fservices%2Fpublications%2Fhealthy-living%2Fcanadian-immunization-guide-part-4-active-vaccines%2Fpage-17-poliomyelitis-vaccine.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-17"><span><b><a href="#cite_ref-17">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.cdc.gov/vaccines/vpd/polio/public/index.html">"Polio Vaccination: What Everyone Should Know | CDC"</a>. <i>www.cdc.gov</i>. 25 March 2021<span>. Retrieved <span>1 August</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.cdc.gov&amp;rft.atitle=Polio+Vaccination%3A+What+Everyone+Should+Know+%7C+CDC&amp;rft.date=2021-03-25&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fvpd%2Fpolio%2Fpublic%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-ReferenceZ-18"><span><b><a href="#cite_ref-ReferenceZ_18-0">^</a></b></span> <span><cite id="CITEREFWahidCannonChow2005">Wahid R, Cannon MJ, Chow M (May 2005). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1091702">"Virus-Specific CD4+ and CD8+ Cytotoxic T-Cell Responses and Long-Term T-Cell Memory in Individuals Vaccinated against Polio"</a>. <i>Journal of Virology</i>. <b>79</b> (10): 5988–5995. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1128%2FJVI.79.10.5988-5995.2005">10.1128/JVI.79.10.5988-5995.2005</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1091702">1091702</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/15857985">15857985</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Virology&amp;rft.atitle=Virus-Specific+CD4%2B+and+CD8%2B+Cytotoxic+T-Cell+Responses+and+Long-Term+T-Cell+Memory+in+Individuals+Vaccinated+against+Polio&amp;rft.volume=79&amp;rft.issue=10&amp;rft.pages=5988-5995&amp;rft.date=2005-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1091702%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15857985&amp;rft_id=info%3Adoi%2F10.1128%2FJVI.79.10.5988-5995.2005&amp;rft.aulast=Wahid&amp;rft.aufirst=R&amp;rft.au=Cannon%2C+MJ&amp;rft.au=Chow%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1091702&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-PinkPages-19"><span>^ <a href="#cite_ref-PinkPages_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PinkPages_19-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-PinkPages_19-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-PinkPages_19-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-PinkPages_19-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-PinkPages_19-5"><sup><i><b>f</b></i></sup></a></span> <span><cite id="CITEREFAtkinsonHamborskyMcIntyreWolfe2008">Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds. (2008). <a rel="nofollow" href="https://web.archive.org/web/20080924184516/http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/polio-508.pdf"><i>Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book)</i></a> <span>(PDF)</span> (10th ed. (2nd printing)&nbsp;ed.). Washington, D.C.: Public Health Foundation. Archived from <a rel="nofollow" href="https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/polio-508.pdf">the original</a> <span>(PDF)</span> on 24 September 2008<span>. Retrieved <span>29 November</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Epidemiology+and+Prevention+of+Vaccine-Preventable+Diseases+%28The+Pink+Book%29&amp;rft.place=Washington%2C+D.C.&amp;rft.edition=10th+ed.+%282nd+printing%29&amp;rft.pub=Public+Health+Foundation&amp;rft.date=2008&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fpubs%2Fpinkbook%2Fdownloads%2Fpolio-508.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Peds-20"><span>^ <a href="#cite_ref-Peds_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Peds_20-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://doi.org/10.1542%2Fpeds.99.2.300">"Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. American Academy of Pediatrics Committee on Infectious Diseases"</a>. <i>Pediatrics</i>. <b>99</b> (2): 300–305. February 1997. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<span title="Freely accessible"><a rel="nofollow" href="https://doi.org/10.1542%2Fpeds.99.2.300">10.1542/peds.99.2.300</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/9024465">9024465</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatrics&amp;rft.atitle=Poliomyelitis+prevention%3A+recommendations+for+use+of+inactivated+poliovirus+vaccine+and+live+oral+poliovirus+vaccine.+American+Academy+of+Pediatrics+Committee+on+Infectious+Diseases&amp;rft.volume=99&amp;rft.issue=2&amp;rft.pages=300-305&amp;rft.date=1997-02&amp;rft_id=info%3Adoi%2F10.1542%2Fpeds.99.2.300&amp;rft_id=info%3Apmid%2F9024465&amp;rft_id=%2F%2Fdoi.org%2F10.1542%252Fpeds.99.2.300&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-ReferenceA-21"><span>^ <a href="#cite_ref-ReferenceA_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ReferenceA_21-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFMarinPatelOberstePallansch2017">Marin M, Patel M, Oberste S, Pallansch MA (January 2017). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5687270">"Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States"</a>. <i>MMWR. Morbidity and Mortality Weekly Report</i>. <b>66</b> (1): 23–25. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.15585%2Fmmwr.mm6601a6">10.15585/mmwr.mm6601a6</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5687270">5687270</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/28081056">28081056</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MMWR.+Morbidity+and+Mortality+Weekly+Report&amp;rft.atitle=Guidance+for+Assessment+of+Poliovirus+Vaccination+Status+and+Vaccination+of+Children+Who+Have+Received+Poliovirus+Vaccine+Outside+the+United+States&amp;rft.volume=66&amp;rft.issue=1&amp;rft.pages=23-25&amp;rft.date=2017-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5687270%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28081056&amp;rft_id=info%3Adoi%2F10.15585%2Fmmwr.mm6601a6&amp;rft.aulast=Marin&amp;rft.aufirst=M&amp;rft.au=Patel%2C+M&amp;rft.au=Oberste%2C+S&amp;rft.au=Pallansch%2C+MA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5687270&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-22"><span><b><a href="#cite_ref-22">^</a></b></span> <span><cite id="CITEREFAl_Idrus2016">Al Idrus A (13 April 2016). <a rel="nofollow" href="http://www.fiercepharma.com/vaccines/worldwide-switch-to-bivalent-oral-polio-vaccine-to-kick-off-on-Sunday">"Worldwide switch to bivalent oral polio vaccine to kick off on Sunday"</a>. fiercepharma.com. <a rel="nofollow" href="https://web.archive.org/web/20160415210126/http://www.fiercepharma.com/vaccines/worldwide-switch-to-bivalent-oral-polio-vaccine-to-kick-off-on-sunday">Archived</a> from the original on 15 April 2016<span>. Retrieved <span>1 May</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Worldwide+switch+to+bivalent+oral+polio+vaccine+to+kick+off+on+Sunday&amp;rft.pub=fiercepharma.com&amp;rft.date=2016-04-13&amp;rft.aulast=Al+Idrus&amp;rft.aufirst=Amirah&amp;rft_id=http%3A%2F%2Fwww.fiercepharma.com%2Fvaccines%2Fworldwide-switch-to-bivalent-oral-polio-vaccine-to-kick-off-on-Sunday&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-pmid28838179-23"><span><b><a href="#cite_ref-pmid28838179_23-0">^</a></b></span> <span><cite id="CITEREFRamirez_GonzalezFarrellMenningGaron2017">Ramirez Gonzalez A, Farrell M, Menning L, Garon J, Everts H, Hampton LM, Dolan SB, Shendale S, Wanyoike S, Veira CL, Châtellier GM, Kurji F, Rubin J, Boualam L, Chang Blanc D, Patel M (July 2017). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5854099">"Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective"</a>. <i>The Journal of Infectious Diseases</i>. <b>216</b> (suppl 1): S183–S192. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1093%2Finfdis%2Fjiw626">10.1093/infdis/jiw626</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5854099">5854099</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/28838179">28838179</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Infectious+Diseases&amp;rft.atitle=Implementing+the+Synchronized+Global+Switch+from+Trivalent+to+Bivalent+Oral+Polio+Vaccines-Lessons+Learned+From+the+Global+Perspective&amp;rft.volume=216&amp;rft.issue=suppl+1&amp;rft.pages=S183-S192&amp;rft.date=2017-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5854099%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28838179&amp;rft_id=info%3Adoi%2F10.1093%2Finfdis%2Fjiw626&amp;rft.aulast=Ramirez+Gonzalez&amp;rft.aufirst=A&amp;rft.au=Farrell%2C+M&amp;rft.au=Menning%2C+L&amp;rft.au=Garon%2C+J&amp;rft.au=Everts%2C+H&amp;rft.au=Hampton%2C+LM&amp;rft.au=Dolan%2C+SB&amp;rft.au=Shendale%2C+S&amp;rft.au=Wanyoike%2C+S&amp;rft.au=Veira%2C+CL&amp;rft.au=Ch%C3%A2tellier%2C+GM&amp;rft.au=Kurji%2C+F&amp;rft.au=Rubin%2C+J&amp;rft.au=Boualam%2C+L&amp;rft.au=Chang+Blanc%2C+D&amp;rft.au=Patel%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5854099&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-24"><span><b><a href="#cite_ref-24">^</a></b></span> <span><cite><a rel="nofollow" href="https://polioeradication.org/wp-content/uploads/2021/03/GPEI-cVDPV2-nOPV2-Factsheet-20210312-EN.pdf">"GPEI Strategy for the Response to cVDPV2 2020-2021"</a> <span>(PDF)</span>. <i>Polio Global Eradication Initiative</i><span>. Retrieved <span>1 August</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Polio+Global+Eradication+Initiative&amp;rft.atitle=GPEI+Strategy+for+the+Response+to+cVDPV2+2020-2021&amp;rft_id=https%3A%2F%2Fpolioeradication.org%2Fwp-content%2Fuploads%2F2021%2F03%2FGPEI-cVDPV2-nOPV2-Factsheet-20210312-EN.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-25"><span><b><a href="#cite_ref-25">^</a></b></span> <span><cite><a rel="nofollow" href="https://ourworldindata.org/grapher/polio-vaccine-coverage-of-one-year-olds">"Share of one-year-olds vaccinated against polio (Pol3)"</a>. <i>Our World in Data</i><span>. Retrieved <span>4 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Our+World+in+Data&amp;rft.atitle=Share+of+one-year-olds+vaccinated+against+polio+%28Pol3%29&amp;rft_id=https%3A%2F%2Fourworldindata.org%2Fgrapher%2Fpolio-vaccine-coverage-of-one-year-olds&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-26"><span><b><a href="#cite_ref-26">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.webmd.com/drugs/2/drug-14411/poliovirus-vaccine-injection/details/list-sideeffects">"Common and Rare Side Effects for poliovirus vaccine injection"</a>. <i>www.webmd.com</i><span>. Retrieved <span>24 August</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.webmd.com&amp;rft.atitle=Common+and+Rare+Side+Effects+for+poliovirus+vaccine+injection&amp;rft_id=https%3A%2F%2Fwww.webmd.com%2Fdrugs%2F2%2Fdrug-14411%2Fpoliovirus-vaccine-injection%2Fdetails%2Flist-sideeffects&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Shimizu_2004-27"><span><b><a href="#cite_ref-Shimizu_2004_27-0">^</a></b></span> <span><cite id="CITEREFShimizuThorleyPaladinBrussen2004">Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, Yuen L, Utama A, Tano Y, Arita M, Yoshida H, Yoneyama T, Benegas A, Roesel S, Pallansch M, Kew O, Miyamura T (December 2004). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC533948">"Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001"</a>. <i>Journal of Virology</i>. <b>78</b> (24): 13512–13521. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1128%2FJVI.78.24.13512-13521.2004">10.1128/JVI.78.24.13512-13521.2004</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC533948">533948</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/15564462">15564462</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Virology&amp;rft.atitle=Circulation+of+type+1+vaccine-derived+poliovirus+in+the+Philippines+in+2001&amp;rft.volume=78&amp;rft.issue=24&amp;rft.pages=13512-13521&amp;rft.date=2004-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC533948%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15564462&amp;rft_id=info%3Adoi%2F10.1128%2FJVI.78.24.13512-13521.2004&amp;rft.aulast=Shimizu&amp;rft.aufirst=H&amp;rft.au=Thorley%2C+B&amp;rft.au=Paladin%2C+FJ&amp;rft.au=Brussen%2C+KA&amp;rft.au=Stambos%2C+V&amp;rft.au=Yuen%2C+L&amp;rft.au=Utama%2C+A&amp;rft.au=Tano%2C+Y&amp;rft.au=Arita%2C+M&amp;rft.au=Yoshida%2C+H&amp;rft.au=Yoneyama%2C+T&amp;rft.au=Benegas%2C+A&amp;rft.au=Roesel%2C+S&amp;rft.au=Pallansch%2C+M&amp;rft.au=Kew%2C+O&amp;rft.au=Miyamura%2C+T&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC533948&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-28"><span><b><a href="#cite_ref-28">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.who.int/features/qa/64/en/">"What is vaccine-derived polio?"</a>. <i><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO)</i>. <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO). April 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization+%28WHO%29&amp;rft.atitle=What+is+vaccine-derived+polio%3F&amp;rft.date=2017-04&amp;rft_id=https%3A%2F%2Fwww.who.int%2Ffeatures%2Fqa%2F64%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Cono-29"><span><b><a href="#cite_ref-Cono_29-0">^</a></b></span> <span><cite id="CITEREFConoAlexander2002">Cono J, Alexander LN (2002). <a rel="nofollow" href="https://web.archive.org/web/20111022064610/http://cdc.gov/vaccines//pubs/surv-manual/3rd-edition-chpt10_polio.pdf">"Chapter 10: Poliomyelitis"</a> <span>(PDF)</span>. <i>Vaccine-Preventable Disease Surveillance Manual</i> (3rd&nbsp;ed.). Archived from <a rel="nofollow" href="https://cdc.gov/vaccines//pubs/surv-manual/3rd-edition-chpt10_polio.pdf">the original</a> <span>(PDF)</span> on 22 October 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Vaccine-Preventable+Disease+Surveillance+Manual&amp;rft.atitle=Chapter+10%3A+Poliomyelitis&amp;rft.date=2002&amp;rft.aulast=Cono&amp;rft.aufirst=J&amp;rft.au=Alexander%2C+LN&amp;rft_id=http%3A%2F%2Fcdc.gov%2Fvaccines%2F%2Fpubs%2Fsurv-manual%2F3rd-edition-chpt10_polio.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-who-Q&amp;A-30"><span><b><a href="#cite_ref-who-Q&amp;A_30-0">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.who.int/features/qa/64/en/">"What is vaccine-derived polio?"</a>. <i><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO)</i>. October 2014. <a rel="nofollow" href="https://web.archive.org/web/20150907005325/http://www.who.int/features/qa/64/en/">Archived</a> from the original on 7 September 2015<span>. Retrieved <span>6 September</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization+%28WHO%29&amp;rft.atitle=What+is+vaccine-derived+polio%3F&amp;rft.date=2014-10&amp;rft_id=https%3A%2F%2Fwww.who.int%2Ffeatures%2Fqa%2F64%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Kew_2002-31"><span><b><a href="#cite_ref-Kew_2002_31-0">^</a></b></span> <span><cite id="CITEREFKewMorris-GlasgowLandaverdeBurns2002">Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z,  et&nbsp;al. (April 2002). <a rel="nofollow" href="https://zenodo.org/record/1230812">"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus"</a>. <i>Science</i>. <b>296</b> (5566): 356–359. <a href="/wiki/Bibcode_(identifier)" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" href="https://ui.adsabs.harvard.edu/abs/2002Sci...296..356K">2002Sci...296..356K</a>. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1126%2Fscience.1068284">10.1126/science.1068284</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/11896235">11896235</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:38725709">38725709</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Outbreak+of+poliomyelitis+in+Hispaniola+associated+with+circulating+type+1+vaccine-derived+poliovirus&amp;rft.volume=296&amp;rft.issue=5566&amp;rft.pages=356-359&amp;rft.date=2002-04&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1068284&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A38725709%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11896235&amp;rft_id=info%3Abibcode%2F2002Sci...296..356K&amp;rft.aulast=Kew&amp;rft.aufirst=O&amp;rft.au=Morris-Glasgow%2C+V&amp;rft.au=Landaverde%2C+M&amp;rft.au=Burns%2C+C&amp;rft.au=Shaw%2C+J&amp;rft.au=Garib%2C+Z&amp;rft.au=Andr%C3%A9%2C+J&amp;rft.au=Blackman%2C+E&amp;rft.au=Freeman%2C+CJ&amp;rft.au=Jorba%2C+J&amp;rft.au=Sutter%2C+R&amp;rft.au=Tambini%2C+G&amp;rft.au=Venczel%2C+L&amp;rft.au=Pedreira%2C+C&amp;rft.au=Laender%2C+F&amp;rft.au=Shimizu%2C+H&amp;rft.au=Yoneyama%2C+T&amp;rft.au=Miyamura%2C+T&amp;rft.au=van+Der+Avoort%2C+H&amp;rft.au=Oberste%2C+MS&amp;rft.au=Kilpatrick%2C+D&amp;rft.au=Cochi%2C+S&amp;rft.au=Pallansch%2C+M&amp;rft.au=de+Quadros%2C+C&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F1230812&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Yang_2003-32"><span><b><a href="#cite_ref-Yang_2003_32-0">^</a></b></span> <span><cite id="CITEREFYangNaguibYangNasr2003">Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, Campagnoli R, van der Avoort H, Shimizu H, Yoneyama T, Miyamura T, Pallansch M, Kew O (August 2003). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC165252">"Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993"</a>. <i>Journal of Virology</i>. <b>77</b> (15): 8366–8377. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1128%2FJVI.77.15.8366-8377.2003">10.1128/JVI.77.15.8366-8377.2003</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC165252">165252</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/12857906">12857906</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Virology&amp;rft.atitle=Circulation+of+endemic+type+2+vaccine-derived+poliovirus+in+Egypt+from+1983+to+1993&amp;rft.volume=77&amp;rft.issue=15&amp;rft.pages=8366-8377&amp;rft.date=2003-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC165252%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12857906&amp;rft_id=info%3Adoi%2F10.1128%2FJVI.77.15.8366-8377.2003&amp;rft.aulast=Yang&amp;rft.aufirst=CF&amp;rft.au=Naguib%2C+T&amp;rft.au=Yang%2C+SJ&amp;rft.au=Nasr%2C+E&amp;rft.au=Jorba%2C+J&amp;rft.au=Ahmed%2C+N&amp;rft.au=Campagnoli%2C+R&amp;rft.au=van+der+Avoort%2C+H&amp;rft.au=Shimizu%2C+H&amp;rft.au=Yoneyama%2C+T&amp;rft.au=Miyamura%2C+T&amp;rft.au=Pallansch%2C+M&amp;rft.au=Kew%2C+O&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC165252&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-33"><span><b><a href="#cite_ref-33">^</a></b></span> <span><cite id="CITEREFKunasekaran">Kunasekaran M. <a rel="nofollow" href="https://sphcm.med.unsw.edu.au/infectious-diseases-blog/eradication-polio-syria-being-left-behind">"Eradication of polio – Is Syria being left behind?"</a>. <i>UNSW School of Public Health and Community Medicine</i><span>. Retrieved <span>6 October</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=UNSW+School+of+Public+Health+and+Community+Medicine&amp;rft.atitle=Eradication+of+polio+%E2%80%93+Is+Syria+being+left+behind%3F&amp;rft.aulast=Kunasekaran&amp;rft.aufirst=Mohana&amp;rft_id=https%3A%2F%2Fsphcm.med.unsw.edu.au%2Finfectious-diseases-blog%2Feradication-polio-syria-being-left-behind&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-34"><span><b><a href="#cite_ref-34">^</a></b></span> <span><cite><a rel="nofollow" href="https://web.archive.org/web/20150311165339/http://www.who.int/immunization/diseases/poliomyelitis/endgame_objective2/oral_polio_vaccine/en/">"Replacing trivalent OPV with bivalent OPV"</a>. <i><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO)</i>. Archived from <a rel="nofollow" href="https://www.who.int/immunization/diseases/poliomyelitis/endgame_objective2/oral_polio_vaccine/en/">the original</a> on 11 March 2015<span>. Retrieved <span>30 May</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization+%28WHO%29&amp;rft.atitle=Replacing+trivalent+OPV+with+bivalent+OPV&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fimmunization%2Fdiseases%2Fpoliomyelitis%2Fendgame_objective2%2Foral_polio_vaccine%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-35"><span><b><a href="#cite_ref-35">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.who.int/news-room/fact-sheets/detail/poliomyelitis">"Poliomyelitis"</a>. <i><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO)</i>. 22 July 2019<span>. Retrieved <span>18 October</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization+%28WHO%29&amp;rft.atitle=Poliomyelitis&amp;rft.date=2019-07-22&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fnews-room%2Ffact-sheets%2Fdetail%2Fpoliomyelitis&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-SV-36"><span>^ <a href="#cite_ref-SV_36-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-SV_36-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-SV_36-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-SV_36-3"><sup><i><b>d</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://web.archive.org/web/20130522091608/http://www.cdc.gov/vaccinesafety/updates/archive/polio_and_cancer_factsheet.htm">"Simian Virus 40 (SV40), Polio Vaccine, and Cancer"</a>. <i>Vaccine Safety</i>. Centers for Disease Control. 22 April 2004. Archived from <a rel="nofollow" href="https://www.cdc.gov/vaccinesafety/updates/archive/polio_and_cancer_factsheet.htm">the original</a> on 22 May 2013<span>. Retrieved <span>22 May</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Vaccine+Safety&amp;rft.atitle=Simian+Virus+40+%28SV40%29%2C+Polio+Vaccine%2C+and+Cancer&amp;rft.date=2004-04-22&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fvaccinesafety%2Fupdates%2Farchive%2Fpolio_and_cancer_factsheet.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Eddy_1961-37"><span><b><a href="#cite_ref-Eddy_1961_37-0">^</a></b></span> <span><cite id="CITEREFEddyBormanBerkeleyYoung1961">Eddy BE, Borman GS, Berkeley WH, Young RD (May 1961). "Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts". <i>Proceedings of the Society for Experimental Biology and Medicine</i>. <b>107</b>: 191–197. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.3181%2F00379727-107-26576">10.3181/00379727-107-26576</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/13725644">13725644</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:31275908">31275908</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+Society+for+Experimental+Biology+and+Medicine&amp;rft.atitle=Tumors+induced+in+hamsters+by+injection+of+rhesus+monkey+kidney+cell+extracts&amp;rft.volume=107&amp;rft.pages=191-197&amp;rft.date=1961-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A31275908%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F13725644&amp;rft_id=info%3Adoi%2F10.3181%2F00379727-107-26576&amp;rft.aulast=Eddy&amp;rft.aufirst=BE&amp;rft.au=Borman%2C+GS&amp;rft.au=Berkeley%2C+WH&amp;rft.au=Young%2C+RD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-38"><span><b><a href="#cite_ref-38">^</a></b></span> <span><cite id="CITEREFCarbone1999">Carbone M (December 1999). "Simian virus 40 and human tumors: It is time to study mechanisms". <i>Journal of Cellular Biochemistry</i>. <b>76</b> (2): 189–193. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1002%2F%28SICI%291097-4644%2820000201%2976%3A2%3C189%3A%3AAID-JCB3%3E3.0.CO%3B2-J">10.1002/(SICI)1097-4644(20000201)76:2&lt;189::AID-JCB3&gt;3.0.CO;2-J</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/10618636">10618636</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Cellular+Biochemistry&amp;rft.atitle=Simian+virus+40+and+human+tumors%3A+It+is+time+to+study+mechanisms&amp;rft.volume=76&amp;rft.issue=2&amp;rft.pages=189-193&amp;rft.date=1999-12&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291097-4644%2820000201%2976%3A2%3C189%3A%3AAID-JCB3%3E3.0.CO%3B2-J&amp;rft_id=info%3Apmid%2F10618636&amp;rft.aulast=Carbone&amp;rft.aufirst=M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-39"><span><b><a href="#cite_ref-39">^</a></b></span> <span><cite id="CITEREFVilchezKozinetzArringtonMadden2003">Vilchez RA, Kozinetz CA, Arrington AS, Madden CR, Butel JS (June 2003). "Simian virus 40 in human cancers". <i>The American Journal of Medicine</i>. <b>114</b> (8): 675–684. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2FS0002-9343%2803%2900087-1">10.1016/S0002-9343(03)00087-1</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/12798456">12798456</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Medicine&amp;rft.atitle=Simian+virus+40+in+human+cancers&amp;rft.volume=114&amp;rft.issue=8&amp;rft.pages=675-684&amp;rft.date=2003-06&amp;rft_id=info%3Adoi%2F10.1016%2FS0002-9343%2803%2900087-1&amp;rft_id=info%3Apmid%2F12798456&amp;rft.aulast=Vilchez&amp;rft.aufirst=RA&amp;rft.au=Kozinetz%2C+CA&amp;rft.au=Arrington%2C+AS&amp;rft.au=Madden%2C+CR&amp;rft.au=Butel%2C+JS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Engels-40"><span>^ <a href="#cite_ref-Engels_40-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Engels_40-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFEngels2005">Engels EA (April 2005). <a rel="nofollow" href="https://zenodo.org/record/1235758">"Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research"</a>. <i>Expert Review of Vaccines</i>. <b>4</b> (2): 197–206. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1586%2F14760584.4.2.197">10.1586/14760584.4.2.197</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/15889993">15889993</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:5861910">5861910</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Review+of+Vaccines&amp;rft.atitle=Cancer+risk+associated+with+receipt+of+vaccines+contaminated+with+simian+virus+40%3A+epidemiologic+research&amp;rft.volume=4&amp;rft.issue=2&amp;rft.pages=197-206&amp;rft.date=2005-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5861910%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15889993&amp;rft_id=info%3Adoi%2F10.1586%2F14760584.4.2.197&amp;rft.aulast=Engels&amp;rft.aufirst=EA&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F1235758&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-41"><span><b><a href="#cite_ref-41">^</a></b></span> <span><cite id="CITEREFBookchin2004">Bookchin D (7 July 2004). <a rel="nofollow" href="https://web.archive.org/web/20040720074452/http://www.newscientist.com/news/news.jsp?id=ns99996116">"Vaccine scandal revives cancer fear"</a>. <i>New Scientist</i>. Archived from <a rel="nofollow" href="https://www.newscientist.com/news/news.jsp?id=ns99996116">the original</a> on 20 July 2004<span>. Retrieved <span>29 November</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+Scientist&amp;rft.atitle=Vaccine+scandal+revives+cancer+fear&amp;rft.date=2004-07-07&amp;rft.aulast=Bookchin&amp;rft.aufirst=D&amp;rft_id=https%3A%2F%2Fwww.newscientist.com%2Fnews%2Fnews.jsp%3Fid%3Dns99996116&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Strickler_1998-42"><span><b><a href="#cite_ref-Strickler_1998_42-0">^</a></b></span> <span><cite id="CITEREFStricklerRosenbergDevesaHertel1998">Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF, Goedert JJ (January 1998). <a rel="nofollow" href="https://doi.org/10.1001%2Fjama.279.4.292">"Contamination of poliovirus vaccines with simian virus 40 (1955–1963) and subsequent cancer rates"</a>. <i>JAMA</i>. <b>279</b> (4): 292–295. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<span title="Freely accessible"><a rel="nofollow" href="https://doi.org/10.1001%2Fjama.279.4.292">10.1001/jama.279.4.292</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/9450713">9450713</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Contamination+of+poliovirus+vaccines+with+simian+virus+40+%281955%E2%80%931963%29+and+subsequent+cancer+rates&amp;rft.volume=279&amp;rft.issue=4&amp;rft.pages=292-295&amp;rft.date=1998-01&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.279.4.292&amp;rft_id=info%3Apmid%2F9450713&amp;rft.aulast=Strickler&amp;rft.aufirst=HD&amp;rft.au=Rosenberg%2C+PS&amp;rft.au=Devesa%2C+SS&amp;rft.au=Hertel%2C+J&amp;rft.au=Fraumeni%2C+JF&amp;rft.au=Goedert%2C+JJ&amp;rft_id=%2F%2Fdoi.org%2F10.1001%252Fjama.279.4.292&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Olin_1998-43"><span><b><a href="#cite_ref-Olin_1998_43-0">^</a></b></span> <span><cite id="CITEREFOlinGiesecke1998">Olin P, Giesecke J (1998). "Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993". <i>Developments in Biological Standardization</i>. <b>94</b>: 227–233. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/9776244">9776244</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Developments+in+Biological+Standardization&amp;rft.atitle=Potential+exposure+to+SV40+in+polio+vaccines+used+in+Sweden+during+1957%3A+no+impact+on+cancer+incidence+rates+1960+to+1993&amp;rft.volume=94&amp;rft.pages=227-233&amp;rft.date=1998&amp;rft_id=info%3Apmid%2F9776244&amp;rft.aulast=Olin&amp;rft.aufirst=P&amp;rft.au=Giesecke%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Sanofi-44"><span>^ <a href="#cite_ref-Sanofi_44-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sanofi_44-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Sanofi_44-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Sanofi_44-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Sanofi_44-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Sanofi_44-5"><sup><i><b>f</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://web.archive.org/web/20071007095443/http://www.polio.info/polio-eradication/front/templates/index.jsp?siteCode=POLIO&amp;codeRubrique=34&amp;lang=EN">"Competition to develop an oral vaccine"</a>. <i>Conquering Polio</i>. <a href="/wiki/Sanofi_Pasteur" title="Sanofi Pasteur">Sanofi Pasteur</a> SA. 2 February 2007. Archived from <a rel="nofollow" href="http://www.polio.info/polio-eradication/front/templates/index.jsp?siteCode=POLIO&amp;codeRubrique=34&amp;lang=EN">the original</a> on 7 October 2007.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Conquering+Polio&amp;rft.atitle=Competition+to+develop+an+oral+vaccine&amp;rft.date=2007-02-02&amp;rft_id=http%3A%2F%2Fwww.polio.info%2Fpolio-eradication%2Ffront%2Ftemplates%2Findex.jsp%3FsiteCode%3DPOLIO%26codeRubrique%3D34%26lang%3DEN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Plotkin-45"><span>^ <a href="#cite_ref-Plotkin_45-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Plotkin_45-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFPlotkin2001">Plotkin SA (April 2001). <a rel="nofollow" href="https://doi.org/10.1086%2F319612">"CHAT oral polio vaccine was not the source of human immunodeficiency virus type 1 group M for humans"</a>. <i>Clinical Infectious Diseases</i>. <b>32</b> (7): 1068–1084. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<span title="Freely accessible"><a rel="nofollow" href="https://doi.org/10.1086%2F319612">10.1086/319612</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/11264036">11264036</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Infectious+Diseases&amp;rft.atitle=CHAT+oral+polio+vaccine+was+not+the+source+of+human+immunodeficiency+virus+type+1+group+M+for+humans&amp;rft.volume=32&amp;rft.issue=7&amp;rft.pages=1068-1084&amp;rft.date=2001-04&amp;rft_id=info%3Adoi%2F10.1086%2F319612&amp;rft_id=info%3Apmid%2F11264036&amp;rft.aulast=Plotkin&amp;rft.aufirst=SA&amp;rft_id=%2F%2Fdoi.org%2F10.1086%252F319612&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Kowproski5-46"><span>^ <a href="#cite_ref-Kowproski5_46-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kowproski5_46-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Kowproski5_46-2"><sup><i><b>c</b></i></sup></a></span> <span><cite id="CITEREFKoprowski1960">Koprowski H (July 1960). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2096806">"Historical aspects of the development of live virus vaccine in poliomyelitis"</a>. <i>British Medical Journal</i>. <b>2</b> (5192): 85–91. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1136%2Fbmj.2.5192.85">10.1136/bmj.2.5192.85</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2096806">2096806</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/14410975">14410975</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Medical+Journal&amp;rft.atitle=Historical+aspects+of+the+development+of+live+virus+vaccine+in+poliomyelitis&amp;rft.volume=2&amp;rft.issue=5192&amp;rft.pages=85-91&amp;rft.date=1960-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2096806%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F14410975&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.2.5192.85&amp;rft.aulast=Koprowski&amp;rft.aufirst=H&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2096806&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Collins_2000-47"><span><b><a href="#cite_ref-Collins_2000_47-0">^</a></b></span> <span><cite id="CITEREFCollins2000">Collins, Huntly (6 November 2000). <a rel="nofollow" href="https://web.archive.org/web/20040405233046/http://www.koprowski.net/Polio%20Article.htm">"The Gulp Heard Round the World"</a>. <i>The Philadelphia Inquirer</i>. p.&nbsp;D-1. Archived from <a rel="nofollow" href="http://www.koprowski.net/Polio+Article.htm">the original</a> on 5 April 2004<span>. Retrieved <span>29 November</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Philadelphia+Inquirer&amp;rft.atitle=The+Gulp+Heard+Round+the+World&amp;rft.pages=D-1&amp;rft.date=2000-11-06&amp;rft.aulast=Collins&amp;rft.aufirst=Huntly&amp;rft_id=http%3A%2F%2Fwww.koprowski.net%2FPolio%2BArticle.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-48"><span><b><a href="#cite_ref-48">^</a></b></span> <span><cite><a rel="nofollow" href="http://news.bbc.co.uk/2/hi/africa/2070634.stm">"Nigeria Muslims oppose polio vaccination"</a>. BBC News Online. 27 June 2002. <a rel="nofollow" href="https://web.archive.org/web/20081129152933/http://news.bbc.co.uk/2/hi/africa/2070634.stm">Archived</a> from the original on 29 November 2008<span>. Retrieved <span>29 November</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Nigeria+Muslims+oppose+polio+vaccination&amp;rft.date=2002-06-27&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fafrica%2F2070634.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-49"><span><b><a href="#cite_ref-49">^</a></b></span> <span><cite id="CITEREFDuggerMcNeil2006">Dugger CW, McNeil DG (20 March 2006). <a rel="nofollow" href="https://www.nytimes.com/2006/03/20/international/asia/20polio.html">"Rumor, Fear and Fatigue Hinder Final Push to End Polio"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a rel="nofollow" href="https://web.archive.org/web/20081210212451/http://www.nytimes.com/2006/03/20/international/asia/20polio.html?pagewanted=2">Archived</a> from the original on 10 December 2008<span>. Retrieved <span>29 November</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Rumor%2C+Fear+and+Fatigue+Hinder+Final+Push+to+End+Polio&amp;rft.date=2006-03-20&amp;rft.aulast=Dugger&amp;rft.aufirst=CW&amp;rft.au=McNeil%2C+DG&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F03%2F20%2Finternational%2Fasia%2F20polio.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-50"><span><b><a href="#cite_ref-50">^</a></b></span> <span><cite><a rel="nofollow" href="http://news.bbc.co.uk/2/hi/africa/4539757.stm">"Anti-polio vaccine Malians jailed"</a>. <a href="/wiki/BBC_News_Online" title="BBC News Online">BBC News Online</a>. 12 May 2005. <a rel="nofollow" href="https://web.archive.org/web/20060110000559/http://news.bbc.co.uk/2/hi/africa/4539757.stm">Archived</a> from the original on 10 January 2006<span>. Retrieved <span>29 November</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Anti-polio+vaccine+Malians+jailed&amp;rft.date=2005-05-12&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fafrica%2F4539757.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Jegede-51"><span>^ <a href="#cite_ref-Jegede_51-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jegede_51-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFJegede2007">Jegede AS (March 2007). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1831725">"What led to the Nigerian boycott of the polio vaccination campaign?"</a>. <i>PLOS Medicine</i>. <b>4</b> (3): e73. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1371%2Fjournal.pmed.0040073">10.1371/journal.pmed.0040073</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1831725">1831725</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/17388657">17388657</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+Medicine&amp;rft.atitle=What+led+to+the+Nigerian+boycott+of+the+polio+vaccination+campaign%3F&amp;rft.volume=4&amp;rft.issue=3&amp;rft.pages=e73&amp;rft.date=2007-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1831725%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17388657&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pmed.0040073&amp;rft.aulast=Jegede&amp;rft.aufirst=AS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1831725&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Kew_2005-52"><span>^ <a href="#cite_ref-Kew_2005_52-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kew_2005_52-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Kew_2005_52-2"><sup><i><b>c</b></i></sup></a></span> <span><cite id="CITEREFKewSutterde_GourvilleDowdle2005">Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA (2005). <a rel="nofollow" href="https://zenodo.org/record/1235033">"Vaccine-derived polioviruses and the endgame strategy for global polio eradication"</a>. <i>Annual Review of Microbiology</i>. <b>59</b>: 587–635. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1146%2Fannurev.micro.58.030603.123625">10.1146/annurev.micro.58.030603.123625</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/16153180">16153180</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annual+Review+of+Microbiology&amp;rft.atitle=Vaccine-derived+polioviruses+and+the+endgame+strategy+for+global+polio+eradication&amp;rft.volume=59&amp;rft.pages=587-635&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev.micro.58.030603.123625&amp;rft_id=info%3Apmid%2F16153180&amp;rft.aulast=Kew&amp;rft.aufirst=OM&amp;rft.au=Sutter%2C+RW&amp;rft.au=de+Gourville%2C+EM&amp;rft.au=Dowdle%2C+WR&amp;rft.au=Pallansch%2C+MA&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F1235033&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-UK-53"><span>^ <a href="#cite_ref-UK_53-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-UK_53-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-UK_53-2"><sup><i><b>c</b></i></sup></a></span> <span><cite id="CITEREFJoint_Committee_on_Vaccination_and_Immunisation2006">Joint Committee on Vaccination and Immunisation (2006). <a rel="nofollow" href="https://web.archive.org/web/20070615150746/http://www.immunisation.nhs.uk/files/GB_26_polio.pdf">"26: Poliomyelitis"</a> <span>(PDF)</span>.  In Salisbury D, Ramsay M, Noakes K (eds.). <i>Immunisation Against Infectious Disease</i>. Edinburgh: Stationery Office. pp.&nbsp;313–329. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0-11-322528-6" title="Special:BookSources/978-0-11-322528-6"><bdi>978-0-11-322528-6</bdi></a>. Archived from <a rel="nofollow" href="http://www.immunisation.nhs.uk/files/GB_26_polio.pdf">the original</a> <span>(PDF)</span> on 15 June 2007.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=26%3A+Poliomyelitis&amp;rft.btitle=Immunisation+Against+Infectious+Disease&amp;rft.place=Edinburgh&amp;rft.pages=313-329&amp;rft.pub=Stationery+Office&amp;rft.date=2006&amp;rft.isbn=978-0-11-322528-6&amp;rft.au=Joint+Committee+on+Vaccination+and+Immunisation&amp;rft_id=http%3A%2F%2Fwww.immunisation.nhs.uk%2Ffiles%2FGB_26_polio.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Sabin_1960-54"><span>^ <a href="#cite_ref-Sabin_1960_54-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sabin_1960_54-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFSabinRamos-AlvarezAlvarez-AmezquitaPelon1960">Sabin AB, Ramos-Alvarez M, Alvarez-Amezquita J, Pelon W, Michaels RH, Spigland I, Koch MA, Barnes JM, Rhim JS (August 1960). "Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses". <i>JAMA</i>. <b>173</b> (14): 1521–1526. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1001%2Fjama.1960.03020320001001">10.1001/jama.1960.03020320001001</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/14440553">14440553</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Live%2C+orally+given+poliovirus+vaccine.+Effects+of+rapid+mass+immunization+on+population+under+conditions+of+massive+enteric+infection+with+other+viruses&amp;rft.volume=173&amp;rft.issue=14&amp;rft.pages=1521-1526&amp;rft.date=1960-08&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.1960.03020320001001&amp;rft_id=info%3Apmid%2F14440553&amp;rft.aulast=Sabin&amp;rft.aufirst=AB&amp;rft.au=Ramos-Alvarez%2C+M&amp;rft.au=Alvarez-Amezquita%2C+J&amp;rft.au=Pelon%2C+W&amp;rft.au=Michaels%2C+RH&amp;rft.au=Spigland%2C+I&amp;rft.au=Koch%2C+MA&amp;rft.au=Barnes%2C+JM&amp;rft.au=Rhim%2C+JS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-55"><span><b><a href="#cite_ref-55">^</a></b></span> <span><cite id="CITEREFSabin1987">Sabin AB (1987). "Role of my cooperation with Soviet scientists in the elimination of polio: possible lessons for relations between the U.S.A. and the USSR". <i>Perspectives in Biology and Medicine</i>. <b>31</b> (1): 57–64. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1353%2Fpbm.1987.0023">10.1353/pbm.1987.0023</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/3696960">3696960</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:45655185">45655185</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Perspectives+in+Biology+and+Medicine&amp;rft.atitle=Role+of+my+cooperation+with+Soviet+scientists+in+the+elimination+of+polio%3A+possible+lessons+for+relations+between+the+U.S.A.+and+the+USSR&amp;rft.volume=31&amp;rft.issue=1&amp;rft.pages=57-64&amp;rft.date=1987&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A45655185%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F3696960&amp;rft_id=info%3Adoi%2F10.1353%2Fpbm.1987.0023&amp;rft.aulast=Sabin&amp;rft.aufirst=AB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-56"><span><b><a href="#cite_ref-56">^</a></b></span> <span><cite id="CITEREFBenison1982">Benison S (1982). "International medical cooperation: Dr. Albert Sabin, live poliovirus vaccine and the Soviets". <i>Bulletin of the History of Medicine</i>. <b>56</b> (4): 460–483. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/6760938">6760938</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bulletin+of+the+History+of+Medicine&amp;rft.atitle=International+medical+cooperation%3A+Dr.+Albert+Sabin%2C+live+poliovirus+vaccine+and+the+Soviets&amp;rft.volume=56&amp;rft.issue=4&amp;rft.pages=460-483&amp;rft.date=1982&amp;rft_id=info%3Apmid%2F6760938&amp;rft.aulast=Benison&amp;rft.aufirst=S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-57"><span><b><a href="#cite_ref-57">^</a></b></span> <span><cite id="CITEREFOchsZellerSalehBassili2003">Ochs K, Zeller A, Saleh L, Bassili G, Song Y, Sonntag A, Niepmann M (January 2003). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC140626">"Impaired binding of standard initiation factors mediates poliovirus translation attenuation"</a>. <i>Journal of Virology</i>. <b>77</b> (1): 115–122. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1128%2FJVI.77.1.115-122.2003">10.1128/JVI.77.1.115-122.2003</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC140626">140626</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/12477816">12477816</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Virology&amp;rft.atitle=Impaired+binding+of+standard+initiation+factors+mediates+poliovirus+translation+attenuation&amp;rft.volume=77&amp;rft.issue=1&amp;rft.pages=115-122&amp;rft.date=2003-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC140626%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12477816&amp;rft_id=info%3Adoi%2F10.1128%2FJVI.77.1.115-122.2003&amp;rft.aulast=Ochs&amp;rft.aufirst=K&amp;rft.au=Zeller%2C+A&amp;rft.au=Saleh%2C+L&amp;rft.au=Bassili%2C+G&amp;rft.au=Song%2C+Y&amp;rft.au=Sonntag%2C+A&amp;rft.au=Niepmann%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC140626&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-58"><span><b><a href="#cite_ref-58">^</a></b></span> <span><cite id="CITEREFGromeierBossertAritaNomoto1999">Gromeier M, Bossert B, Arita M, Nomoto A, Wimmer E (February 1999). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC103915">"Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence"</a>. <i>Journal of Virology</i>. <b>73</b> (2): 958–964. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1128%2FJVI.73.2.958-964.1999">10.1128/JVI.73.2.958-964.1999</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC103915">103915</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/9882296">9882296</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Virology&amp;rft.atitle=Dual+stem+loops+within+the+poliovirus+internal+ribosomal+entry+site+control+neurovirulence&amp;rft.volume=73&amp;rft.issue=2&amp;rft.pages=958-964&amp;rft.date=1999-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC103915%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9882296&amp;rft_id=info%3Adoi%2F10.1128%2FJVI.73.2.958-964.1999&amp;rft.aulast=Gromeier&amp;rft.aufirst=M&amp;rft.au=Bossert%2C+B&amp;rft.au=Arita%2C+M&amp;rft.au=Nomoto%2C+A&amp;rft.au=Wimmer%2C+E&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC103915&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Pearce-59"><span><b><a href="#cite_ref-Pearce_59-0">^</a></b></span> <span><cite id="CITEREFPearce2004">Pearce JM (November 2004). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1738787">"Salk and Sabin: poliomyelitis immunisation"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>75</b> (11): 1552. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1136%2Fjnnp.2003.028530">10.1136/jnnp.2003.028530</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1738787">1738787</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/15489385">15489385</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Salk+and+Sabin%3A+poliomyelitis+immunisation&amp;rft.volume=75&amp;rft.issue=11&amp;rft.pages=1552&amp;rft.date=2004-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1738787%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15489385&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.2003.028530&amp;rft.aulast=Pearce&amp;rft.aufirst=JM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1738787&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Smallman-60"><span><b><a href="#cite_ref-Smallman_60-0">^</a></b></span> <span><cite id="CITEREFSmallman-Raynor2006">Smallman-Raynor M (2006). <i>Poliomyelitis: A World Geography: Emergence to Eradication</i>. Oxford University Press (US). <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0-19-924474-4" title="Special:BookSources/978-0-19-924474-4"><bdi>978-0-19-924474-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Poliomyelitis%3A+A+World+Geography%3A+Emergence+to+Eradication&amp;rft.pub=Oxford+University+Press+%28US%29&amp;rft.date=2006&amp;rft.isbn=978-0-19-924474-4&amp;rft.aulast=Smallman-Raynor&amp;rft.aufirst=Matthew&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span><sup>[<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="This citation requires a reference to the specific page or range of pages in which the material appears. (August 2021)">page&nbsp;needed</span></a></i>]</sup></span>
</li>
<li id="cite_note-PAHO-61"><span><b><a href="#cite_ref-PAHO_61-0">^</a></b></span> <span><cite><i>Poliomyelitis Eradication: Field Guide</i>. Washington: Pan American Health Organization. 2006. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-92-75-11607-4" title="Special:BookSources/978-92-75-11607-4"><bdi>978-92-75-11607-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Poliomyelitis+Eradication%3A+Field+Guide&amp;rft.place=Washington&amp;rft.pub=Pan+American+Health+Organization&amp;rft.date=2006&amp;rft.isbn=978-92-75-11607-4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span><sup>[<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="This citation requires a reference to the specific page or range of pages in which the material appears. (August 2021)">page&nbsp;needed</span></a></i>]</sup></span>
</li>
<li id="cite_note-:0-62"><span>^ <a href="#cite_ref-:0_62-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_62-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFLöwy2006">Löwy, Ilana (1 April 2006). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1472109">"Book Review"</a>. <i>Medical History</i>. <b>50</b> (2): 253–254. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1017%2FS0025727300009790">10.1017/S0025727300009790</a>. <a href="/wiki/ISSN_(identifier)" title="ISSN (identifier)">ISSN</a>&nbsp;<a rel="nofollow" href="//www.worldcat.org/issn/0025-7273">0025-7273</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1472109">1472109</a></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medical+History&amp;rft.atitle=Book+Review&amp;rft.volume=50&amp;rft.issue=2&amp;rft.pages=253-254&amp;rft.date=2006-04-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1472109%23id-name%3DPMC&amp;rft.issn=0025-7273&amp;rft_id=info%3Adoi%2F10.1017%2FS0025727300009790&amp;rft.aulast=L%C3%B6wy&amp;rft.aufirst=Ilana&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1472109&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-:1-63"><span>^ <a href="#cite_ref-:1_63-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:1_63-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:1_63-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:1_63-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-:1_63-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-:1_63-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-:1_63-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-:1_63-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-:1_63-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-:1_63-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-:1_63-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-:1_63-11"><sup><i><b>l</b></i></sup></a></span> <span><cite id="CITEREFRivers1967">Rivers, T. (1967). <a rel="nofollow" href="https://hdl.handle.net/2027/heb.05734"><i>Tom Rivers: reflections on a life in medicine and science&nbsp;: an oral history memoir</i></a>. MIT Press. <a href="/wiki/Hdl_(identifier)" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" href="//hdl.handle.net/2027%2Fheb.05734">2027/heb.05734</a>. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0262020268" title="Special:BookSources/978-0262020268"><bdi>978-0262020268</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Tom+Rivers%3A+reflections+on+a+life+in+medicine+and+science+%3A+an+oral+history+memoir&amp;rft.pub=MIT+Press&amp;rft.date=1967&amp;rft_id=info%3Ahdl%2F2027%2Fheb.05734&amp;rft.isbn=978-0262020268&amp;rft.aulast=Rivers&amp;rft.aufirst=T.&amp;rft_id=https%3A%2F%2Fhdl.handle.net%2F2027%2Fheb.05734&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-:2-64"><span>^ <a href="#cite_ref-:2_64-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:2_64-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:2_64-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:2_64-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-:2_64-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-:2_64-5"><sup><i><b>f</b></i></sup></a></span> <span><cite id="CITEREFHalpern2006">Halpern, Sydney A. (2006). <i>Lesser harms: The morality of risk in medical research</i>. Chicago, Ill: University of Chicago Press. <a href="/wiki/OCLC_(identifier)" title="OCLC (identifier)">OCLC</a>&nbsp;<a rel="nofollow" href="//www.worldcat.org/oclc/877210630">877210630</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Lesser+harms%3A+The+morality+of+risk+in+medical+research&amp;rft.place=Chicago%2C+Ill&amp;rft.pub=University+of+Chicago+Press&amp;rft.date=2006&amp;rft_id=info%3Aoclcnum%2F877210630&amp;rft.aulast=Halpern&amp;rft.aufirst=Sydney+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-:3-65"><span>^ <a href="#cite_ref-:3_65-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:3_65-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:3_65-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:3_65-3"><sup><i><b>d</b></i></sup></a></span> <span><cite id="CITEREFHovern2018">Hovern, Dayna (2018). <a rel="nofollow" href="https://rdw.rowan.edu/cmsru_capstones/4"><i>The Trials and Triumphs of the American Polio Vaccine</i></a> (Thesis). Cooper Medical School of Rowan University.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adissertation&amp;rft.title=The+Trials+and+Triumphs+of+the+American+Polio+Vaccine&amp;rft.inst=Cooper+Medical+School+of+Rowan+University&amp;rft.date=2018&amp;rft.aulast=Hovern&amp;rft.aufirst=Dayna&amp;rft_id=https%3A%2F%2Frdw.rowan.edu%2Fcmsru_capstones%2F4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-66"><span><b><a href="#cite_ref-66">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.historyofvaccines.org/index.php/content/articles/vaccine-testing-and-vulnerable-human-subjects">"Vaccine Testing and Vulnerable Human Subjects | History of Vaccines"</a>. <i>www.historyofvaccines.org</i><span>. Retrieved <span>18 July</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.historyofvaccines.org&amp;rft.atitle=Vaccine+Testing+and+Vulnerable+Human+Subjects+%7C+History+of+Vaccines&amp;rft_id=https%3A%2F%2Fwww.historyofvaccines.org%2Findex.php%2Fcontent%2Farticles%2Fvaccine-testing-and-vulnerable-human-subjects&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-:4-67"><span>^ <a href="#cite_ref-:4_67-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:4_67-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:4_67-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:4_67-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-:4_67-4"><sup><i><b>e</b></i></sup></a></span> <span><cite id="CITEREFGould1997">Gould, Tony (1997). <a rel="nofollow" href="http://www.worldcat.org/oclc/38243151"><i>A Summer Plague: Polio and Its Survivors</i></a>. New Haven: Yale University Press. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0300072761" title="Special:BookSources/978-0300072761"><bdi>978-0300072761</bdi></a>. <a href="/wiki/OCLC_(identifier)" title="OCLC (identifier)">OCLC</a>&nbsp;<a rel="nofollow" href="//www.worldcat.org/oclc/38243151">38243151</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=A+Summer+Plague%3A+Polio+and+Its+Survivors&amp;rft.place=New+Haven&amp;rft.pub=Yale+University+Press&amp;rft.date=1997&amp;rft_id=info%3Aoclcnum%2F38243151&amp;rft.isbn=978-0300072761&amp;rft.aulast=Gould&amp;rft.aufirst=Tony&amp;rft_id=http%3A%2F%2Fwww.worldcat.org%2Foclc%2F38243151&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-68"><span><b><a href="#cite_ref-68">^</a></b></span> <span><cite id="CITEREFWilson1963">Wilson, John Rowan (1963). <i>Margin of Safety: The Story of Poliomyelitis Vaccine</i>. Garden City, NY: Collins. <a href="/wiki/OCLC_(identifier)" title="OCLC (identifier)">OCLC</a>&nbsp;<a rel="nofollow" href="//www.worldcat.org/oclc/630735949">630735949</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Margin+of+Safety%3A+The+Story+of+Poliomyelitis+Vaccine&amp;rft.place=Garden+City%2C+NY&amp;rft.pub=Collins&amp;rft.date=1963&amp;rft_id=info%3Aoclcnum%2F630735949&amp;rft.aulast=Wilson&amp;rft.aufirst=John+Rowan&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-69"><span><b><a href="#cite_ref-69">^</a></b></span> <span>Paul, J.R. (1971). <i>A History of Poliomyelitis</i>. New Haven: Yale University Press.<sup>[<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="Please supply an ISBN for this book.">ISBN&nbsp;missing</span></a></i>]</sup><sup>[<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="This citation requires a reference to the specific page or range of pages in which the material appears. (August 2021)">page&nbsp;needed</span></a></i>]</sup></span>
</li>
<li id="cite_note-:5-70"><span>^ <a href="#cite_ref-:5_70-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:5_70-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:5_70-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:5_70-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-:5_70-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-:5_70-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-:5_70-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-:5_70-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-:5_70-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-:5_70-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-:5_70-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-:5_70-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-:5_70-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-:5_70-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-:5_70-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-:5_70-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-:5_70-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-:5_70-17"><sup><i><b>r</b></i></sup></a></span> <span><cite id="CITEREFBerk1989">Berk, Lawrence B. (1989). "Polio Vaccine Trials of 1935". <i>Transactions &amp; Studies of the College of Physicians of Philadelphia</i>. 5. <b>11</b> (4): 321–336. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/2692236">2692236</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Transactions+%26+Studies+of+the+College+of+Physicians+of+Philadelphia&amp;rft.atitle=Polio+Vaccine+Trials+of+1935.&amp;rft.volume=11&amp;rft.issue=4&amp;rft.pages=321-336&amp;rft.date=1989&amp;rft_id=info%3Apmid%2F2692236&amp;rft.aulast=Berk&amp;rft.aufirst=Lawrence+B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Offit_2007-71"><span>^ <a href="#cite_ref-Offit_2007_71-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Offit_2007_71-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Offit_2007_71-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Offit_2007_71-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Offit_2007_71-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Offit_2007_71-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Offit_2007_71-6"><sup><i><b>g</b></i></sup></a></span> <span><cite id="CITEREFOffit2007">Offit PA (2007). <i>The Cutter Incident: How America's First Polio Vaccine Led to the Growing Vaccine Crisis</i>. Yale University Press. p.&nbsp;38. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0-300-12605-1" title="Special:BookSources/978-0-300-12605-1"><bdi>978-0-300-12605-1</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Cutter+Incident%3A+How+America%27s+First+Polio+Vaccine+Led+to+the+Growing+Vaccine+Crisis&amp;rft.pages=38&amp;rft.pub=Yale+University+Press&amp;rft.date=2007&amp;rft.isbn=978-0-300-12605-1&amp;rft.aulast=Offit&amp;rft.aufirst=Paul+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-:6-72"><span>^ <a href="#cite_ref-:6_72-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:6_72-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFBroadiePark1935">Broadie, Maurice; Park, William (5 October 1935). <a rel="nofollow" href="http://ccat.sas.upenn.edu/goldenage/wonder/Archive/Science/wd_brodie&amp;park.htm">"Active immunization against poliomyelitis"</a>. <i>Journal of the American Medical Association</i>. <b>105</b> (14): 1089–1093. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1001%2Fjama.1935.02760400005002">10.1001/jama.1935.02760400005002</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:1640997">1640997</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Medical+Association&amp;rft.atitle=Active+immunization+against+poliomyelitis&amp;rft.volume=105&amp;rft.issue=14&amp;rft.pages=1089-1093&amp;rft.date=1935-10-05&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.1935.02760400005002&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A1640997%23id-name%3DS2CID&amp;rft.aulast=Broadie&amp;rft.aufirst=Maurice&amp;rft.au=Park%2C+William&amp;rft_id=http%3A%2F%2Fccat.sas.upenn.edu%2Fgoldenage%2Fwonder%2FArchive%2FScience%2Fwd_brodie%26park.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-73"><span><b><a href="#cite_ref-73">^</a></b></span> <span><cite id="CITEREFBrodie1935">Brodie, Maurice (1935). "Active immunization in monkeys against poliomyelitis with germicidally inactivated virus". <i>The Journal of Immunology</i>. <b>28</b> (1): 1–18.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Active+immunization+in+monkeys+against+poliomyelitis+with+germicidally+inactivated+virus&amp;rft.volume=28&amp;rft.issue=1&amp;rft.pages=1-18&amp;rft.date=1935&amp;rft.aulast=Brodie&amp;rft.aufirst=Maurice&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-:7-74"><span>^ <a href="#cite_ref-:7_74-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:7_74-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:7_74-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:7_74-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-:7_74-4"><sup><i><b>e</b></i></sup></a></span> <span><cite id="CITEREFJohnston2021">Johnston, Keith (22 February 2021). <a rel="nofollow" href="https://www.macleans.ca/society/the-tragic-story-of-a-canadian-vaccine-trailblazer/">"The tragic story of a Canadian vaccine trailblazer"</a>. <i>Macleans.ca</i><span>. Retrieved <span>18 July</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Macleans.ca&amp;rft.atitle=The+tragic+story+of+a+Canadian+vaccine+trailblazer&amp;rft.date=2021-02-22&amp;rft.aulast=Johnston&amp;rft.aufirst=Keith&amp;rft_id=https%3A%2F%2Fwww.macleans.ca%2Fsociety%2Fthe-tragic-story-of-a-canadian-vaccine-trailblazer%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-75"><span><b><a href="#cite_ref-75">^</a></b></span> <span><cite id="CITEREFOshinsky2005">Oshinsky, David M. (2005). <a rel="nofollow" href="https://books.google.com/books?id=p4YRDAAAQBAJ&amp;pg=PA57"><i>Polio: An American Story</i></a>. Oxford University Press. p.&nbsp;57. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0-19-515294-4" title="Special:BookSources/978-0-19-515294-4"><bdi>978-0-19-515294-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Polio%3A+An+American+Story&amp;rft.pages=57&amp;rft.pub=Oxford+University+Press&amp;rft.date=2005&amp;rft.isbn=978-0-19-515294-4&amp;rft.aulast=Oshinsky&amp;rft.aufirst=David+M.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Dp4YRDAAAQBAJ%26pg%3DPA57&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-:8-76"><span>^ <a href="#cite_ref-:8_76-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:8_76-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:8_76-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:8_76-3"><sup><i><b>d</b></i></sup></a></span> <span><cite id="CITEREFLeake1936">Leake, James P. (February 1936). <a rel="nofollow" href="https://ajph.aphapublications.org/doi/pdf/10.2105/AJPH.26.2.143">"Discussion of Poliomyelitis Papers Delivered at the Symposium on Poliomyelitis before the Fourth Annual Meeting of the Southern Branch, American Public Health Association in St. Louis, Mo., November 19, 1935"</a>. <i>American Journal of Public Health</i>. <b>26</b> (2): 143–48. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.2105%2FAJPH.26.2.181">10.2105/AJPH.26.2.181</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1562619">1562619</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/18014373">18014373</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Public+Health&amp;rft.atitle=Discussion+of+Poliomyelitis+Papers+Delivered+at+the+Symposium+on+Poliomyelitis+before+the+Fourth+Annual+Meeting+of+the+Southern+Branch%2C+American+Public+Health+Association+in+St.+Louis%2C+Mo.%2C+November+19%2C+1935&amp;rft.volume=26&amp;rft.issue=2&amp;rft.pages=143-48&amp;rft.date=1936-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1562619%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18014373&amp;rft_id=info%3Adoi%2F10.2105%2FAJPH.26.2.181&amp;rft.aulast=Leake&amp;rft.aufirst=James+P.&amp;rft_id=https%3A%2F%2Fajph.aphapublications.org%2Fdoi%2Fpdf%2F10.2105%2FAJPH.26.2.143&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-77"><span><b><a href="#cite_ref-77">^</a></b></span> <span><cite><a rel="nofollow" href="http://www.aai.org/About/History/Past-Presidents-and-Officers/JohnAKolmer">"John A. Kolmer, M.D."</a><span> Retrieved <span>28 November</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=John+A.+Kolmer%2C+M.D.&amp;rft_id=http%3A%2F%2Fwww.aai.org%2FAbout%2FHistory%2FPast-Presidents-and-Officers%2FJohnAKolmer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Enders-78"><span><b><a href="#cite_ref-Enders_78-0">^</a></b></span> <span><cite id="CITEREFEndersWellerRobbins1949">Enders JF, Weller TH, Robbins FC (January 1949). "Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues". <i>Science</i>. <b>109</b> (2822): 85–87. <a href="/wiki/Bibcode_(identifier)" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" href="https://ui.adsabs.harvard.edu/abs/1949Sci...109...85E">1949Sci...109...85E</a>. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1126%2Fscience.109.2822.85">10.1126/science.109.2822.85</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/17794160">17794160</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Cultivation+of+the+Lansing+Strain+of+Poliomyelitis+Virus+in+Cultures+of+Various+Human+Embryonic+Tissues&amp;rft.volume=109&amp;rft.issue=2822&amp;rft.pages=85-87&amp;rft.date=1949-01&amp;rft_id=info%3Apmid%2F17794160&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.109.2822.85&amp;rft_id=info%3Abibcode%2F1949Sci...109...85E&amp;rft.aulast=Enders&amp;rft.aufirst=JF&amp;rft.au=Weller%2C+TH&amp;rft.au=Robbins%2C+FC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Nobel_1954-79"><span><b><a href="#cite_ref-Nobel_1954_79-0">^</a></b></span> <span><cite><a rel="nofollow" href="http://nobelprize.org/nobel_prizes/medicine/laureates/1954/">"The Nobel Prize in Physiology or Medicine 1954"</a>. The Nobel Foundation. <a rel="nofollow" href="https://web.archive.org/web/20081219224515/http://nobelprize.org/nobel_prizes/medicine/laureates/1954/">Archived</a> from the original on 19 December 2008<span>. Retrieved <span>29 November</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Nobel+Prize+in+Physiology+or+Medicine+1954&amp;rft.pub=The+Nobel+Foundation&amp;rft_id=http%3A%2F%2Fnobelprize.org%2Fnobel_prizes%2Fmedicine%2Flaureates%2F1954%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-pmid13034471-80"><span><b><a href="#cite_ref-pmid13034471_80-0">^</a></b></span> <span><cite id="CITEREFHammonCoriellWehrleStokes1953">Hammon WM, Coriell LL, Wehrle PF, Stokes J (April 1953). "Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses". <i>Journal of the American Medical Association</i>. <b>151</b> (15): 1272–1285. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/13034471">13034471</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Medical+Association&amp;rft.atitle=Evaluation+of+Red+Cross+gamma+globulin+as+a+prophylactic+agent+for+poliomyelitis.+IV.+Final+report+of+results+based+on+clinical+diagnoses&amp;rft.volume=151&amp;rft.issue=15&amp;rft.pages=1272-1285&amp;rft.date=1953-04&amp;rft_id=info%3Apmid%2F13034471&amp;rft.aulast=Hammon&amp;rft.aufirst=WM&amp;rft.au=Coriell%2C+LL&amp;rft.au=Wehrle%2C+PF&amp;rft.au=Stokes%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-81"><span><b><a href="#cite_ref-81">^</a></b></span> <span><cite id="CITEREFOchmannRoser2017">Ochmann S, Roser M (9 November 2017). <a rel="nofollow" href="https://ourworldindata.org/polio">"Polio – Polio Cases (OWID based on US Public Health Service (1910–1951) and US Center for Disease Control (1960–2010))"</a>. <i>Our World in Data</i><span>. Retrieved <span>26 March</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Our+World+in+Data&amp;rft.atitle=Polio+%E2%80%93+Polio+Cases+%28OWID+based+on+US+Public+Health+Service+%281910%E2%80%931951%29+and+US+Center+for+Disease+Control+%281960%E2%80%932010%29%29&amp;rft.date=2017-11-09&amp;rft.aulast=Ochmann&amp;rft.aufirst=Sophie&amp;rft.au=Roser%2C+Max&amp;rft_id=https%3A%2F%2Fourworldindata.org%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-82"><span><b><a href="#cite_ref-82">^</a></b></span> <span><cite><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1995293">"Public Health Weekly Reports for October 10, 1947"</a>. <i>Public Health Reports</i>. <b>62</b> (41): 1467–1498. October 1947. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1995293">1995293</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/19316151">19316151</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Public+Health+Reports&amp;rft.atitle=Public+Health+Weekly+Reports+for+October+10%2C+1947&amp;rft.volume=62&amp;rft.issue=41&amp;rft.pages=1467-1498&amp;rft.date=1947-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1995293%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19316151&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1995293&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-83"><span><b><a href="#cite_ref-83">^</a></b></span> <span><cite id="CITEREFKoprowski2010">Koprowski H (15 October 2010). <a rel="nofollow" href="http://www.historyofvaccines.org/content/timelines/polio">"Interview with Hilary Koprowski, sourced at History of Vaccines website"</a>. <a href="/wiki/College_of_Physicians_of_Philadelphia" title="College of Physicians of Philadelphia">College of Physicians of Philadelphia</a>. <a rel="nofollow" href="http://arquivo.pt/wayback/20160515175017/http://www.historyofvaccines.org/content/timelines/polio">Archived</a> from the original on 15 May 2016<span>. Retrieved <span>15 October</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Interview+with+Hilary+Koprowski%2C+sourced+at+History+of+Vaccines+website&amp;rft.pub=College+of+Physicians+of+Philadelphia&amp;rft.date=2010-10-15&amp;rft.aulast=Koprowski&amp;rft.aufirst=Hilary&amp;rft_id=http%3A%2F%2Fwww.historyofvaccines.org%2Fcontent%2Ftimelines%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-84"><span><b><a href="#cite_ref-84">^</a></b></span> <span><cite><a rel="nofollow" href="http://www.science.ca/scientists/scientistprofile.php?pID=438">"science.ca&nbsp;: Leone N. Farrell"</a>. <i>www.science.ca</i><span>. Retrieved <span>1 August</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.science.ca&amp;rft.atitle=science.ca+%3A+Leone+N.+Farrell&amp;rft_id=http%3A%2F%2Fwww.science.ca%2Fscientists%2Fscientistprofile.php%3FpID%3D438&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-85"><span><b><a href="#cite_ref-85">^</a></b></span> <span><cite id="CITEREFElliott2011">Elliott, Carol K. (March 2011). <a rel="nofollow" href="http://www.polioplace.org/people/leone-norwood-farrell-phd">"Leone Norwood Farrell, PhD"</a>. <i>polioplace</i>. Post-polio Health International<span>. Retrieved <span>10 August</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=polioplace&amp;rft.atitle=Leone+Norwood+Farrell%2C+PhD&amp;rft.date=2011-03&amp;rft.aulast=Elliott&amp;rft.aufirst=Carol+K.&amp;rft_id=http%3A%2F%2Fwww.polioplace.org%2Fpeople%2Fleone-norwood-farrell-phd&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Shors2008-86"><span><b><a href="#cite_ref-Shors2008_86-0">^</a></b></span> <span><cite id="CITEREFShors2008">Shors T (2008). <a rel="nofollow" href="https://books.google.com/books?id=VQeamKFwyvgC&amp;pg=PA294"><i>Understanding viruses</i></a>. Jones &amp; Bartlett Learning. pp.&nbsp;294–. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0-7637-2932-5" title="Special:BookSources/978-0-7637-2932-5"><bdi>978-0-7637-2932-5</bdi></a>. <a rel="nofollow" href="https://web.archive.org/web/20140721060240/http://books.google.com/books?id=VQeamKFwyvgC&amp;pg=PA294">Archived</a> from the original on 21 July 2014<span>. Retrieved <span>22 February</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Understanding+viruses&amp;rft.pages=294-&amp;rft.pub=Jones+%26+Bartlett+Learning&amp;rft.date=2008&amp;rft.isbn=978-0-7637-2932-5&amp;rft.aulast=Shors&amp;rft.aufirst=Teri&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DVQeamKFwyvgC%26pg%3DPA294&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Conis-87"><span><b><a href="#cite_ref-Conis_87-0">^</a></b></span> <span><cite id="CITEREFConis2016">Conis E (2016). <a rel="nofollow" href="https://www.sciencehistory.org/distillations/magazine/political-ills">"Political Ills"</a>. <i>Distillations</i>. <b>2</b> (2): 34–37<span>. Retrieved <span>27 March</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Distillations&amp;rft.atitle=Political+Ills&amp;rft.volume=2&amp;rft.issue=2&amp;rft.pages=34-37&amp;rft.date=2016&amp;rft.aulast=Conis&amp;rft.aufirst=Elena&amp;rft_id=https%3A%2F%2Fwww.sciencehistory.org%2Fdistillations%2Fmagazine%2Fpolitical-ills&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-test-88"><span><b><a href="#cite_ref-test_88-0">^</a></b></span> <span><cite id="CITEREFOshinsky2010">Oshinsky D (Winter 2010). <a rel="nofollow" href="http://www.americanheritage.com/content/miracle-workers">"Miracle Workers"</a>. <i>American Heritage</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=American+Heritage&amp;rft.atitle=Miracle+Workers&amp;rft.ssn=winter&amp;rft.date=2010&amp;rft.aulast=Oshinsky&amp;rft.aufirst=David&amp;rft_id=http%3A%2F%2Fwww.americanheritage.com%2Fcontent%2Fmiracle-workers&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-MoD_2004-89"><span><b><a href="#cite_ref-MoD_2004_89-0">^</a></b></span> <span><cite><a rel="nofollow" href="http://www.marchofdimes.org/news/polio-victory-remembered-as-march-of-dimes-marks-50th-anniversary-of-salk-vaccine-field-trials.aspx">"Polio Victory Remembered as March of Dimes Marks 50th Anniversary of Salk Vaccine Field Trials"</a>. <i>News Desk</i>. 26 April 2004. <a rel="nofollow" href="https://web.archive.org/web/20150927112220/http://www.marchofdimes.org/news/polio-victory-remembered-as-march-of-dimes-marks-50th-anniversary-of-salk-vaccine-field-trials.aspx">Archived</a> from the original on 27 September 2015<span>. Retrieved <span>14 November</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=News+Desk&amp;rft.atitle=Polio+Victory+Remembered+as+March+of+Dimes+Marks+50th+Anniversary+of+Salk+Vaccine+Field+Trials&amp;rft.date=2004-04-26&amp;rft_id=http%3A%2F%2Fwww.marchofdimes.org%2Fnews%2Fpolio-victory-remembered-as-march-of-dimes-marks-50th-anniversary-of-salk-vaccine-field-trials.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Smith_1990-90"><span><b><a href="#cite_ref-Smith_1990_90-0">^</a></b></span> <span><cite id="CITEREFSmith1990">Smith JS (1990). <span title="Free registration required"><a rel="nofollow" href="https://archive.org/details/patentingsunpoli00smit"><i>Patenting the Sun: Polio and the Salk Vaccine</i></a></span>. William Morrow &amp; Co. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0-688-09494-2" title="Special:BookSources/978-0-688-09494-2"><bdi>978-0-688-09494-2</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Patenting+the+Sun%3A+Polio+and+the+Salk+Vaccine&amp;rft.pub=William+Morrow+%26+Co&amp;rft.date=1990&amp;rft.isbn=978-0-688-09494-2&amp;rft.aulast=Smith&amp;rft.aufirst=Jane+S.&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fpatentingsunpoli00smit&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Sass-91"><span><b><a href="#cite_ref-Sass_91-0">^</a></b></span> <span><cite id="CITEREFSoremSassGottfried1996">Sorem A, Sass EJ, Gottfried G (1996). <i>Polio's legacy: an oral history</i>. Washington, D.C: University Press of America. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0-7618-0144-3" title="Special:BookSources/978-0-7618-0144-3"><bdi>978-0-7618-0144-3</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Polio%27s+legacy%3A+an+oral+history&amp;rft.place=Washington%2C+D.C&amp;rft.pub=University+Press+of+America&amp;rft.date=1996&amp;rft.isbn=978-0-7618-0144-3&amp;rft.aulast=Sorem&amp;rft.aufirst=A&amp;rft.au=Sass%2C+EJ&amp;rft.au=Gottfried%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Hinman-92"><span><b><a href="#cite_ref-Hinman_92-0">^</a></b></span> <span><cite id="CITEREFHinman1984">Hinman AR (June 1984). "Landmark perspective: Mass vaccination against polio". <i>JAMA</i>. <b>251</b> (22): 2994–2996. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1001%2Fjama.1984.03340460072029">10.1001/jama.1984.03340460072029</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/6371280">6371280</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Landmark+perspective%3A+Mass+vaccination+against+polio&amp;rft.volume=251&amp;rft.issue=22&amp;rft.pages=2994-2996&amp;rft.date=1984-06&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.1984.03340460072029&amp;rft_id=info%3Apmid%2F6371280&amp;rft.aulast=Hinman&amp;rft.aufirst=AR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-93"><span><b><a href="#cite_ref-93">^</a></b></span> <span>The Pasteur Institute stated that an antipoliomyelitis vaccine, developed by Professor Pierre Lepine would soon be produced in large quantities. (Times, London, 4 April 1955).</span>
</li>
<li id="cite_note-94"><span><b><a href="#cite_ref-94">^</a></b></span> <span><cite id="CITEREFPasteur">Pasteur, Archives. <a rel="nofollow" href="http://webext.pasteur.fr/archives/e_lep0.html">"Pierre Lépine (1901–1989) – Notice biographique"</a>. <i>webext.pasteur.fr</i>. <a rel="nofollow" href="https://web.archive.org/web/20161128194930/http://webext.pasteur.fr/archives/e_lep0.html">Archived</a> from the original on 28 November 2016<span>. Retrieved <span>28 November</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=webext.pasteur.fr&amp;rft.atitle=Pierre+L%C3%A9pine+%281901%E2%80%931989%29+%E2%80%93+Notice+biographique&amp;rft.aulast=Pasteur&amp;rft.aufirst=Archives&amp;rft_id=http%3A%2F%2Fwebext.pasteur.fr%2Farchives%2Fe_lep0.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-MC1383764-95"><span>^ <a href="#cite_ref-MC1383764_95-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MC1383764_95-1"><sup><i><b>b</b></i></sup></a></span> <span>Fitzpatrick, Michael (March 2006). "Review: <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383764/">The Cutter Incident: How America's First Polio Vaccine Led to a Growing Vaccine Crisis</a>", <i>J R Soc Med.</i> 99(3): p. 156. MCID: PMC1383764. Retrieved 31 Oct. 2020.</span>
</li>
<li id="cite_note-Juskewitch2010-96"><span><b><a href="#cite_ref-Juskewitch2010_96-0">^</a></b></span> <span><cite id="CITEREFJuskewitchTapiaWindebank2010">Juskewitch JE, Tapia CJ, Windebank AJ (August 2010). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2928990">"Lessons from the Salk polio vaccine: methods for and risks of rapid translation"</a>. <i>Clinical and Translational Science</i> (Review). <b>3</b> (4): 182–185. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1111%2Fj.1752-8062.2010.00205.x">10.1111/j.1752-8062.2010.00205.x</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2928990">2928990</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/20718820">20718820</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+and+Translational+Science&amp;rft.atitle=Lessons+from+the+Salk+polio+vaccine%3A+methods+for+and+risks+of+rapid+translation&amp;rft.volume=3&amp;rft.issue=4&amp;rft.pages=182-185&amp;rft.date=2010-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2928990%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20718820&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1752-8062.2010.00205.x&amp;rft.aulast=Juskewitch&amp;rft.aufirst=JE&amp;rft.au=Tapia%2C+CJ&amp;rft.au=Windebank%2C+AJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2928990&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-NMAH-97"><span>^ <a href="#cite_ref-NMAH_97-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NMAH_97-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="http://amhistory.si.edu/polio/virusvaccine/vacraces2.htm">"Two Vaccines: Sabin and Salk"</a>. <i>Smithsonian National Museum of American History</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Smithsonian+National+Museum+of+American+History&amp;rft.atitle=Two+Vaccines%3A+Sabin+and+Salk&amp;rft_id=http%3A%2F%2Famhistory.si.edu%2Fpolio%2Fvirusvaccine%2Fvacraces2.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-98"><span><b><a href="#cite_ref-98">^</a></b></span> <span><cite><a rel="nofollow" href="http://www.upi.com/Archives/1986/11/20/Sabin-receives-highest-Soviet-civilian-honor/6402532846800/">"Sabin receives highest Soviet civilian honor"</a>. <i>U.P.I. archives</i>. 20 November 1986.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=U.P.I.+archives&amp;rft.atitle=Sabin+receives+highest+Soviet+civilian+honor&amp;rft.date=1986-11-20&amp;rft_id=http%3A%2F%2Fwww.upi.com%2FArchives%2F1986%2F11%2F20%2FSabin-receives-highest-Soviet-civilian-honor%2F6402532846800%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-99"><span><b><a href="#cite_ref-99">^</a></b></span> <span>Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined</span>
</li>
<li id="cite_note-pediarix-100"><span>^ <a href="#cite_ref-pediarix_100-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pediarix_100-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://www.fda.gov/vaccines-blood-biologics/vaccines/pediarix">"Pediarix"</a>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>. 6 November 2019<span>. Retrieved <span>8 July</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.atitle=Pediarix&amp;rft.date=2019-11-06&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fvaccines-blood-biologics%2Fvaccines%2Fpediarix&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-101"><span><b><a href="#cite_ref-101">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.fda.gov/media/75250/download">"FDA Statistical Review and Evaluation"</a> <span>(PDF)</span>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.atitle=FDA+Statistical+Review+and+Evaluation&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F75250%2Fdownload&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-102"><span><b><a href="#cite_ref-102">^</a></b></span> <span><cite id="CITEREFMansoor2015">Mansoor H (23 October 2015). <a rel="nofollow" href="http://tribune.com.pk/story/978251/can-indias-social-mobilisation-strategy-work-in-pakistan/">"Can India's social mobilisation strategy work in Pakistan?"</a>. <i>The Express Tribune</i>. <a rel="nofollow" href="https://web.archive.org/web/20151024053606/http://tribune.com.pk/story/978251/can-indias-social-mobilisation-strategy-work-in-pakistan/">Archived</a> from the original on 24 October 2015<span>. Retrieved <span>24 October</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Express+Tribune&amp;rft.atitle=Can+India%27s+social+mobilisation+strategy+work+in+Pakistan%3F&amp;rft.date=2015-10-23&amp;rft.aulast=Mansoor&amp;rft.aufirst=Halima&amp;rft_id=http%3A%2F%2Ftribune.com.pk%2Fstory%2F978251%2Fcan-indias-social-mobilisation-strategy-work-in-pakistan%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Watch-103"><span><b><a href="#cite_ref-Watch_103-0">^</a></b></span> <span><cite id="CITEREFMastny1999">Mastny L (25 January 1999). <a rel="nofollow" href="http://www.worldwatch.org/node/1644">"Eradicating Polio: A Model for International Cooperation"</a>. Worldwatch Institute. <a rel="nofollow" href="https://web.archive.org/web/20061203222228/https://www.worldwatch.org/node/1644">Archived</a> from the original on 3 December 2006<span>. Retrieved <span>29 November</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eradicating+Polio%3A+A+Model+for+International+Cooperation&amp;rft.pub=Worldwatch+Institute&amp;rft.date=1999-01-25&amp;rft.aulast=Mastny&amp;rft.aufirst=Lisa&amp;rft_id=http%3A%2F%2Fwww.worldwatch.org%2Fnode%2F1644&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-MMWR_1994-104"><span>^ <a href="#cite_ref-MMWR_1994_104-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MMWR_1994_104-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFCenters_for_Disease_Control_and_Prevention_(CDC)1994">Centers for Disease Control and Prevention (CDC) (October 1994). <a rel="nofollow" href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00032760.htm">"Certification of poliomyelitis eradication--the Americas, 1994"</a>. <i>MMWR. Morbidity and Mortality Weekly Report</i>. Centers for Disease Control and Prevention. <b>43</b> (39): 720–722. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/7522302">7522302</a>. <a rel="nofollow" href="https://web.archive.org/web/20170521163051/https://www.cdc.gov/mmwr/preview/mmwrhtml/00032760.htm">Archived</a> from the original on 21 May 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MMWR.+Morbidity+and+Mortality+Weekly+Report&amp;rft.atitle=Certification+of+poliomyelitis+eradication--the+Americas%2C+1994&amp;rft.volume=43&amp;rft.issue=39&amp;rft.pages=720-722&amp;rft.date=1994-10&amp;rft_id=info%3Apmid%2F7522302&amp;rft.au=Centers+for+Disease+Control+and+Prevention+%28CDC%29&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fmmwr%2Fpreview%2Fmmwrhtml%2F00032760.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Pacific-105"><span><b><a href="#cite_ref-Pacific_105-0">^</a></b></span> <span><cite>"General News. Major Milestone reached in Global Polio Eradication: Western Pacific Region is certified Polio-Free". <i>Health Educ Res</i>. <b>16</b> (1): 109–114. 2001. <a href="/wiki/Bibcode_(identifier)" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" href="https://ui.adsabs.harvard.edu/abs/2001PDiff..16..110Y">2001PDiff..16..110Y</a>. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1093%2Fher%2F16.1.109">10.1093/her/16.1.109</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Health+Educ+Res&amp;rft.atitle=General+News.+Major+Milestone+reached+in+Global+Polio+Eradication%3A+Western+Pacific+Region+is+certified+Polio-Free&amp;rft.volume=16&amp;rft.issue=1&amp;rft.pages=109-114&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1093%2Fher%2F16.1.109&amp;rft_id=info%3Abibcode%2F2001PDiff..16..110Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-D'Souza_2002-106"><span><b><a href="#cite_ref-D'Souza_2002_106-0">^</a></b></span> <span><cite id="CITEREFD'_SouzaKennettWatson2002">D' Souza RM, Kennett M, Watson C (2002). "Australia declared polio free". <i>Communicable Diseases Intelligence Quarterly Report</i>. <b>26</b> (2): 253–260. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/12206379">12206379</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Communicable+Diseases+Intelligence+Quarterly+Report&amp;rft.atitle=Australia+declared+polio+free&amp;rft.volume=26&amp;rft.issue=2&amp;rft.pages=253-260&amp;rft.date=2002&amp;rft_id=info%3Apmid%2F12206379&amp;rft.aulast=D%27+Souza&amp;rft.aufirst=RM&amp;rft.au=Kennett%2C+M&amp;rft.au=Watson%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-WHO_Europe_2002-107"><span><b><a href="#cite_ref-WHO_Europe_2002_107-0">^</a></b></span> <span><cite><a rel="nofollow" href="https://web.archive.org/web/20080916065107/http://www.who.int/mediacentre/news/releases/releaseeuro02/en/index.html">"Europe achieves historic milestone as Region is declared polio-free"</a> (Press release). <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO). 21 June 2002. Archived from <a rel="nofollow" href="https://www.who.int/mediacentre/news/releases/releaseeuro02/en/index.html">the original</a> on 16 September 2008<span>. Retrieved <span>23 August</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Europe+achieves+historic+milestone+as+Region+is+declared+polio-free&amp;rft.pub=World+Health+Organization+%28WHO%29&amp;rft.date=2002-06-21&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fmediacentre%2Fnews%2Freleases%2Freleaseeuro02%2Fen%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-108"><span><b><a href="#cite_ref-108">^</a></b></span> <span><cite id="CITEREFRay2012">Ray K (26 February 2012). "India wins battle against dreaded polio". <i>Deccan Herald</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Deccan+Herald&amp;rft.atitle=India+wins+battle+against+dreaded+polio&amp;rft.date=2012-02-26&amp;rft.aulast=Ray&amp;rft.aufirst=Kalyan&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-109"><span><b><a href="#cite_ref-109">^</a></b></span> <span><cite><a rel="nofollow" href="http://www.telegraphindia.com/1120226/jsp/frontpage/story_15181357.jsp">"India polio-free for a year: 'First time in history we're able to put up such a map'<span></span>"</a>. <i>The Telegraph</i>. 26 February 2012. <a rel="nofollow" href="https://web.archive.org/web/20120227220101/http://www.telegraphindia.com/1120226/jsp/frontpage/story_15181357.jsp">Archived</a> from the original on 27 February 2012<span>. Retrieved <span>26 February</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Telegraph&amp;rft.atitle=India+polio-free+for+a+year%3A+%27First+time+in+history+we%27re+able+to+put+up+such+a+map%27&amp;rft.date=2012-02-26&amp;rft_id=http%3A%2F%2Fwww.telegraphindia.com%2F1120226%2Fjsp%2Ffrontpage%2Fstory_15181357.jsp&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-110"><span><b><a href="#cite_ref-110">^</a></b></span> <span><cite><a rel="nofollow" href="https://web.archive.org/web/20170301051406/http://www.searo.who.int/entity/immunization/topics/polio/en/">"India three years polio-free"</a>. <i><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO)</i>. Archived from <a rel="nofollow" href="http://www.searo.who.int/entity/immunization/topics/polio/en/">the original</a> on 1 March 2017<span>. Retrieved <span>19 February</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization+%28WHO%29&amp;rft.atitle=India+three+years+polio-free&amp;rft_id=http%3A%2F%2Fwww.searo.who.int%2Fentity%2Fimmunization%2Ftopics%2Fpolio%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-111"><span><b><a href="#cite_ref-111">^</a></b></span> <span><cite id="CITEREFBarron2013">Barron L (4 November 2013). <a rel="nofollow" href="https://web.archive.org/web/20131219024041/http://cistranfinance.com/news/armenian-health-ministry-urges-syrian-armenian-children-to-get-polio-vaccine/666/">"Armenian Health Ministry: Syrian Armenian children need polio vaccine"</a>. <i>CISTran Finance</i>. Archived from <a rel="nofollow" href="http://cistranfinance.com/news/armenian-health-ministry-urges-syrian-armenian-children-to-get-polio-vaccine/666/">the original</a> on 19 December 2013<span>. Retrieved <span>18 December</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CISTran+Finance&amp;rft.atitle=Armenian+Health+Ministry%3A+Syrian+Armenian+children+need+polio+vaccine&amp;rft.date=2013-11-04&amp;rft.aulast=Barron&amp;rft.aufirst=Lisa&amp;rft_id=http%3A%2F%2Fcistranfinance.com%2Fnews%2Farmenian-health-ministry-urges-syrian-armenian-children-to-get-polio-vaccine%2F666%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-DarrasJr.2014-112"><span><b><a href="#cite_ref-DarrasJr.2014_112-0">^</a></b></span> <span><cite id="CITEREFDe_VivoRyanJonesDarras2014">De Vivo DC, Ryan MM, Jones HR, Darras BT (2014). <a rel="nofollow" href="https://books.google.com/books?id=JlECBAAAQBAJ&amp;pg=PA161"><i>Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach</i></a>. Elsevier Science. p.&nbsp;161. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0-12-417127-5" title="Special:BookSources/978-0-12-417127-5"><bdi>978-0-12-417127-5</bdi></a>. <a rel="nofollow" href="https://web.archive.org/web/20170423222313/https://books.google.com/books?id=JlECBAAAQBAJ&amp;pg=PA161">Archived</a> from the original on 23 April 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Neuromuscular+Disorders+of+Infancy%2C+Childhood%2C+and+Adolescence%3A+A+Clinician%27s+Approach&amp;rft.pages=161&amp;rft.pub=Elsevier+Science&amp;rft.date=2014&amp;rft.isbn=978-0-12-417127-5&amp;rft.aulast=De+Vivo&amp;rft.aufirst=Darryl+C&amp;rft.au=Ryan%2C+Monique+M&amp;rft.au=Jones%2C+H+Royden&amp;rft.au=Darras%2C+Basil+T&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DJlECBAAAQBAJ%26pg%3DPA161&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-113"><span><b><a href="#cite_ref-113">^</a></b></span> <span><cite id="CITEREFCharles_Kurzman">Charles Kurzman. <i>The Missing Martyrs</i>. <a href="/wiki/Oxford_University_Press" title="Oxford University Press">Oxford University Press</a>. p.&nbsp;130. <q>Resistance to polio vaccination is a fringe position. Almost every Muslim scholar and political leader has endorsed the vaccine, and all but a few Muslim-majority countries have wiped out the disease entirely.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Missing+Martyrs&amp;rft.pages=130&amp;rft.pub=Oxford+University+Press&amp;rft.au=Charles+Kurzman&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-Pakistan-114"><span>^ <a href="#cite_ref-Pakistan_114-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pakistan_114-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://www.dailystar.com.lb/News/World/2016/Sep-11/371570-pakistan-polio-official-killed-in-peshawar-police.ashx">"Pakistan polio official killed in Peshawar: police"</a>. The Daily Star: Lebanon. 11 September 2016. <a rel="nofollow" href="https://web.archive.org/web/20160911122228/http://www.dailystar.com.lb/News/World/2016/Sep-11/371570-pakistan-polio-official-killed-in-peshawar-police.ashx">Archived</a> from the original on 11 September 2016<span>. Retrieved <span>11 September</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pakistan+polio+official+killed+in+Peshawar%3A+police&amp;rft.date=2016-09-11&amp;rft_id=https%3A%2F%2Fwww.dailystar.com.lb%2FNews%2FWorld%2F2016%2FSep-11%2F371570-pakistan-polio-official-killed-in-peshawar-police.ashx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-115"><span><b><a href="#cite_ref-115">^</a></b></span> <span><cite id="CITEREFNajafizada2015">Najafizada E (15 December 2015). <a rel="nofollow" href="https://www.bloomberg.com/news/articles/2015-12-15/taliban-join-global-effort-to-kill-off-polio-in-2016">"Taliban Join Global Effort to Kill Off Polio in 2016"</a>. <i>Bloomberg.com</i>. <a rel="nofollow" href="https://web.archive.org/web/20170228052344/https://www.bloomberg.com/news/articles/2015-12-15/taliban-join-global-effort-to-kill-off-polio-in-2016">Archived</a> from the original on 28 February 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg.com&amp;rft.atitle=Taliban+Join+Global+Effort+to+Kill+Off+Polio+in+2016&amp;rft.date=2015-12-15&amp;rft.aulast=Najafizada&amp;rft.aufirst=Eltaf&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2015-12-15%2Ftaliban-join-global-effort-to-kill-off-polio-in-2016&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-116"><span><b><a href="#cite_ref-116">^</a></b></span> <span><cite id="CITEREFKonopka-AnstadtCampagnoliVincentShaw2020">Konopka-Anstadt, Jennifer L.; Campagnoli, Ray; Vincent, Annelet; Shaw, Jing; Wei, Ling; Wynn, Nhien T.; Smithee, Shane E.; Bujaki, Erika; Te Yeh, Ming; Laassri, Majid; Zagorodnyaya, Tatiana (20 March 2020). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7083942">"Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization"</a>. <i>NPJ Vaccines</i>. <b>5</b> (1): 26. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1038%2Fs41541-020-0176-7">10.1038/s41541-020-0176-7</a>. <a href="/wiki/ISSN_(identifier)" title="ISSN (identifier)">ISSN</a>&nbsp;<a rel="nofollow" href="//www.worldcat.org/issn/2059-0105">2059-0105</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7083942">7083942</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/32218998">32218998</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NPJ+Vaccines&amp;rft.atitle=Development+of+a+new+oral+poliovirus+vaccine+for+the+eradication+end+game+using+codon+deoptimization&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=26&amp;rft.date=2020-03-20&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7083942%23id-name%3DPMC&amp;rft.issn=2059-0105&amp;rft_id=info%3Apmid%2F32218998&amp;rft_id=info%3Adoi%2F10.1038%2Fs41541-020-0176-7&amp;rft.aulast=Konopka-Anstadt&amp;rft.aufirst=Jennifer+L.&amp;rft.au=Campagnoli%2C+Ray&amp;rft.au=Vincent%2C+Annelet&amp;rft.au=Shaw%2C+Jing&amp;rft.au=Wei%2C+Ling&amp;rft.au=Wynn%2C+Nhien+T.&amp;rft.au=Smithee%2C+Shane+E.&amp;rft.au=Bujaki%2C+Erika&amp;rft.au=Te+Yeh%2C+Ming&amp;rft.au=Laassri%2C+Majid&amp;rft.au=Zagorodnyaya%2C+Tatiana&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7083942&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-WHO_Travel_and_Health-117"><span><b><a href="#cite_ref-WHO_Travel_and_Health_117-0">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.who.int/ith/CHAPTER_6_For_Publication.pdf">"International Travel and Health. Chapter 6 – Vaccine-preventable diseases and vaccines (2019 update)"</a> <span>(PDF)</span>. <i>World Health Organization</i>. United Nations. 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization&amp;rft.atitle=International+Travel+and+Health.+Chapter+6+%E2%80%93+Vaccine-preventable+diseases+and+vaccines+%282019+update%29&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fith%2FCHAPTER_6_For_Publication.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-WHO_country_list-118"><span>^ <a href="#cite_ref-WHO_country_list_118-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WHO_country_list_118-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-WHO_country_list_118-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-WHO_country_list_118-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-WHO_country_list_118-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-WHO_country_list_118-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-WHO_country_list_118-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-WHO_country_list_118-7"><sup><i><b>h</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://www.who.int/publications/m/item/countries-with-risk-of-yellow-fever-transmission-and-countries-requiring-yellow-fever-vaccination-(july-2019)">"Countries with risk of yellow fever transmission and countries requiring yellow fever vaccination (July 2019)"</a>. <i>World Health Organization</i>. United Nations. 4 July 2019<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization&amp;rft.atitle=Countries+with+risk+of+yellow+fever+transmission+and+countries+requiring+yellow+fever+vaccination+%28July+2019%29&amp;rft.date=2019-07-04&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fpublications%2Fm%2Fitem%2Fcountries-with-risk-of-yellow-fever-transmission-and-countries-requiring-yellow-fever-vaccination-%28july-2019%29&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-:9-119"><span><b><a href="#cite_ref-:9_119-0">^</a></b></span> <span><cite id="CITEREFScherbel-Ball2020">Scherbel-Ball, Naomi (25 August 2020). <a rel="nofollow" href="https://www.bbc.com/news/world-africa-53887947">"Africa declared free of polio"</a>. <i>BBC News</i>. <a rel="nofollow" href="https://web.archive.org/web/20200826154956/https://www.bbc.com/news/world-africa-53887947">Archived</a> from the original on 26 August 2020<span>. Retrieved <span>25 August</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Africa+declared+free+of+polio&amp;rft.date=2020-08-25&amp;rft.aulast=Scherbel-Ball&amp;rft.aufirst=Naomi&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fworld-africa-53887947&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-120"><span><b><a href="#cite_ref-120">^</a></b></span> <span><cite><a rel="nofollow" href="http://polioeradication.org/where-we-work/key-at-risk-countries/">"Key At-Risk Countries"</a>. <i>Global Polio Eradication Initiative</i>. World Health Organization<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Global+Polio+Eradication+Initiative&amp;rft.atitle=Key+At-Risk+Countries&amp;rft_id=http%3A%2F%2Fpolioeradication.org%2Fwhere-we-work%2Fkey-at-risk-countries%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-121"><span><b><a href="#cite_ref-121">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/afghanistan/risk/polio">"Afghanistan Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 1 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Afghanistan+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-01&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fafghanistan%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-122"><span><b><a href="#cite_ref-122">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/belize/risk/polio">"Belize Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Belize+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fbelize%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-123"><span><b><a href="#cite_ref-123">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/brunei-darussalam/risk/polio">"Brunei Darussalam Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Brunei+Darussalam+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fbrunei-darussalam%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-124"><span><b><a href="#cite_ref-124">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/egypt/risk/polio">"Egypt Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Egypt+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fegypt%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-125"><span><b><a href="#cite_ref-125">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/georgia/risk/polio">"Georgia Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Georgia+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fgeorgia%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-126"><span><b><a href="#cite_ref-126">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/india/risk/polio">"India Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=India+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Findia%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-127"><span><b><a href="#cite_ref-127">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/iran/risk/polio">"Iran Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Iran+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Firan%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-128"><span><b><a href="#cite_ref-128">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/iraq/risk/polio">"Iraq Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Iraq+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Firaq%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-129"><span><b><a href="#cite_ref-129">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/jordan/risk/polio">"Jordan Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Jordan+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fjordan%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-130"><span><b><a href="#cite_ref-130">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/lebanon/risk/polio">"Lebanon Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Lebanon+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Flebanon%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-131"><span><b><a href="#cite_ref-131">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/libya/risk/polio">"Libya Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Libya+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Flibya%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-132"><span><b><a href="#cite_ref-132">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/maldives/risk/polio">"Maldives Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Maldives+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fmaldives%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-133"><span><b><a href="#cite_ref-133">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/morocco/risk/polio">"Morocco Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Morocco+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fmorocco%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-134"><span><b><a href="#cite_ref-134">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/nepal/risk/polio">"Nepal Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Nepal+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fnepal%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-135"><span><b><a href="#cite_ref-135">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/oman/risk/polio">"Oman Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Oman+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Foman%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-136"><span><b><a href="#cite_ref-136">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/pakistan/risk/polio">"Pakistan Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Pakistan+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fpakistan%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-137"><span><b><a href="#cite_ref-137">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/philippines/risk/polio">"Philippines Recommended Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Philippines+Recommended+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fphilippines%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-138"><span><b><a href="#cite_ref-138">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/qatar/risk/polio">"Qatar Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Qatar+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fqatar%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-139"><span><b><a href="#cite_ref-139">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/saint-kitts-and-nevis/risk/polio">"Saint Kitts &amp; Nevis Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Saint+Kitts+%26+Nevis+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fsaint-kitts-and-nevis%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-140"><span><b><a href="#cite_ref-140">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/saudi-arabia/risk/polio">"Saudi Arabia Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Saudi+Arabia+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fsaudi-arabia%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-141"><span><b><a href="#cite_ref-141">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/seychelles/risk/polio">"Seychelles Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Seychelles+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fseychelles%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-142"><span><b><a href="#cite_ref-142">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/syria/risk/polio">"Syria Required Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Syria+Required+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fsyria%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-143"><span><b><a href="#cite_ref-143">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.iamat.org/country/ukraine/risk/polio">"Ukraine Recommended Vaccinations: Polio"</a>. <i>iamat.org</i>. International Association for Medical Assistance to Travellers (IAMAT). 23 October 2020<span>. Retrieved <span>2 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=iamat.org&amp;rft.atitle=Ukraine+Recommended+Vaccinations%3A+Polio&amp;rft.date=2020-10-23&amp;rft_id=https%3A%2F%2Fwww.iamat.org%2Fcountry%2Fukraine%2Frisk%2Fpolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-144"><span><b><a href="#cite_ref-144">^</a></b></span> <span><cite><a rel="nofollow" href="https://web.archive.org/web/20150411021753/http://www.polioeradication.org/Mediaroom/Newsstories(old)/Newsstories2013/tabid/488/iid/354/Default.aspx">"Availability and price of inactivated polio vaccine"</a>. <i>The Global Polio Eradication Initiative</i>. Archived from <a rel="nofollow" href="http://www.polioeradication.org/Mediaroom/Newsstories(old)/Newsstories2013/tabid/488/iid/354/Default.aspx#sthash.jGhJ4YUB.dpuf">the original</a> on 11 April 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Global+Polio+Eradication+Initiative&amp;rft.atitle=Availability+and+price+of+inactivated+polio+vaccine&amp;rft_id=http%3A%2F%2Fwww.polioeradication.org%2FMediaroom%2FNewsstories%28old%29%2FNewsstories2013%2Ftabid%2F488%2Fiid%2F354%2FDefault.aspx%23sthash.jGhJ4YUB.dpuf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-145"><span><b><a href="#cite_ref-145">^</a></b></span> <span><cite><a rel="nofollow" href="http://news.bbc.co.uk/2/hi/south_asia/6299325.stm">"Impotence fears hit polio drive"</a>. <i>BBC News Online</i>. 25 January 2007. <a rel="nofollow" href="https://web.archive.org/web/20151009221811/http://news.bbc.co.uk/2/hi/south_asia/6299325.stm">Archived</a> from the original on 9 October 2015<span>. Retrieved <span>15 December</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News+Online&amp;rft.atitle=Impotence+fears+hit+polio+drive&amp;rft.date=2007-01-25&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fsouth_asia%2F6299325.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
<li id="cite_note-146"><span><b><a href="#cite_ref-146">^</a></b></span> <span><cite id="CITEREFJunaidi2015">Junaidi I (14 January 2015). <a rel="nofollow" href="http://www.dawn.com/news/1156931">"Lab tests show polio vaccine is not 'Haram'<span></span>"</a>. <i>dawn.com</i>. <a rel="nofollow" href="https://web.archive.org/web/20151222173149/http://www.dawn.com/news/1156931">Archived</a> from the original on 22 December 2015<span>. Retrieved <span>15 December</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=dawn.com&amp;rft.atitle=Lab+tests+show+polio+vaccine+is+not+%27Haram%27&amp;rft.date=2015-01-14&amp;rft.aulast=Junaidi&amp;rft.aufirst=Ikram&amp;rft_id=http%3A%2F%2Fwww.dawn.com%2Fnews%2F1156931&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></span>
</li>
</ol></div>
<h2><span id="Further_reading">Further reading</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=31" title="Edit section: Further reading">edit</a><span>]</span></span></h2>
<ul><li><cite id="CITEREFRamsay2013">Ramsay M, ed. (2013). <a rel="nofollow" href="https://www.gov.uk/government/publications/polio-the-green-book-chapter-26">"Polio: the green book, chapter 26"</a>. <a rel="nofollow" href="https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book"><i>Immunisation against infectious disease</i></a>. London: Public Health England.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Polio%3A+the+green+book%2C+chapter+26&amp;rft.btitle=Immunisation+against+infectious+disease&amp;rft.place=London&amp;rft.pub=Public+Health+England&amp;rft.date=2013&amp;rft_id=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fpolio-the-green-book-chapter-26&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></li>
<li><cite id="CITEREFWallaceAlexander2015">Wallace G, Alexander J (2015). <a rel="nofollow" href="https://www.cdc.gov/vaccines/pubs/pinkbook/polio.html">"Chapter 18: Poliomyelitis"</a>.  In Hamborsky J, Kroger A, Wolfe S (eds.). <a rel="nofollow" href="https://www.cdc.gov/vaccines/pubs/pinkbook/index.html"><i>Epidemiology and Prevention of Vaccine-Preventable Diseases</i></a> (13th&nbsp;ed.). Washington D.C.: U.S. <a href="/wiki/Centers_for_Disease_Control_and_Prevention" title="Centers for Disease Control and Prevention">Centers for Disease Control and Prevention</a> (CDC). <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0990449119" title="Special:BookSources/978-0990449119"><bdi>978-0990449119</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+18%3A+Poliomyelitis&amp;rft.btitle=Epidemiology+and+Prevention+of+Vaccine-Preventable+Diseases&amp;rft.place=Washington+D.C.&amp;rft.edition=13th&amp;rft.pub=U.S.+Centers+for+Disease+Control+and+Prevention+%28CDC%29&amp;rft.date=2015&amp;rft.isbn=978-0990449119&amp;rft.aulast=Wallace&amp;rft.aufirst=G&amp;rft.au=Alexander%2C+J&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fpubs%2Fpinkbook%2Fpolio.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></li>
<li><cite id="CITEREFRouthOberstePatel2018">Routh JA, Oberste MS, Patel M (2018). <a rel="nofollow" href="https://www.cdc.gov/vaccines/pubs/surv-manual/chpt12-polio.html">"Chapter 12: Poliomyelitis"</a>.  In Roush SW, Baldy LM, Hall MH (eds.). <a rel="nofollow" href="https://www.cdc.gov/vaccines/pubs/surv-manual/"><i>Manual for the surveillance of vaccine-preventable diseases</i></a>. Atlanta, Georgia: U.S. <a href="/wiki/Centers_for_Disease_Control_and_Prevention" title="Centers for Disease Control and Prevention">Centers for Disease Control and Prevention</a> (CDC).</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+12%3A+Poliomyelitis&amp;rft.btitle=Manual+for+the+surveillance+of+vaccine-preventable+diseases&amp;rft.place=Atlanta%2C+Georgia&amp;rft.pub=U.S.+Centers+for+Disease+Control+and+Prevention+%28CDC%29&amp;rft.date=2018&amp;rft.aulast=Routh&amp;rft.aufirst=JA&amp;rft.au=Oberste%2C+MS&amp;rft.au=Patel%2C+M&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fpubs%2Fsurv-manual%2Fchpt12-polio.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></li></ul>
<h2><span id="External_links">External links</span><span><span>[</span><a href="/w/index.php?title=Polio_vaccine&amp;action=edit&amp;section=32" title="Edit section: External links">edit</a><span>]</span></span></h2>
<ul><li><cite><a rel="nofollow" href="https://www.cdc.gov/vaccines/hcp/vis/vis-statements/ipv.html">"Polio Vaccine Information Statement"</a>. <i><a href="/wiki/Centers_for_Disease_Control_and_Prevention" title="Centers for Disease Control and Prevention">Centers for Disease Control and Prevention</a> (CDC)</i>. 10 August 2021.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Centers+for+Disease+Control+and+Prevention+%28CDC%29&amp;rft.atitle=Polio+Vaccine+Information+Statement&amp;rft.date=2021-08-10&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fhcp%2Fvis%2Fvis-statements%2Fipv.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></li>
<li><a rel="nofollow" href="https://www.historyofvaccines.org/content/timelines/polio">History of Vaccines Website – History of Polio</a> History of Vaccines, a project of the <a href="/wiki/College_of_Physicians_of_Philadelphia" title="College of Physicians of Philadelphia">College of Physicians of Philadelphia</a></li>
<li><a rel="nofollow" href="https://www.pbs.org/wgbh/aso/databank/entries/dm52sa.html">PBS.org</a> – 'People and Discoveries: Salk Produces Polio Vaccine 1952', <a href="/wiki/Public_Broadcasting_Service" title="Public Broadcasting Service">Public Broadcasting Service</a> (PBS)</li>
<li><cite><a rel="nofollow" href="https://www.fda.gov/vaccines-blood-biologics/vaccines/ipol-poliovirus-vaccine-inactivated-monkey-kidney-cell">"IPOL – Poliovirus Vaccine Inactivated (Monkey Kidney Cell)"</a>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>. 11 December 2019. STN: 103930.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.atitle=IPOL+%E2%80%93+Poliovirus+Vaccine+Inactivated+%28Monkey+Kidney+Cell%29&amp;rft.date=2019-12-11&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fvaccines-blood-biologics%2Fvaccines%2Fipol-poliovirus-vaccine-inactivated-monkey-kidney-cell&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolio+vaccine"></span></li>
<li><a rel="nofollow" href="https://meshb.nlm.nih.gov/record/ui?name=Poliovirus%20Vaccines">Poliovirus Vaccines</a> at the US National Library of Medicine <a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">Medical Subject Headings</a> (MeSH)</li></ul>



<!-- 
NewPP limit report
Parsed by mw1451
Cached time: 20220406122450
Cache expiry: 1814400
Reduced expiry: false
Complications: [vary‐revision‐sha1]
CPU time usage: 2.441 seconds
Real time usage: 2.718 seconds
Preprocessor visited node count: 14504/1000000
Post‐expand include size: 359099/2097152 bytes
Template argument size: 10950/2097152 bytes
Highest expansion depth: 20/100
Expensive parser function count: 10/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 480836/5000000 bytes
Lua time usage: 1.211/10.000 seconds
Lua memory usage: 10292102/52428800 bytes
Lua Profile:
    ?                                                                260 ms       18.3%
    <mw.lua:690>                                                     160 ms       11.3%
    Scribunto_LuaSandboxCallback::callParserFunction                 140 ms        9.9%
    Scribunto_LuaSandboxCallback::sub                                120 ms        8.5%
    Scribunto_LuaSandboxCallback::preprocess                          80 ms        5.6%
    recursiveClone <mwInit.lua:41>                                    80 ms        5.6%
    Scribunto_LuaSandboxCallback::match                               60 ms        4.2%
    Scribunto_LuaSandboxCallback::gsub                                60 ms        4.2%
    select_one <Module:Citation/CS1/Utilities:426>                    60 ms        4.2%
    dataWrapper <mw.lua:668>                                          60 ms        4.2%
    [others]                                                         340 ms       23.9%
Number of Wikibase entities loaded: 1/400
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 2322.021      1 -total
 53.92% 1252.088      1 Template:Reflist
 16.62%  385.808     45 Template:Cite_journal
 14.56%  338.098      1 Template:Drugbox
 14.54%  337.556     65 Template:Cite_web
  9.79%  227.394      1 Template:Infobox
  5.04%  117.058     21 Template:Cite_book
  3.84%   89.117      1 Template:Vaccines
  3.60%   83.567      3 Template:Page_needed
  3.43%   79.643      1 Template:USD
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:192198-0!canonical and timestamp 20220406122447 and revision id 1078787729. Serialized with JSON.
 -->
</div></div>
                
                </main>
                <footer>

                </footer>
            </div>
            <!--[if !IE]><script>fixScale(document);</script><![endif]-->
        </body>
    </html>
